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PEMBANGUNAN ASAI TINDAK BALAS RANTAI POLYMERASE TAHAN 
HABA DENGAN PELBAGAI SASARAN BAGI MENGESAN PATOGEN 
YANG MENYEBABKAN DEMAM 
 
ABSTRAK 
 
Sehingga kini, terdapat beberapa ujian molekular untuk mengesan penyakit 
kencing tikus, melioidosis, salmonellosis invasif dan malaria. Ujian-ujian ini 
membolehkan pengesanan awal asid nukleik patogen, seterusnya berpotensi menjadi 
alternatif kepada ujian-ujian sedia ada seperti kaedah kultur (pembiakan patogen 
dalam media tiruan), serologi dan pemeriksaan mikroskopik. Walaubagaimanapun, 
sebilangan besar ujian-ujian molekular ini tidak mempunyai kawalan kualiti 
amplifikasi dalaman (IAC), tidak mematuhi garis panduan MIQE dan biasanya hanya 
dapat mengesan satu jenis patogen sahaja. Untuk menangani kekangan-kekangan 
tersebut, kajian ini menyasarkan untuk membangunkan satu asai (ujian) molekular 
menggunakan pentas ‗probe hidrolis TaqMan‘ bagi tujuan pengesanan asid 
deoksiribonukleik dari empat jenis patogen (iaitu Leptospira, B. pseudomallei, 
Salmonella and Plasmodium) berserta  IAC dalam satu tiub. Untuk mencapai tujuan 
tersebut, empat pasang primer pencetus dan empat ‗probe hidrolis TaqMan‘ telah 
direka untuk mengesan patogen Leptospira, B. pseudomallei, Salmonella and 
Plasmodium. Primer-primer pencetus ini mengandungi penyesuai (UN-adapter) dan 
primer UN untuk menambahkan lagi kadar sensitiviti asai ini. Selain itu, sepasang 
primer pencetus dan probe tambahan turut direka untuk tujuan kawalan kualiti 
amplifikasi dalaman (IAC). IAC yang digunakan adalah gabungan antara gen rpoB 
daripada bakteria batuk kering dan juga gen HLY5mc1 daripada patogen Entamoeba 
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histolytica. Selepas itu, prestasi asai ini divalidasi selaras dengan garis panduan 
MIQE. Kemampuan analitikal asai ini diuji dengan asid deoksiribonukleik dari 
empat jenis patogen utama yang dilarutkan sebanyak 10 kali ganda, dalam beberapa 
siri. Selain itu juga, kekhususan asai ini diuji terhadap 357 patogen, antaranya 131 
patogen Leptospira, 105 patogen B. pseudomallei, 44 patogen Salmonella, 31 
patogen Plasmodium  dan 46 lain-lain patogen. Tambahan lagi, kestabilan asai ini 
pada beberapa suhu dan prestasinya terhadap 518 sampel pesakit turut dinilai. Dalam 
kajian ini, adalah didapati bahawa asai yang dibangunkan berjaya mengenalpasti 
patogen Leptospira, B. pseudomallei, Salmonella dan Plasmodium pada kadar 
serendah  5.61 salinan, 8.24 salinan, 19.3 salinan dan 18.1 salinan DNA bagi setiap 
ujian. Tiada signal meragukan dikesan pada patogen-patogen yang lain. Selain itu, 
penilaian klinikal menggunakan 518 sampel pesakit menunjukkan bahawa asai ini 
mempunyai kadar sensitiviti yang sempurna (100%) dan kadar spesifisiti yang tinggi 
(98.8% – 100%). Tiada tanda-tanda perencatan PCR ditemui dalam sampel yang 
digunakan. Tambahan lagi, ujian kestabilan asai kering dengan kehadiran 5% gula 
trehalos menunjukan bahawa asai ini masih lagi stabil selepas 84.7 hari, pada suhu 
bilik. Kesimpulannya, kajian ini berjaya membangunkan asai molekular yang sensitif 
dan khusus bagi mengesan patogen penyebab deman kencing tikus, melioidosis, 
invasif salmonellosis dan malaria. 
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DEVELOPMENT OF THERMOSTABLE MULTIPLEX qPCR FOR 
SIMULTANEOUS DETECTION OF PATHOGENS ASSOCIATED WITH 
FEBRILE ILLNESSES 
 
ABSTRACT 
 
To date, several molecular assays are available for the diagnosis of 
leptospirosis, melioidosis, invasive salmonellosis and malaria. These reported assays 
allow early detection of pathogens nucleic acids; hence serve as potential alternatives 
to the conventional methods including culture, serology and microscopic 
examination. However, majority of the reported molecular assays lack of internal 
amplification control (IAC), do not adhere to the MIQE guidelines and usually detect 
a single organism. To address these major limitations of current molecular assays, 
this study is aimed to develop a multiplex TaqMan hydrolysis probe-based qPCR 
that can detect nucleic acids of four different organisms (Leptospira, B. 
pseudomallei, Salmonella and Plasmodium) and an IAC within a single reaction. To 
achieve these objectives, four pairs of primers and four TaqMan hydrolysis probes 
were designed against Leptospira, B. pseudomallei, Salmonella and Plasmodium 
genomes. These primer pairs were conjugated with a universal adapter (UN-adapter) 
and combined with UN primers in order to increase the performance of the assay. In 
addition, another pair of primers and probe against Mycobacterium tuberculosis rpoB 
gene and Entamoeba histolytica HLY5mc1 gene was also developed as IAC tool. 
Validation of the assay was performed according to the MIQE guidelines. First, 
analytical sensitivity of the multiplex qPCR assay was evaluated on 10-fold serial 
dilutions of genomic DNA from each microbial target, as well as its specificity on 
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357 microbial isolates, made up of 131 Leptospira isolates, 105 B. pseudomallei 
isolates, 44 Salmonella isolates, 31 Plasmodium strains and 46 other organisms. 
Following stability testing at different temperatures, the clinical performance of the 
qPCR assay was evaluated on 518 retrospective specimens from suspected patients. 
In this study, it was found that the developed multiplex qPCR assay correctly 
amplified and differentiated all Leptospira, B. pseudomallei, Salmonella and 
Plasmodium isolates, with limit of detections (LODs) of 5.61 copies, 8.24 copies, 
19.3 copies and 18.1 copies per reaction, respectively. No undesired amplification 
was observed in other tested organisms. Similarly, the clinical evaluation showed 
that the qPCR assays had clinical sensitivities of 100% and clinical specificities of 
between 98.8% and 100%. No evidence of PCR inhibition was observed. In terms of 
stability, in the presence of 5% trehalose, the lyophilised qPCR mix had an estimated 
shelf-life of 84.7 days, at ambient temperature. Overall, this study successfully 
developed a multiplex qPCR assay for early detection of four common febrile 
causing infections, in particular leptospirosis, melioidosis, invasive salmonellosis and 
malaria, at high sensitivity and specificity, both analytically and clinically. 
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CHAPTER 1 
INTRODUCTION 
 
1.1 Leptospira and leptospirosis 
Leptospira, a causative organism of leptospirosis was first observed in 1907 
by A.M. Stimson from a kidney specimen of a deceased patient (Stimson, 1907). The 
organism was then called Spirocheta interrogans. In July 1913, a Japanese group led 
by Inada successfully isolated Leptospira from guinea-pigs injected with the blood of 
suspected patients. The organism was named Spirochaeta icterohaemorrhagiae 
(Inada et al., 1916). Approximately a year after the Inada‘s discovery, another two 
independent German groups successfully propagated Leptospira from the same 
animal host and named the organism as Spirochaeta nodosa and Spirochaeta 
icterogenes, respectively (Sellards, 1940).   
 
1.1.1 Biology of Leptospira and cultivation 
Leptospira spirochetes are thin and helical in shape, with a diameter of 0.1 to 
0.3 µm and a length of 6 – 20 µm. The spirochetes usually have pointed ends that 
resemble a distinctive hook, at either or both poles. At both poles of the bacteria is a 
pair of endoflagella (also known as periplasmic flagella) that gives motility to this 
organism (Johnson, 2018). 
This bacterium is cultivatable aerobically in artificial media enriched with 
several essential supplements. Among the important nutritional requirements is the 
fatty acid that acts as carbon and energy source to Leptospira. Unlike L. biflexa, the 
pathogenic L. interrogans can only metabolise long chain (>C15) unsaturated fatty 
acids (Cameron, 2015). At high concentration, this essential carbon-energy source, 
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however, can be toxic to Leptospira. Therefore, the artificial growth medium must 
also contain detoxicants such as bovine serum albumin (BSA) or sorbitol-fatty acid 
complexes that promote slow release of fatty acid or serves as a non-toxic form of 
fatty acid source (Mythri, 2016). Other important supplements include ammonium 
ions, thiamin, cobalamin, biotin, iron and some salts. In addition, Leptospira grows 
optimally at slightly alkaline pH of 7.2–7.6 (Cameron, 2015). 
The most commonly used medium is Ellinghausen-McCullough-Johnson-
Harris (EMJH) medium. The liquid or semisolid EMJH (contain additional agar) 
medium is incubated at a temperature ranging between 28 and 30 °C (Samir and 
Wasfy, 2013). Unlike the saprophytic group, the growth of most pathogenic strains 
of Leptospira is inhibited at lower temperature, 11–13 °C. The growth of leptospires 
in the artificial medium can be monitored under the dark field microscope or 
predicted by the presence of Dinger‘s ring, located close to the bottom of the medium 
tube (Nally et al., 2018). In terms of doubling time, the growth rate of Leptospira 
depends on the passage and strains. Generally, Leptospira growth rate on primary 
isolation is often slower than a pure subculture. Therefore, during clinical diagnostic, 
the culture medium is incubated for up to 13 weeks before being discarded (Sayyed 
Mousavi et al., 2017).  
In addition, saprophytic Leptospira grow faster than the pathogenic 
counterparts, with maximal growth after 2 – 3 days versus 4 – 7 days, respectively. 
In terms of generation time, the pathogenic group grows slower (~20 hours) in 
contrast to the saprophytic group that replicates more rapidly, approximately 5 hours 
(WHO, 2013). This observation may due to the ability of the saprophytic group to 
synthesise many essential metabolites such as purines and pyrimidines, as well as its 
resistance in the environment (Cameron, 2015).  Based on these unique cellular 
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metabolisms, both pathogenic (L. interrogans sensu lato) and saprophytic (L. biflexa 
sensu lato) groups can be differentiated based on the nutritional requirement. For 
instance, in the presence of 8-azaguanine, a purine analogue, the growth of 
pathogenic group is inhibited, unlike the latter group that is resistant to the 
supplement (Musso et al., 2013).  
 
1.1.2 Classification and taxonomy 
The current genus name was proposed by Noguchi, in 1918, to discriminate 
Leptospira from other spirochetes such as Treponema pallidum and Spironema 
recurrentis. This genus belongs to Spirochaetes phylum, Spirochaetales order and 
family of Leptospiraceae. Historically, species name was given based on each new 
serovar isolated, such as Leptospira pomona and Leptospira canicola. However, in 
1982, this genus was separated into two species, Leptospira interrogans sensu lato 
and L. biflexa sensu lato based on its pathogenicity (M. Picardeau, 2012).  
With the availability of DNA–DNA hybridization and genome sequencing, 
modern Leptospira genus are speciated according to their DNA relatedness (Levett, 
2015). Extensive molecular and phylogenetic analyses revealed that there is a total of 
35 distinctive species belong to the Leptospira genus, comprised of 13 pathogenic 
species, 11 intermediate species and remaining 11 saprophytic species (Bourhy et al., 
2014; Brenner et al., 1999; Faine and Stallman, 1982; Matthias et al., 2008; Puche et 
al., 2017; L. Smythe et al., 2013; Yasuda et al., 1987). In 2018 alone, 13 new 
leptospiral species were described (Thibeaux et al., 2018). Details of the latest 
Leptospira species are listed in Table  1.1. 
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In addition, Leptospira is also concurrently classified into different serovars, 
based on their antigenic relatedness, using cross agglutination absorption test 
(CAAT). This test is cumbersome and laborious due to the stringent requirement of 
rabbit immune sera that need to be prepared and maintained (Mgode et al., 2015). 
Each serovar contains different carbohydrate component of the outer membrane 
lipopolysaccharide (LPS). To date, more than 250 serovars have been described. 
Related serovars are clustered into serogroups and identified using the 
microagglutination test (MAT). In the clinical application, serological typing of 
Leptospira poses limited usefulness for early detection of clinical leptospirosis 
(Sayyed Mousavi et al., 2017). However, MAT is significant in epidemiological 
research and disease surveillance (Jorge et al., 2017).  
Yet, these molecular and serology classification systems do not correlate well 
with each another. It is because a given serogroup or serovar may present across 
several Leptospira species (David A Haake and Levett, 2015). For example, 26 
described serovars of the Tarassovi serogroup are found in L. alexanderi (n = 1), L. 
borgpetersenii (n = 7), L.  kmetyi (n = 1), L. santarosai (n = 11), L. weilii (n = 4), L.  
inadai (n = 1) and one unknown species. Similarly, 20 serovars within 
Icterohaemorrhagiae serogroup are found in L. interrogans (n = 10), L. 
borgpetersenii (n = 1), L. kirschneri (n = 6), L. terpstrae (n = 1) and two unknown 
species. The poor relationship between molecular and serotyping classification may 
due to potential horizontal gene transfer between the leptospiral species (Cerqueira 
and Picardeau, 2009).  
Remarkably, approximately 90% of the described serovars belong to the 
pathogenic group of Leptospira, which is significant to human infections. Of this 
pathogenic group, 150 serovars belong to L. interrogans, Leptospira santarosai and 
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L. borgpetersenii. Meanwhile, the remaining 27 serovars belong to the intermediate 
and saprophytic groups of Leptospira which rarely isolated from human cases 
(Levett, 2015). Table  1.2 showed the distribution of serovars across the Leptospira 
genus.  
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Table ‎1.1 Latest species classification of Leptospira and their pathogenicity 
group. Adapted from Thibeaux et al. (2018) 
No Organism Group Reference 
1 Leptospira adleri 
Pathogenic 
Thibeaux et al. (2018) 
2 Leptospira alexanderi Brenner et al. (1999)  
3 Leptospira alstonii Smythe et al. (2013) 
4 Leptospira barantonii  Thibeaux et al. (2018) 
5 Leptospira borgpetersenii Yasuda et al. (1987) 
6 Leptospira ellisii  Thibeaux et al. (2018) 
7 Leptospira interrogans  Faine and Stallman (1982) 
8 Leptospira kirschneri Levett et al. (2005) 
9 Leptospira kmetyi Slack et al. (2009) 
10 Leptospira mayottensis Bourhy et al. (2014) 
11 Leptospira noguchii Yasuda et al. (1987) 
12 Leptospira santarosai Yasuda et al. (1987) 
13 Leptospira weilii Yasuda et al. (1987) 
14 Leptospira broomii 
Intermediate 
Levett et al. (2005) 
15 Leptospira fainei Levett et al. (2005) 
16 Leptospira haakeii Thibeaux et al. (2018) 
17 Leptospira hartskeerlii  Thibeaux et al. (2018) 
18 Leptospira inadai Yasuda et al. (1987) 
19 Leptospira licerasiae Matthias et al. (2008) 
20 Leptospira neocaledonica  Thibeaux et al. (2018) 
21 Leptospira perolatii  Thibeaux et al. (2018) 
22 Leptospira saintgironsiae Thibeaux et al. (2018) 
23 Leptospira venezuelensis Puche et. al. (2017) 
24 Leptospira wolffii Slack et al. (2009) 
25 Leptospira biflexa 
Saprophytic 
Faine and Stallman (1982) 
26 Leptospira brenneri Thibeaux et al. (2018) 
27 Leptospira harrisiae Thibeaux et al. (2018) 
28 Leptospira idonii Saito et al. (2013) 
29 Leptospira levettii Thibeaux et al. (2018) 
30 Leptospira macculloughii  Thibeaux et al. (2018) 
31 Leptospira meyeri Yasuda et al. (1987) 
32 Leptospira terpstrae Smythe et al. (2013) 
33 Leptospira vanthielii Smythe et al. (2013) 
34 Leptospira wolbachii Yasuda et al. (1987) 
35 Leptospira yanagawae Smythe et al. (2013) 
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Table ‎1.2 Distribution of Leptospira serovars and species. The respective 
species within the pathogenic group is shaded in red, intermediate 
group in blue and saprophytic group in green. Adapted from Levett 
(2015). 
 
 
 
 
 
  
Serogroup # serovars
Andaman 1 L.  biflexa
Australis 14 L.  borgpetersenii L.  interrogans L.  kirschneri L.  noguchii
L.  borgpetersenii L.  interrogans L.  kirschneri L.  noguchii
L.  santarosai
Ballum 7 L.  borgpetersenii L.  mayottensis L.  santarosai
Bataviae 11 L.  interrogans L.  kirschneri L.  noguchii L.  santarosai
Canicola 13 L.  interrogans L.  kirschneri
Celledoni 5 L.  borgpetersenii L.  weilii
Codice 1 L.  wolbachii
Cynopteri 2 L.  kirschneri L.  santarosai
Djasiman 6 L.  interrogans L.  kirschneri L.  noguchii
Grippotyphosa 9 L.  interrogans L.  kirschneri L.  santarosai Undetermined
L.  alexanderi L.  borgpetersenii L.  interrogans L.  kirschneri
L.  santarosai L.  idonii
Holland 1 L.  vanthielii
Hurstbridge 2 L.  broomii L.  fainei
L.  borgpetersenii L.  interrogans L.  kirschneri L.  terpstrae
Undetermined
Iquitos 1 L.  licerasiae
L.  alexanderi L.  borgpetersenii L.  santarosai L.  weilii
L.  meyeri
Louisiana 3 L.  interrogans L.  noguchii
Manhao 5 L.  alexanderi L.  weilii L.  inadai
L.  alexanderi L.  borgpetersenii L.  interrogans L.  mayottensis
L.  santarosai L.  weilii
Panama 3 L.  noguchii L.  inadai
L.  borgpetersenii L.  interrogans L.  kirschneri L.  noguchii
L.  santarosai
L.  borgpetersenii L.  interrogans L.  noguchii L.  santarosai
L.  weilii
Ranarum 3 L.  alstonii L.  interrogans L.  weilii
Sarmin 6 L.  interrogans L.  santarosai L.  weilii Undetermined
Sehgali 1 L.  interrogans 
Sejroe 22 L.  borgpetersenii L.  interrogans L.  santarosai Undetermined
Semaranga 4 L.  biflexa L.  meyeri L.  yanagawae
Shermani 5 L.  noguchii L.  santarosai L.  inadai
L.  alexanderi L.  borgpetersenii L.  kmetyi L.  santarosai
L.  weilii L.  inadai Undetermined
Undesignated 3 L.  alstonii L.  inadai L.  wolffii
Total 254
17Pyrogenes
26Tarassovi
Leptospira species
Javanica 16
10Mini
Pomona 8
Hebdomadis 13
Autumnalis 16
Icterohaemorrhagiae 20
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1.1.3 Sources of leptospirosis infections 
Rodents are considered an important animal reservoir that can continuously 
excrete Leptospira throughout their lifespan without any apparent symptoms. Among 
the most common Leptospira serovars isolated from rodents are 
Ichterohaemorrhagiae, Copenhageni, Pomona and Ballum (Andersen-Ranberg et al., 
2016). In dogs, serovar Canicola and Bratislava are more common, in contrast to 
serovar Hardjo and Sejroe that are more prevalent in cattle (Jorge et al., 2017; Nally 
et al., 2018). The prevalence of Leptospira serovars among these animal hosts, 
however, may differ by the locations (Ellis, 2015). Apart from rodents, ruminants 
and canine, Leptospira also may present in wildlife mammals such as foxes, racoons 
and skunks (Shearer et al., 2014).  
These animal reservoirs (also known as maintenance host) are the main 
source of environmental Leptospira contamination. In general, rats shed 8 × 10
8
 
leptospires cells per mL of urine, the highest concentration as compared to other 
mammals. This animal host (rodents), as well as dogs play more significant roles in 
the urban areas, in which the animal density and prevalence of carrier among host 
will increase higher dissemination of leptospires (Guernier et al., 2017). In terms of 
absolute quantity, cattle and deer excrete the biggest amount of Leptospira, 6.3 × 10
8
 
and 6.1 × 10
8
 cells, respectively due to the significantly larger volume of urine (V. 
Barragan et al., 2017). The sheer volumes of urine from large mammal provide 
consistent inoculation of Leptospira to the environment, even at low density of 
animal carrier (V. Barragan et al., 2016).   
Upon dissemination onto the environment (soils and water), the persistence of 
leptospires are affected by many physical factors. The moisture content of ˃20 % and 
approximately neutral pH (6.2 to 7.2) improve recovery of viable leptospires 
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contaminated soils (Saito et al., 2013). In freshwater, Leptospira can remain 
pathogenic and viable at low temperature, poor-nutrient and acidic conditions over at 
least 10 months (Andre-Fontaine et al., 2015). Another factor that affects the 
viability of Leptospira is the presence of environmental microbiota. Potential 
syntrophic interactions between leptospires and Sphingomonas and Azospirillum 
brasilensis improve growth and/or resistance of Leptospira to an antibiotic, increased 
temperature and UV radiation, possibly due to the formation of biofilms (V. A. 
Barragan et al., 2011; Vinod Kumar et al., 2016). 
In addition, extreme weather, such as floods and storms is also associated 
with leptospirosis outbreaks. The incidence of such water-related catastrophes 
increases dispersal and persistence of Leptospira in the environments (Cann et al., 
2013). In urban settings, floods overwhelm sewage systems and disperse 
environmental leptospires to wider areas. Meanwhile, in other circumstances, floods 
attract more peridomestic animal to readily limited spaces of dry habitat and lead to a 
higher number of infected animal hosts. Subsequently, more Leptospira is shed into 
the environments, increasing the risk of human leptospirosis (Gomes-Solecki et al., 
2017). Figure  1.1 illustrates the roles of animal reservoirs and environments to 
human leptospirosis. 
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Figure ‎1.1 Factors that contribute to human leptospirosis and the relationships 
between the incidental host (humans), natural animal reservoirs and environments. 
Adapted from Haake and Levett (2015). 
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1.1.4 Pathogenesis 
Currently, the overall pathogenesis mechanism of Leptospira remains poorly 
understood. However, the presence of several putative virulence factors, such as 
lipopolysaccharides (LPS), hemolysins and outer membrane proteins (OMPs) 
provide some possible causes of the leptospiral pathogenicity. Noticeably, many of 
these genes present only in the pathogenic Leptospira group (Adler, 2014). Table 1.3 
summarises common putative Leptospira virulence proteins associated with human 
leptospirosis. 
During entry, Leptospira bind to extracellular matrix (ECM) components of 
the hosts using several outer surface proteins such as OmpL36, OmpL37, OmpL47 
and OmpL54, also known as adhesins. These molecule complexes are capable of 
binding to the fibroblasts, renal epithelial cells and endothelial cells efficiently 
(Adler, 2014). Other accessory proteins that probably play roles in facilitating 
leptospiral adhesion include LigA, LigB and LigC. These lig-proteins resemble 
immunoglobulin-like domains and are partially exposed on the leptospiral surface 
(Mathieu Picardeau, 2015).  
Hemolysin is another virulence factor that plays important roles in 
pathogenicity of leptospirosis. This protein is able to lyse the cellular membrane of 
erythrocytes. Among the described hemolysin proteins are Tly, sphingomyelinase C 
(encoded by sphA), SphH and Sph2 (Evangelista and Coburn, 2010). Upon invasion, 
the bacteria disseminate through the blood before settling in the interstitium and 
tubular lumen of liver, renal and lung. During leptospiremia, the burden of bacteria 
can be as high as 10
6
 per ml of blood (S. B. Agampodi et al., 2012). As such, a 
concentration of more than 10
4
 per ml of blood (or ≥104 per g lung, kidney and 
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muscle) was associated with a severe form of leptospirosis (Patrick Hochedez et al., 
2015; Segura et al., 2005). 
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Table ‎1.3 Putative leptospiral proteins and its associated host components. 
Adopted from Adler (2014) and Evangelista and Coburn (2010). 
Leptospiral component Host component 
LigA, LigB ECM, fibronectin 
LigB fragment Elastin, tropoelastin 
LigB fragment Fibronectin, collagen III 
LipL32 Laminin, collagen I, collagen V 
LipL32 Fibronectin, collagen IV 
Lipl32, LIC12730, LIC10494, Plasminogen 
LMB216 expressed in L. biflexa Fibronectin 
Lp29, Lp49, LipL40, MPL36, LIC12238 Plasminogen 
Lp95 Laminin, fibronectin 
Lsa20 Laminin, plasminogen 
Lsa21 Laminin, collagen IV, fibronectin 
Lsa24 Laminin 
Lsa25, Lsa33 Laminin 
Lsa27 Laminin 
Lsa30 Plasminogen 
Lsa44, Lsa45 Laminin 
Lsa63 Laminin 
Lsa66 Fibronectin, laminin, plasminogen 
OmpL1 Fibronectin, laminin, plasminogen 
OmpL37 Elastin, fibronectin, fibrinogen, laminin 
Unidentified 36 kDa protein Fibronectin 
Viable leptospires L929 fibroblasts 
Viable leptospires Primary renal epithelial cells 
Viable leptospires L929 fibroblast ECM 
Viable leptospires Vero fibroblasts 
Viable leptospires Chondroitin sulfate B 
Viable leptospires Cadherin 
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1.1.5 Leptospirosis in human 
Exposure to contaminated environments and animal reservoirs are the two 
main sources of human leptospirosis.  Usually, Leptospira gains entrance into the 
body via cut or abrasion or via penetration through the mucous membranes of the 
conjunctivae or respiratory tract or oral cavity during occupational or recreational 
activities (De Brito et al., 2018). Following infection, the onset of disease appears on 
average between 7 and 12 days, although it can be as early as 1 day, and up to 
months (Evangelista and Coburn, 2010; David A Haake and Levett, 2015). Most 
leptospirosis cases are mild or subclinical, while some may develop into severe form 
and potentially fatal.  
During the early phase of leptospirosis, infected patients typically present 
nonspecific symptoms, especially a sudden onset of febrile illness, chills and severe 
headache. The frontal, bitemporal throbbing headache is usually accompanied by 
light sensitivity and retro-orbital pain (Toyokawa et al., 2011). These symptoms can 
be easily misidentified as influenza, melioidosis, malaria or dengue fever. Other 
common symptoms are myalgia (associated with calves and lower back) and 
conjunctival suffusion, occurred in 54.6% to 78.3% of confirmed cases (Vanasco et 
al., 2008). Meanwhile, nausea, arthralgia, sore throat, vomiting, diarrhoea and 
abdominal pain could also be reported.  
Meanwhile, severe leptospirosis involves multiple organs failures including 
liver, renal and brain. Classically, one of the most recognizable severe forms of 
leptospirosis is the Weil disease, characterised by jaundice and renal dysfunction. 
Jaundice is caused by acute hemolytic anaemia that elevates the amount of bilirubin 
in the blood and is more common in patients with glucose-6-phosphate 
dehydrogenase deficiency (Miyahara et al., 2014). Moreover, infection with certain 
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Leptospira serogroup i.e. Icterohaemorrhagiae also was associated with the elevated 
bilirubin and jaundice (Katz et al., 2001). Kidney is another important organ affected 
by leptospirosis, in which tubule-interstitial nephritis and proteinuria are commonly 
observed. In the tropical area, a severe renal complication of leptospirosis has 
become an emerging cause of chronic kidney disease among the survivors (CKD) 
(C.-W. Yang, 2018). Dry cough has been commonly reported in acute leptospirosis 
and may be confused with influenza. In 17% – 50% of leptospirosis cases, this non-
specific dry cough precedes pathological changes in alveolar septa and intra-alveolar 
spaces and potentially fatal pulmonary haemorrhage (Gulati and Gulati, 2012).  
Furthermore, severe leptospirosis manifestation may also include aseptic meningitis, 
and myocarditis, albeit at less common circumstances but are associated with an 
increased risk of death (David A Haake and Levett, 2015). 
 
1.1.6 Epidemiology 
Early epidemiological studies explored the incidence of leptospirosis in 
certain occupational groups related to domestic animals especially cattle (Benacer et 
al., 2016; Goris et al., 2013). With better availability of diagnostic tests and 
awareness, increasing numbers of institutional-based epidemiology data were 
reported worldwide. In 1999, the first global effort to determine the leptospirosis 
incidence was initiated (WHO, 1999). However, the initiative was hampered by 
limited capacity of the vast majority of countries in the establishment of effective 
notification systems. As a result, Leptospirosis Burden Epidemiology Reference 
Group (LERG) was established to develop models for the estimation of human 
leptospirosis burden via existing data and to identify technical gaps related to the 
endeavour (WHO, 2010) A year later, the LERG successfully provided the earliest 
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data on global burden of leptospirosis; a median of 5 cases per 100 000 population 
(WHO, 2011). Notably, a more recent study estimated the leptospirosis burden was 
significantly higher in tropical areas, particularly the South East Asia (55.54 cases 
per 100 000) as compared to other temperate countries (0.65 cases per 100 000) 
(Costa et al., 2015). 
In Malaysia, leptospirosis classified as a mandatory notifiable disease. 
Following the regulatory enforcement, it was found that the annual leptospirosis 
incidence rates ranged between 7.94 and 30.2 cases per 100 000 population (Abdul 
Wahab, 2015; MOH, 2016). Figure  1.2 illustrates incidence and mortality due to 
leptospirosis in Malaysia, between the year 2001 and 2017. In general, there was a 
slight increase in leptospirosis incidence, peaked in 2015. Meanwhile, the mortality 
rate coincided with the incidence, except in the year of 2011 and 2012. Of the 12 
states and 3 federal territories, Perak, Selangor, Kelantan and Pahang recorded the 
highest number of leptospirosis cases. Most of these cases were associated with the 
monsoon seasons (Benacer et al., 2016).  
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Figure ‎1.2 Leptospirosis incidence and mortality (per 100,0000 population) in 
Malaysia between 2004 and 2016 based on MOH annual reports. 
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1.1.7 Risk factors 
Several factors are associated with increased risk of leptospirosis in both 
tropical and temperate countries. In general, it can be divided into (i) socioeconomic 
and (ii) environmental factors. Socioeconomic factors include rapid urbanisation, 
rural area and type of occupations. During urbanisation, the size and density of 
population increased rapidly within a limited area of living. Consequently, an 
increased number of people live in poor housing or slum dwellings with poor 
sanitation and are in close proximity to open sewage (Mgode et al., 2015). Moreover, 
overcrowded areas usually have garbage management problem that attracts presences 
of stray animals, especially rodents and stray dogs. In several prevalence studies, 
between 16% and 82% of captured rodents and stray dogs were positive for 
Leptospira (Agudelo-Flórez et al., 2009; Kimari, 2016; Zaidi et al., 2018).  
In addition, certain occupational group also associated with higher risk of 
leptospirosis. Of all, mining is the earliest sectors that were identified as leptospirosis 
occupational risk group (Inada et al., 1916). The prevalence of leptospiral antibodies 
among miners was as high as 65.3%. Those mine workers who exposed to waters, 
cattle rearing and rat infestation had augmented risk, with odds ratio (OR) of 10.6, 
10.4 and 4.6, respectively (Natarajaseenivasan et al., 2016). Farmers also have higher 
risk of leptospiral infection. Due to this occupational association, leptospirosis was 
also called as rice-field worker's disease, cane cutter's fever, harvest fever and 
Japanese (akiyami) autumnal fever (Rovid Spickler and Leedom Larson, 2013). 
Other occupations include animal farmers, abattoir workers, military, veterinarians 
and others who have direct contact with animals (Guerra, 2013; A. A. N. Rafizah et 
al., 2013). Importantly, the magnitude of the risk depends on the degree of exposure, 
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frequency, prevalence of leptospiral carrier, personal protective equipment 
availability, knowledge and awareness (David A Haake and Levett, 2015). 
Environmental factors also influence the risk of leptospirosis. Usually, a 
higher number of leptospirosis cases and outbreaks were reported following climatic 
events such as floods and typhoon. For example, after the 2009 typhoon in Metro 
Manila, more than 2000 patients were hospitalised due to leptospirosis, of which, 178 
died (Amilasan et al., 2012).  Apart from occasional typhoons, an upsurge in regular 
rainfall, as well as increase in humidity were associated with 2% to 4% escalation of 
leptospirosis cases (Joshi et al., 2017). Hospitalisation usually occurred after 2 weeks 
of the heavy rainfalls (Matsushita et al., 2018). 
Recreational activities such as freshwater swimming, caving, rafting and 
triathlons have emerged as another important risk factor of leptospirosis. The 
importance of recreational exposures become more significant in recent years due to 
the increased popularity of adventurous sports and cheaper cost of travelling to 
exotic areas. Among the recreational related outbreaks that occurred are; Springfield 
triathlon (n = 98) (Morgan et al., 2002), Malaysia Borneo Eco-Challenge (n = 80) 
(Sejvar et al., 2003), Guam triathlon (n = 21) (Haddock et al., 2002), Florida 
Adventure Race (n = 21) (Stern et al., 2010), Réunion Island triathlon (n = 9) (Pagés 
et al., 2016), and Martinique canyoning (n = 8) (P Hochedez et al., 2013). 
 
1.1.8 Diagnosis 
Clinical diagnosis of leptospirosis is challenging and requires a high index of 
suspicion. It is because; the clinical presentations are non-specific, often resembling 
other tropical infections (e.g. melioidosis). Therefore, a complementary laboratory 
test is always necessary for a definite result. Laboratory diagnosis of leptospirosis 
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can be either direct demonstration or indirect demonstration of Leptospira from 
clinical specimens.  
 
1.1.8 (a) Microscopic observation 
Direct observation of Leptospira from body fluid or artificial EMJH culture 
can be carried out using a dark field microscope. Under the microscope, the 
leptospires appear as thin, bright and motile spirochetes. In order to be detectable in 
the microscopic field, the initial Leptospira concentration in clinical specimens 
should be 10
4
 cells per mL (Toyokawa et al., 2011). A false negativity may happen 
when a low number of Leptospira present in the sample. In addition, this method is 
prone to false positivity when artefacts such as fibrin or protein threads and cellular 
debris are mistakenly identified as leptospires. Differential centrifugation can be 
performed to concentrate the organism, the technique is only useful for a large 
volume of specimens (WHO, 2013). Alternatively, some staining procedures, such as 
Warthin-Starry silver nitrate staining, immunohistochemistry and in situ 
hybridization to increase sensitivity and specificity. These methods, however, 
requires highly experienced technicians and laborious, hence are less useful as 
routine diagnostic tests (Ahmad et al., 2005). 
 
1.1.8 (b) Isolation of Leptospira 
Demonstration of leptospiral growth in artificial media is a definitive 
indicator of Leptospira presence. Body fluids such as blood, plasma, urine and CSF 
can be inoculated into a primary culture. To date, several culture media has been 
described, such as EMJH media, Fletcher's media and Leptospira Vanaporn 
Wuthiekanun (LVW) agar (Philip et al., 2018). Additional additives, including 
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rabbit‘s serum (8-15% v/v), fetal bovine serum,  sodium pyruvate, Tween-80, 
superoxide dismutase enzyme and magnesium salts can be included to improve 
recovery of Leptospira (Chideroli et al., 2017). Moreover, 5-fluorouracil, nalidixic 
acid, rifampicin, polymyxin B, vancomycin can be added to inhibit the growth of 
contaminating organisms. Yet, the addition of selective antibiotics may compromise 
the growth of certain leptospiral strains or when low numbers of viable leptospires 
are available. Culture media for Leptospira are incubated at 30 C, for up to 6 
months to accommodate the slow growth of certain serovars, such as Hardjo and 
Bratislava (Khaki, 2016). Due to this slow growth rate and long incubation time, 
culture is less useful for routine diagnostic testing (Chideroli et al., 2017; Wagenaar 
et al., 2006). 
 
1.1.8 (c) Molecular diagnosis 
PCR has been used for direct detection of Leptospira DNA for more than 20 
years (Mérien et al., 1992). Since then, many molecular assays have been developed, 
utilising conventional PCR, real-time PCR (qPCR), reverse-transcription PCR 
(rtPCR) and isothermal amplification platforms. These assays are useful for early 
diagnosis of leptospirosis (first week of infection), in which Leptospira usually 
present in the bloodstream at low concentration. PCR amplify unique sequences of 
housekeeping genes such as rrs, fliC, gyrB and secY or virulence genes associated 
with pathogenic species of Leptospira, including lipL32, lipL21 and lfb1 
(Thaipadungpanit et al., 2011). 
Historically, conventional PCR was widely used to detect Leptospira DNA 
from various clinical samples. Among the commonly used primers were targeting 
331 bp sequence of Leptospira rrs gene and the G1/G2 primers targeting 285 bp of 
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secY (Gravekamp et al., 1993). Conventional PCR had sensitivity approximately 10 
pg Leptospira DNA (equivalent to 2 × 10
3
 DNA copies) per reaction (Fonseca et al., 
2006; Mérien et al., 1992). Amplicon of conventional PCR subsequently can be used 
for sequencing and identification of infecting Leptospira species (Andrew T Slack et 
al., 2006). 
SYBR and TaqMan hydrolysis qPCR are better alternatives to conventional 
PCR. qPCR is more sensitive and independent of gel electrophoresis step. To date, 
several SYBR and TaqMan hydrolysis qPCR have been described. Those assays had 
limits of detection between 10 to 50 DNA copies per reaction, hence are more 
sensitive than the conventional PCR (Ahmed et al., 2009). Moreover, TaqMan 
hydrolysis qPCR enable broader application of assay in which multiple targets are 
possible. Such assays allow detection and differentiation between pathogenic and 
non-pathogenic groups of Leptospira (Bedir et al., 2010). Due to high sensitivity and 
specificity, qPCR is useful for routine testing but provides limited data on the 
infecting serovars.  
 
1.1.8 (d) Serological diagnosis 
Serological assays are commonly used to screen and to diagnose 
leptospirosis. The assays are also widely utilised in surveillance and prevalence 
studies. In these assays, antibodies (IgM or IgG or both) against Leptospira are 
detected to demonstrate the indirect presence of the organism. Antibodies are 
produced after 5 – 7 days of infection and may persist for months or years (Budihal 
and Perwez, 2014). Serology-based assays include microscopic agglutination test 
(MAT) and enzyme-linked immunosorbent assay (ELISA). 
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MAT or microscopic agglutination test was first described by Pettit and 
Martin in 1918 and remains as a reference test for diagnosis of leptospirosis (Martin 
and Pettit, 1918). In this test, agglutination between patient‘s sera and viable 
Leptospira cultures is observed under darkfield microscopy. Maintenance of at least 
19 Leptospira strains of certain serogroups is necessary, yet laborious. Positivity is 
confirmed when more than 50% of leptospiral cells agglutinate with patient‘s sera 
relative to the control well. At this stage, the MAT requires experienced technicians 
to perform and to analyse the agglutinations (WHO, 2003). 
Alternatively, ELISA is less laborious and does not require viable Leptospira 
cells. This method allows detection of IgM against Leptospira, using recombinant 
proteins or cellular extract of circulating strains. Despite its commercial availability 
and widely used, performances of leptospiral ELISA are inconsistent. For instance, 
the sensitivity & specificity of Leptospira IgM ELISA varies depending on location, 
i.e. 96.6 % and 93.3% in Brazil (Ooteman et al., 2006), 76.1% and 82.6% in 
Thailand (Desakorn et al., 2012) and 70% and 78% in Laos (Tanganuchitcharnchai 
et al., 2012). In other studies, the sensitivity and specificity highly ranged, 32% – 
99% and 52% – 100%, respectively (Rosa et al., 2017). As a result, complementary 
tests, such as MAT and PCR are highly recommended to confirm the diagnosis of 
leptospirosis. 
Other more rapid tests that screen the presence of anti-Leptospira antibodies 
are also available. These tests are aimed for application at resource-limited settings, 
in which results are ready in as early as 10 minutes (J.-W. Lee et al., 2016). Those 
tests include latex bead agglutination, indirect immunofluorescence, indirect 
hemagglutination and immunochromatography tests (Mathieu Picardeau et al., 
2014).  
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1.1.9 Management and treatment 
Majority of leptospirosis cases are mild and self-limiting, hence do not 
require antimicrobial treatment. However, in some circumstances, early initiation of 
antibiotic prevents a severe form of leptospirosis. According to the WHO, less severe 
leptospirosis can be treated with oral antibiotics, such as amoxicillin and ampicillin. 
Other options include doxycycline, erythromycin, ceftriaxone, cefotaxime, and 
quinolones. Meanwhile, in severe leptospirosis, the WHO recommends high doses of 
intravenous (IV) penicillin, with some supportive care such as dialysis and 
mechanical ventilation, when necessary (WHO, 2003). In very rare cases, high dose 
penicillin cause Jarisch-Herxheimer reaction (JHR), characterised by acute 
inflammatory response due to the production of large amounts of cytokines (also 
known hypercytokinemia) and fever (Guerrier and D‘Ortenzio, 2013). 
In Malaysia, recommended treatment for severe leptospirosis in adults is 2 M 
unit IV C-penicillin, every 6 hours, for 5 to 7 days. For less severe cases, 2 mg to 100 
mg per kg doxycycline (or tetracycline, ampicillin, amoxicillin) can be prescribed 
orally every 12 hours for 5 – 7 days. Meanwhile, in paediatric patients, 100000 U IV 
C-penicillin per kg, every 6 hours, for 7 days is preferred. Alternatively, patients of 
below 8 years old may be prescribed with oral doxycycline 4mg per kg for 12 hours, 
for 1 week (MOH, 2011).  
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1.2 Burkholderia pseudomallei and melioidosis 
B. pseudomallei, a causative organism of melioidosis was first observed in 
1911 by Alfred Whitmore and C. S. Krishnaswami from postmortem tissues of 
morphine addicts in Rangoon, Burma (Whitmore, 1913). Upon inoculation into 
guinea pigs, the isolated bacilli were similar to Burkholderia mallei, a causative 
agent for glanders, but the organism was motile. Eventually, the organism was called 
Bacillus pseudomallei or Bacille de Whitmore (or Bacillus whitmorii). In other 
occasions of the last decade, the B. pseudomallei was also referred to as 
Actinobacillus pseudomallei, Lofflerella whitmori, Malleomyces pseudomallei, 
Pfeifferella pseudomallei, Pfeifferella whitmori, Pseudomonas pseudomallei (Bart J 
Currie, 2015). Until 1992, the organism is officially recognised as Burkholderia 
pseudomallei, based on the DNA-DNA homology and 16S rRNA relatedness 
(Yabuuchi et al., 1992).  
During the early days, Whitmore‘s reported that first 38 fatal cases of this 
disease in morphine injectors who had abscesses in multiple organs and bacteraemia. 
Consequently, the disease was called the ‗Whitmore‘s disease‘ or the ‗morphine 
injector‘s septicaemia‘. The term, melioidosis was given by Stanton and Fletcher in 
1932, which detailed similar diseases in patients from Malaya, Ceylon and 
Indochina. The name was taken from the Greek ‗melis‘ (distemper of asses), ‗oid‘ 
(like) and ‗osis‘ (condition) which refer to glanders-like infection  (Stanton and 
Fletcher, 1921). Figure 1.3 summarises the important events in regards to 
melioidosis. 
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Figure ‎1.3 Important milestones in the history of melioidosis. Adopted from 
Wiersinga et al. (2018)  
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1.2.1 Biology of B. pseudomallei and cultivation 
B. pseudomallei are motile Gram-negative bacilli, with a diameter of 0.4 to 
0.8 µm and a length of approximately 1.5 µm. The motility is due to the presence of 
a cluster of two to four flagella, located at one end of the organism. Microscopically, 
B. pseudomallei exhibit bipolar staining resembles ‗safety-pin‘ appearance (Liu, 
2014).  
This organism is non-fastidious and metabolically versatile. It can utilise 
many carbon sources, both aerobically and anaerobically. In anaerobic condition, B. 
pseudomallei require the presence of arginine or nitrate (Vietri and DeShazer, 2007). 
Despite its ability to grow in various routine media, selective media such as the 
Ashdown medium and Mac Conkey agar are favourable for the non-sterile specimen 
in order to prevent potential misdetection due to overgrowth of other organisms. The 
culture media can be incubated at 24 °C  to 32 °C, and up to 42 °C (Hemarajata et 
al., 2016). On the Ashdown media, overnight B. pseudomallei colonies are typically 
pinpoint in size and will develop into flat, purplish, wrinkled colonies post 48 hours 
incubation. Meanwhile, on MacConkey agar, overnight colonies are typically 
colourless, non-lactose-fermenting and will develop into a pinkish rigours colony 
with metallic sheen after 48 hours. Additional biochemical tests, i.e. oxidase test, L-
arabinose and other monosaccharide fermentations and indole test, as well as 
susceptibility to gentamicin, polymyxin B and amoxicillin/clavulanic acid are 
necessary to identify B. pseudomallei (Wiersinga et al., 2018). 
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1.2.2 Classification and taxonomy 
Historically, Burkholderia was placed under the rRNA group II of the 
Pseudomonas genus. Following taxonomic advancement through rRNA–DNA 
hybridization technology, Burkholderia spp. were transferred into its own genus, 
which was first described by Walter H. Burkholder in 1942 (Hemarajata et al., 2016). 
The genus belongs to class Betaproteobacteria, order Burkholderiales and family 
Burkholderiaceae and consist of more than 50 species (listed at 
http://www.bacterio.net/burkholderia.html)  (Wisplinghoff, 2017). 
Genetically, Burkholderia species are divided into three main clusters; (i) B. 
pseudomallei-complex (Bpc) group, (ii) B. cepacia-complex (Bcc) group and (iii) 
Paraburkholderia group, as illustrated in Figure  1.4.  In the last two years, the latter 
group eventually was proposed to be placed into a new genus due to its unique 
genetic composition, phenotypic similarities and non-pathogenicity on humans, 
animals and plants (Anatoly and Mansour, 2016). The B. pseudomallei-complex 
contains B. pseudomallei (melioidosis), B. mallei (glanders) and B. thailandensis 
(avirulent). Meanwhile, remaining species are clustered in the Bcc group, that may 
become opportunistic pathogens in cystic fibrosis (CF) and immunocompromised 
patients (Lowe et al., 2016). 
The whole genome of B. pseudomallei was completely sequenced in 2004. 
The chromosome of this organism present in two copies, Chromosome 1 (~4.07 Mb) 
that encodes genes related to metabolisms, biosynthesis of cellular 
components, DNA replication and transcription and the smaller Chromosome 2 
(~3.17 Mb) that contains genes involving host-environmental adaptation functions 
(Holden et al., 2004). There are 16 ‗genomic islands‘ (GI) within the B. pseudomallei 
genome, potentially acquired through horizontal gene transfer and are responsible for 
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various metabolic and virulence advantage. Among the encoded virulence genes are 
adhesins, fimbriae, capsular exopolysaccharides, LPS and Type III secretion systems 
(TTSS), responsible for the invasion and pathogenesis of B. pseudomallei (White, 
2013). 
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Figure ‎1.4 Phylogenetic tree of Burkholderia species based on 16S rRNA gene 
sequences. Adopted from Eberl and Vandamme (2016).  
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1.2.3 Pathogenesis 
B. pseudomallei usually infect humans who are regularly in contact with 
water and soils. The common routes of infection are percutaneous inoculation, 
inhalation, and ingestion of contaminated soil or water or aerosolised organisms 
(Nathan et al., 2018). This initial route of infection was found to be associated with 
the clinical manifestation of melioidosis. For instance, infections through inhalation 
were associated with pneumonia, while infections through ingestion were associated 
with septicaemia (C. Lim et al., 2016). In terms of the animal host, melioidosis has 
affected various animals including cattle, camels and kangaroos. However, there is 
very limited data on zoonotic melioidosis and its associated animal reservoir (Choy 
et al., 2000).  
During entry into the human body, B. pseudomallei attaches to epithelial cells 
of broken skin or the mucosal surface, mediated by the type IV pili (such as PilA 
protein), polysaccharides capsule and BoaA and BoaB adhesin proteins. 
Subsequently, the bacteria enter the cell through endocytosis and can remain in the 
endocytic vesicles. Prior to lysozyme activation, type III secretion system (TTSS) 
transports certain effector proteins, such as ecotin (a periplasmic serine protease 
inhibitor), BopA (BPSS1524), BopB (BPSS1514), BopC (BPSS1516), BopE 
(BPSS1525) and CHBP (BPSS1385). These proteins are responsible for bacterial 
endocytic escape (J. K. Stone et al., 2014). B. pseudomallei can replicate in various 
cells including neutrophils, monocytes and macrophages and some epithelial cell 
lines (J. K. Stone et al., 2014). 
Apart of important virulence proteins that are responsible for invasion, 
endocytic escape and intracellular survival, pathogenicity of B. pseudomallei is also 
caused by the production of BLF1 (Burkholderia lethal factor 1) toxin that 
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inactivates host protein synthesis (Hautbergue and Wilson, 2012). Other virulence 
proteins and their associated function are listed in Table  1.4. Due to the high 
pathogenicity, B. pseudomallei are regarded as CDC Tier 1 select agent and a 
Category B Priority Pathogen by the National Institute of Allergy and Infectious 
Diseases (NIAID). 
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Table ‎1.4 Selected B. pseudomallei virulent proteins. Adapted from Wiersinga 
et al. (2018)  
Gene Antigen Function 
ahpC Alkyl hydroperoxide 
reductase 
Resistance to oxidative stress 
bimA T5SS autotransporter Escape from phagosome and actin tail 
formation 
bipB Translocator protein TTSS components 
bipC Effector protein Involved in endocytic vesicle survival, 
escape and cell invasion 
bipD Translocator protein Involved in endocytic vesicle survival, 
escape and cell invasion 
boaA Adhesins T5SS autotransporters 
boaB Adhesins Role in cell attachment and possibly 
intracellular replication 
bopA Effector protein • TTSS component 
• Involved in endocytic vesicle membrane 
disruption and avoidance of autophagy 
bopE Guanine nucleotide exchange TTSS effector 
bpaC Adhesin • T5SS trimeric autotransporter adhesin 
• Protects from complement killing 
• Involved in cell attachment 
bsaQ TTSS structural component Involved in endocytic vesicle escape, cell 
invasion and plaque formation 
bsaU TTSS structural component Involved in endocytic vesicle escape and 
early onset activation of the caspase 1 
bsaZ TTSS structural component Implicated in endocytic vesicle escape and 
intracellular replication 
CHBP ATP and GTP binding 
protein 
TTSS structural component 
dpsA DNA starvation and 
stationary 
Resistance to oxidative stress 
fliC Flagellin structural 
component 
• Required for flagellar assembly 
• Involved in cell adherence 
hcp1 Hcp1 family T6SS effector Role in cell fusion and macrophage 
cytotoxicity 
irlR Transcriptional activator 
protein IrlR 
Mutants displayed reduced invasion 
katG Catalase-peroxidase Resistance to oxidative stress 
pilA Type IV pilin subunit protein 
PilA 
• Temperature-dependent adherence and 
formation of microcolonies  
• Intracellular motility 
purM Phosphoribosylformylglycina
midine 
Purine biosynthetic pathway 
rpoE RNA polymerase σ-factor 
RpoE 
Biofilm formation, heat stress response via 
RNA polymerase σ-factor 
rpoS RNA polymerase σ-factor 
RpoS 
Suppresses iNOS activity by upregulating 
SOCS3 and CIS cytokines 
sodC Superoxide dismutase Resistance to oxidative stress 
virAG  Two-component regulatory 
system 
Regulates T6SS transcription 
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1.2.4 Melioidosis in human 
Exposure to contaminated environments is an exclusive source of human 
melioidosis.  B. pseudomallei may enter the body via percutaneous cut or abrasion, 
inhalation or ingestion during occupational or recreational activities. Upon entry, the 
disease progression is influenced by many aspects such as mode of infection, host 
risk factors, pathogenicity of the infecting strains and its inoculum (C. Lim et al., 
2016).  
On average, the onset of melioidosis appears after 9 days (range: 1 – 21 days) 
(Bart J Currie, 2015). In other instances, the symptoms appeared within 24 hours of 
presumed infection, i.e. after severe climatic events or near-drowning incidence 
(Chierakul et al., 2005; Bart J. Currie and Jacups, 2003; Hinjoy et al., 2018). 
Meanwhile, the longest reported incubation period was 62 years, in an American 
veteran who was previously imprisoned during World War II (Ngauy et al., 2005). 
The most common presenting symptom of melioidosis is fever and cough. 
During hospital admission, between 78.5% – 100% melioidosis patients had reported 
fever (Afroze et al., 2017; Churuangsuk et al., 2016; Deris et al., 2010). Other 
common clinical presentation includes pneumonia (36% – 58%) and soft tissue or 
skin abscess (17% – 36%) (Kingsley et al., 2016; Nathan et al., 2018; Zueter et al., 
2016). Meanwhile, less common clinical presentations are liver abscess, splenic 
abscess, prostate abscess, parotid abscess, genitourinary, neurologic abscess and 
osteomyelitis/septic arthritis (Tipre et al., 2018). In an unusual case, a 56-year-old 
melioidosis patient presented with jaundice (Tyagi et al., 2014). On the other hand, 
majority of exposure to B. pseudomallei are subclinical and do not cause active 
infection (Limmathurotsakul and Peacock, 2011). Figure  1.5 summarises association 
between mode of B. pseudomallei infection and disease progression of melioidosis. 
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Figure ‎1.5 Association between mode of B. pseudomallei entry and progression 
of melioidosis. Adopted from Currie (2015). 
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1.2.5 Epidemiology 
Melioidosis is endemic to the tropic regions, located between 20 °N and 20 °S 
of the equator. In the early 1900s, limited data were available on melioidosis cases, 
in which, most of the reported cases were in travellers. In more recent years, 
emerging data suggested that the wider geographic areas are affected by melioidosis, 
such as the Hong Kong, Taiwan and the Indian subcontinent (Bart J. Currie et al., 
2008). Moreover, sporadic cases have been reported in the Middle East, Africa and 
the Americas, especially after heavy rainfalls. Overall, it is estimated that more than 
3 billion people are at risk of melioidosis, with 5.0 cases per 100,000 people. Of 
these, South Asia and East Asia & Pacific are the most affected regions with 73,000 
and 65,000 cases, annually (Limmathurotsakul et al., 2016). 
Thailand and Northern Territory of Australia are two classical melioidosis 
endemic countries. In both regions, as high as 24.63% of community-acquired 
septicemic cases are caused by B. pseudomallei (Churuangsuk et al., 2016). In 
Malaysia, melioidosis was first described in 1913 by Stanton and Fletcher, from the 
Institute of Medical Research (Jayaram, 2005). To date, this disease is not 
compulsorily notifiable in Malaysia. Noticeably, melioidosis incidences vary 
between states. For example, in Pahang and Kedah, the 4.3 cases per 100,000 
population and 16.35 cases per 100,000 population were reported, respectively (How 
et al., 2009; Nathan et al., 2018). Few melioidosis outbreaks have been reported, 
associated with environmental exposure during public evacuation and among 
military personnel (Sapian et al., 2012; Thin et al., 1970). Figure  1.6 illustrates 
melioidosis cases and death in Malaysia, between 1975 and 2015. 
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Figure ‎1.6 Reported melioidosis cases and deaths in Malaysia, between 1975 and 
2015. Adopted from Kingsley et al. (2016).    
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1.2.6 Risk factors 
 Diabetes mellitus is the most common risk factor associated with melioidosis. 
This predisposing condition present in more than 50% melioidosis patients 
worldwide (Wiersinga et al., 2018). In a certain region, as high as 60.9% of affected 
patients also had this diabetes mellitus (Suputtamongkol et al., 1999). It is shown 
that patients with diabetes mellitus have impaired immune response to B. 
pseudomallei, in particular, reduced capacity of macrophages phagocytic and 
bacteriolysis activity, that eventually lead to increased susceptibility to this infection 
(Dunachie et al., 2017). In addition to diabetes mellitus, other comorbidities 
associated with increased risk of melioidosis are; renal impairment (10% – 27%), 
pulmonary disease (27%), thalassaemia (7% – 8%, due to excessive iron and 
subsequent neutrophil dysfunction), congestive heart failure, corticosteroid therapy, 
malignancy and immunosuppression (Wiersinga et al., 2018). 
Certain occupational classes are also known risk factors to melioidosis. For 
instance,  paddy rice worker or farmer accounted for 78% – 84.9% of melioidosis 
patients in Thailand and Sri Lanka (Corea et al., 2016; Suputtamongkol et al., 1999). 
Other high-risk occupation groups include military, fishing and veterinary. 
Interestingly, recreational/non-occupational activities have become an emerging 
source of infection. For instance, a retrospective study in Darwin, Australia revealed 
that 75% (n = 407) patients were infected during recreational activities, in contrast to 
18% (n = 96) who had direct exposure during occupational activities (Currie et al., 
2010). Similarly, only 18.6% of melioidosis patients in Kedah, Malaysia worked in 
the farming, forestry, fishing (Hassan et al., 2010). 
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Occupational status is also related to gender and age group. Overall, male 
were frequently associated with melioidosis, with the percentage of between 73.4% 
and 84%. Similarly, those who were of mean age of between 44 – 50  were also 
associated with increased risk of melioidosis (L. Pang et al., 2017; Zueter et al., 
2016). In a certain region, specific race, ie. people of Malay ethnicity in Malaysia 
were predominate melioidosis patients (71% – 89%) (Nathan et al., 2018). A similar 
incidence was observed in Singapore, in which on average, 2.4 Malays per 100,000 
population were reported to have melioidosis, as compared to the Chinese and Indian 
(L. Pang et al., 2017). In another study, the aboriginality and alcohol consumption 
were shown to have relative risk of 2.1 and 8.1, respectively, in contrast to the other 
counterparts (Cheng and Currie, 2005). 
 
1.2.7 Diagnosis 
Early diagnosis enables the initiation of appropriate treatment and improves 
prognosis. Clinically, acute melioidosis features are non-specific and mimicking 
other diseases, as described previously (Meumann et al., 2012). Therefore, 
complementary laboratory tests are important for confirmation of melioidosis. To 
date, several laboratory tests have been described to assert the presence of B. 
pseudomallei in clinical specimens. These laboratory tests are categorised into; (i) 
culture methods, (ii) serology method and (iii) molecular assays.  
 
1.2.7 (a) Culture method 
Culture method, paired with additional biochemical tests (for identification) is 
considered the gold standard for direct demonstration of viable B. pseudomallei. This 
ubiquitous non-fastidious organism may grow on various culture media, such as 
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blood agar, Mac Conkey agar and Ashdown media. On non-selective agar, B. 
pseudomallei growth may be mistakenly identified as contaminating microorganism. 
It is because, following 18 – 24 hours incubation, the colonies are colourless and 
non-lactose fermenting resemble oxidase-positive Pseudomonas (on Mac Conkey) or 
are small, smooth, cream-coloured on blood agar. The wrinkled metallic sheen or 
pinkish, rugose appearance only manifest after prolonged incubation (usually >48 
hours or up to 5 days) (Hemarajata et al., 2016).  The slow growth of B. 
pseudomallei on the suboptimal media may be out-competed by other normal 
commensals. As a result, when melioidosis is highly suspected, more selective agar, 
such as Ashdown agar should be considered. On this agar, colonies are typically 
pinpoint in size after 18 – 24 hours incubation and will become flat, purple in colour 
and wrinkled at 48 hours. Other clues for suspicion of B. pseudomallei is the bipolar 
staining of Gram-negative bacilli, earthy or musty smell and intrinsic resistant to 
polymyxins and gentamicin (albeit not all strains) (Podin et al., 2014).  
In addition, routine biochemical test such as oxidase, indole, L-arabinose test 
or commercial tests i.e. API 20NE, Remel RapID NF, Phoenix, Vitek 2 and matrix-
assisted laser desorption/ionisation time-of-flight (MALDI-TOF) mass spectrometry 
can be used for identification of B. pseudomallei. However, the performance of the 
assays varied among laboratory hence validation on local strains may be warranted. 
For instance, the commercial API 20NE identified 99.0% of 800 isolates and 37% of 
71 isolates respectively in two independent evaluation studies, from Thailand and 
Australia (Amornchai et al., 2007; Inglis et al., 2005). 
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1.2.7 (b) Serological diagnosis 
Different serological assays have been developed for detecting anti-
B. pseudomallei antibodies using whole cell lysates or poorly characterised antigens. 
Most of these tests are ‗in-house‘ and not validated extensively. Among others, the 
indirect hemagglutination assay (IHA) is commonly used to detect antibodies 
produced against B. pseudomallei. In this assay, sheep red blood cells (RBCs) are 
sensitised with crude antigen, prepared from local clinical strains of B. pseudomallei. 
The sensitized red blood cells are then mixed with serially diluted inactivated patient 
serum. Titre is denoted by the highest dilution of patient serum that distinctively 
agglutinated with the sensitised RBCs (Alexander et al., 1970). Although IHA is 
relatively simple, the reported sensitivity of this test was between 56% and 73% 
(Wiersinga et al., 2018). Moreover, in another study, 68% of patients who were 
initially negative on admission subsequently exhibited seroconversion (Cheng et al., 
2006). Due to these inconsistent sensitivities and delayed seroconversion, serology-
based assays are not routinely used as a sole method for diagnosis of melioidosis. 
In other laboratories, ELISA is available for detection of melioidosis specific 
IgM and/or IgG. These tests are rapid and omit the bias of IHA observer. Whole 
bacterial cells, exopolysaccharide (EPS) and lipopolysaccharide (LPS) are commonly 
used antigens. However, utilisation of unpurified antigens leads to lack of 
standardization and reproducibility. For instance, dual evaluations of an in-house 
ELISA within the same institute revealed that the sensitivity of the developed IgM 
ELISA reduced from 82.2% to 79.8%. Similarly, the specificity reduced from 94.9% 
to 89.7% (Noor et al., 2015; Yi et al., 2017). 
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1.2.7 (c) Molecular diagnosis 
A number of molecular assays for the detection of B. pseudomallei nuclei 
acid have been described in the literature including conventional and real-time PCR. 
Some of the described PCR assays exclusively detect B. pseudomallei, while the 
remaining were designed to identify and differentiate B. pseudomallei from its close 
genetic relatives, such as B. thailandensis or B. mallei (Lowe et al., 2016).  
In general, real-time PCR is more sensitive and more rapid than the 
conventional PCR. For instance, the PPM2 conventional PCR could detect 1 ng 
DNA per reaction, while the TaqMan qPCR may detect 0.000076 ng DNA (Lew and 
Desmarchelier, 1994; Novak et al., 2006). Even though qPCR is more sensitive, only 
a few of the reported assays were validated clinically. Evaluation of qPCR on clinical 
specimens is important to confirm its usability and practicality. In an instance, two 
developed TaqMan qPCR (designated 8653 and 9438) had analytical specificity of 
100%, both. However, upon validation on confirmed specimens, the actual clinical 
specificity were 82% and 88 %, and clinical sensitivity of 71% and 54%, respectively 
(Supaprom et al., 2007). Relative to culture and serology method, direct detection of 
B. pseudomallei DNA is more sensitive and specific, hence potentially enable early 
diagnosis of melioidosis.  
 
1.2.8 Management and treatment 
Timely initiation of appropriate antibiotic treatment reduces the mortality rate 
by approximately 50% (Dance, 2014). Usually, melioidosis treatment is divided into 
two phases: (i) induction phase, in which intravenous antibiotics are prescribed for at 
least 10 days, to prevent overwhelming sepsis and potential death, and (ii) 
maintenance phase, in which oral antibiotics are prescribed, usually for 20 weeks, 
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with the aim to prevent relapse episode of melioidosis. Table  1.5 summarises 
recommended antibiotic treatment for melioidosis. 
Apart of antibiotic treatment, management of melioidosis includes, correction 
of electrolytes, fluids and acid-base imbalances, initiation of insulin therapy (for 
diabetic patients), respiratory support (when necessary) and drainage of abscess (if 
present).  
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Table ‎1.5 Recommended antibiotic regimes and melioidosis phase. Adapted 
from Dance (2014) and MOH (2011). 
Phase Antibiotics Duration   
Induction 
Ceftazidime 50 mg/kg/dose (up to 2 g) every 6–8 h 10-14 days or ≥4 
weeks for deep-
seated infection  Meropenem 25 mg/kg/dose (up to 1 g) every 8 h  
Maintenance  
Trimethoprim/sulfamethoxazole  
 8/40 mg/kg/dose orally BD*  
 >60 kg : 2 × 160/800 mg (960 mg) tablets BD  
 40–60 kg : 3 × 80/400 mg (480 mg) tablets BD 
 <40 kg : 1 × 160/800 mg (960 mg) or  
             : 2 × 80/400 mg (480 mg) tablets BD  
 3–6 months, 
depending on 
clinical response 
to therapy  
With or without doxycycline 2.5 mg/kg/dose  
(up to 100 mg) orally BD  
Life 
threatening 
melioidosis  
 
• IV Meropenem  
(25mg/kg/dose; usual dose for adult: 1 gm TDS), or 
• IV Imipenem  
(50mg/kg/day; usual adult dose 1gm TDS) 
at least 2 weeks 
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1.3 Salmonella and invasive salmonellosis 
Salmonella are ubiquitous Gram-negative facultative anaerobic, Gram-
negative bacteria belong to Enterobacteriaceae family. This organism was first 
isolated from infected bovine in 1855 by Theobald Smith and named after the 
research team leader, Dr Daniel Elmer Salmon (Schultz, 2008). Salmonella genus is 
made up of two species, Salmonella enterica and Salmonella bongori. The earlier 
species is commonly isolated, and further divided into six subspecies; enterica, 
salamae, arizonae, diarizonae, houtenae, indica.  
Apart from classification based on the genetic relatedness, Salmonella 
serovars have been described based on their antigenic determinants and designation 
by the White-Kauffmann-Le Minor scheme (Issenhuth-Jeanjean et al., 2014). Most 
of these serovars are adapted to humans and animal host. In clinical settings, invasive 
human salmonellosis is caused by the serovars Typhi or Paratyphi A, B, C, or 
invasive non-typhoidal Salmonella (iNTS) serovars. 
 
1.3.1 Biology of Salmonella and cultivation 
Salmonellae are motile non-spore forming Gram-negative bacilli with a 
dimension of approximately 1 m (in diameter)  2 – 5 m (in length) (Kawamoto et 
al., 2013). The motility of this organism is due to the presence of peritrichous 
flagella, located all over of the bacterial cell (Andino and Hanning, 2015). 
Microscopically, Salmonella are indistinguishable to other Gram-negative bacilli and 
do not display unique staining pattern (Malt et al., 2015). 
Salmonella ferment glucose, sucrose, mannitol and citrate as a carbon source 
(Steven and David, 2014).  These organisms are non-fastidious facultative anaerobes 
and can be cultivated in the microbiology laboratory using various basic agars, such 
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as blood agar and nutrient agar. Besides, selective (and/or differential) agar can be 
used including Mac Conkey agar, Hektoen (HE) agar and selenite broth with brilliant 
green (Steven and David, 2014). These organisms are oxidase-negative, 
predominantly non-lactose fermenting and can produce hydrogen sulphide (H2S). 
Emerging number of Salmonella (particularly non-typhoidal serovars)  are either H2S 
negative (7% – 40%) or lactose fermenter (<1%) (Latif et al., 2014; Lin et al., 2014; 
Wu et al., 2016). These atypical phenotypic characteristics of Salmonella may cause 
misidentification of the organism, like E. coli or other Enterobacteriaceae.  
 
1.3.2 Classification and taxonomy 
During its discovery, Salmonella were formerly named as Bacillus 
choleraesuis. In 1900, the name was changed to Salmonella choleraesuis (Ryan et 
al., 2017). Since then the nomenclature remains complex and evolving. In 2005, the 
Judicial Commission of the International Committee on Systematics of Prokaryotes 
has decided that the Salmonella genus consists of two species; Salmonella enterica 
and Salmonella bongori (Tindall et al., 2005). The earlier species is further divided 
into six subspecies; designated with respectively Roman numeral (not italicised), S. 
enterica subsp. enterica (I), S. enterica subsp. salamae (II), S. enterica subsp. 
arizonae (IIIa), S. enterica subsp. diarizonae (IIIb), S. enterica subsp. houtenae (IV), 
and S. enterica subsp. indica (VI) (Lamas et al., 2018). Among all subspecies, S. 
enterica subsp. enterica (I) are commonly isolated and accounted for 99% of 
salmonellosis in human and mammals. Meanwhile, the remaining subspecies II – VI 
and S. bongori (V) rarely infect human and predominantly isolated from cold-
blooded animal and the environment (Fookes et al., 2011; Heredia and García, 
2018). 
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Furthermore, the species or subspecies are further classified into different 
serovars (or serotypes). This classification is based on the surface antigenic 
compositions of the bacterium. The antigens include somatic (O), capsular (K) and 
flagellar (H) determinants. In all antigens present in the S. enterica subsp. enterica 
(I), the serovar can be named after the location where it was isolated. Otherwise, 
serovar with partial antigenic determinants will be named according to the antigenic 
formula, similar to the other five subspecies (II, IIIa, IIIb, IV and V) (Ryan et al., 
2017).  
To date, 2659 different serovars have been described. Some serovars, such 
Typhi and Paratyphi A are exclusive to the human host. Meanwhile, serovar Rissen, 
Derby and Lexington are more prevalent in animals (Vo et al., 2006). For both 
human and animals, serovar Enteritidis, Typhimurium and Weltevreden are 
commonly encountered (Fardsanei et al., 2016; Vo et al., 2006). Details of reported 
serovars are listed in Table  1.6 and Figure 1.7. 
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Table ‎1.6 Numbers of serovars of S. enterica subspecies and S. bongori determined 
by the White-Kauffmann-Le Minor scheme. Adapted from Fardsanei 
et al. (2016).  
Salmonella    
species/subspecies 
Number # serovar 
S. enterica  
 
      subsp. enterica I 1586 
      subsp. salamae II 522 
      subsp. arizonae IIIa 102 
      subsp. diarizonae IIIb 338 
      subsp. houtenae IV 76 
      subsp. indica VI 13 
S. bongori V 22 
Total  2659 
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Figure ‎1.7 Summary of Salmonella nomenclature, their respective host and clinical 
involvement. 
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1.3.3 Pathogenesis 
Following ingestion, Salmonella attach to the non-phagocytic epithelial M 
cells of the Peyer patches using fimbriae or pili. Subsequently, the bacteria invade 
the cells by exploiting the cellular antigen uptake and transport function (Andino and 
Hanning, 2015). Upon entry, Salmonella disseminate into macrophages, neutrophils 
and several other cells. Once reside in the host cells, Salmonella survive and replicate 
within a specialised compartment called Salmonella-containing vacuoles (SCV). 
Intracellular survival of Salmonella is due to many pathogenic factors, including 
effector proteins associated with the Type III secretion system (TTSS), encoded by 
the Salmonella pathogenicity island 2 (SPI-2). The effector proteins include GogB, 
SodC and SspHI (Fookes et al., 2011). Apart from intracellular replication, certain 
serovars, especial non-typhoidal, replicates vastly in the gastrointestinal lumen 
(Dougan and Baker, 2014). Figure  1.8 illustrates invasion and replication of 
typhoidal and non-typhoidal Salmonella. 
 The ability of Salmonella to survive in the host cells is paramount for its 
pathogenicity. For instance, the complement-mediated lysis and antibody-mediated 
opsonisation are effectively blocked by the Vi antigen (Ilyas et al., 2017). Besides, 
by exploiting the mononuclear cell migration, Salmonella spread through the system, 
especially the liver, spleen and bone marrow. In few cases, gallbladder became the 
main location of S. Typhi (or Paratyphi), in which long-term excretion have been 
reported (Gunn et al., 2014).  
Moreover, the presence of typhoid toxin, encoded by CdtB, PltA, and PltB 
further improve the virulence of serovar Typhi (Chong et al., 2017). In non-typhoidal 
serovars, another homologue, Javiana toxin has been described (Rodriguez-Rivera et 
al., 2015). These toxins protein contains an N-terminal Sec signal peptide, which 
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mediates the transportation from the cytoplasm to the periplasm. Upon release, the 
toxins bind to Neu5Ac-terminated glycans, which are exclusively expressed in 
human cells (Gao et al., 2017). At high concentration, typhoid toxin is capable of 
inducing the death of host cells (Chong et al., 2017). In addition to these proteins, 
other putative pathogenic genes and their associated functions in salmonellosis are 
listed in Table  1.7. 
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Figure ‎1.8 Invasion and replication of typhoidal and non-typhoidal Salmonella. 
Adopted from Dougan and Baker (2014).  
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Table ‎1.7 Selected Salmonella virulence genes and putative roles in infection. 
Adapted from Ilyas, Tsai and Coombes (2017)   
Gene Gene location Role in infection 
GogB Gifsy-1 
Inhibition of pro-inflammatory response, 
survival within macrophages 
SodC Gifsy-2 
Resistance to oxidative stress, survival within 
SCV 
SspH1 Gifsy-3 Immune suppression, survival within SCV 
SopE SopEΦ iNOS activation, luminal colonization 
SipA, SipB SPI-1 Membrane ruffling, invasion 
SseF, SseG SPI-2 SCV localization, intracellular survival 
MisL SPI-3 Attachment, long term colonization 
SiiE SPI-4 
Attachment to intestinal epithelium, aids in 
invasion 
SopB SPI-5 
Membrane ruffling, invasion of epithelial cells, 
activation of pro-inflammatory response 
SciG, SciS SPI-6 Intracellular survival, systemic infection 
Tae4 SPI-6 
Overcoming colonization resistance, luminal 
colonization 
PagC, PagD, 
EnvE, EnvF 
SPI-11 
Resistance to antimicrobial peptides, survival 
within macrophages 
SspH2 SPI-12 Immune evasion, intracellular survival 
STM3118, 
STM3119 
SPI-13 Immune evasion, survival within macrophages 
LoiA SPI-14 
Regulation of SPI-1 genes, important for 
invasion 
STM0557 SPI-16 Serotype conversion, long term colonization 
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1.3.4 Salmonellosis in human 
Contaminated food is the major cause of Salmonella outbreaks in humans. 
Among reported sources of foodborne outbreaks were peanut butter, snacks, dog 
food, cereal and pies. This association was supported by close genetic relatedness 
found between Salmonella isolates from humans and foods (Fardsanei et al., 2016). 
Besides, human to human infections, post-climatic events outbreaks are also possible 
but are less frequent.  
To infect humans, at least 1000 Salmonella are necessary. To reach that 
number, it is possible that the bacterium multiplies in food sample until reaching the 
infective dose (Fangtham and Wilde, 2008). In human infections, the clinical 
manifestations occur after 7 to 14 days, and are divided into (i) enteric fever, (ii) 
gastroenteritis, (iii) bacteraemia and other extra-intestinal complications (invasive 
salmonellosis) and (iv) chronic carrier state (Crump et al., 2015). 
Enteric fever is caused by typhoidal Salmonella serovars, i.e. S. Typhi 
(caused typhoid fever) and S. Paratyphi A, B and C (caused paratyphoid fever). 
These serovars exclusively infect humans and transmitted via contact with water or 
food, contaminated with stools of the chronic carrier or infected patients. Following 
infection, the incubation period ranges between 7 – 14 days. Enteric fever is 
characterised by a myriad of non-specific symptoms including headache, coated 
tongue, rose-spots on chest (not always), abdominal pain, bradycardia, diarrhoea (or 
constipation) and high fever. In addition, infected patients may also develop 
hepatomegaly, splenomegaly,  pancreatitis, cholecystitis and gastrointestinal 
haemorrhage (Eng et al., 2015).  
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Gastroenteritis (or stomach flu) is caused by serovars other than Typi and 
Paratyphi, also known as non-typhoidal Salmonella (NTS). Medically important NTS 
include the S. Enteritidis, S. Typhimurium and S. Weltevreden. Infection by NTS has 
a shorter incubation period (6 – 12 hours) with common symptoms of headache, 
vomiting, nausea, non-bloody diarrhoea, abdominal cramps and myalgia. These 
symptoms usually are self-limiting and last for approximately 10 days. A certain 
group, such as immunocompromised patients, infants, young children and elderly 
people (> 50 years) have higher risks of NTS infection and may develop severe 
invasive salmonellosis (Asmar and Abdel-Haq, 2015; Dhanoa and Fatt, 2009). 
Invasive salmonellosis is a spectrum of extra-intestinal diseases which 
include enteric fever (i.e., typhoid and paratyphoid fever) and invasive nontyphoidal 
Salmonella (iNTS) infection (Khan et al., 2016). Bacteraemia is an example of major 
extra-intestinal complications, in which Salmonella disseminate into the bloodstream 
after invading the intestinal barrier. Like enteric fever, bacteraemia is characterised 
by high-grade fever (≥ 38°C), persists for more than 12 hours (Gibani et al., 2015). 
In certain circumstances, bacteraemia develops into septic shock, due to 
dysregulation of immune response (Thompson Bastin et al., 2016). It is estimated 
that 5% – 9% NTS bacteraemia patients developed septic shock, commonly with 
pulmonary involvement (Dhanoa and Fatt, 2009; Eng et al., 2015). Other extra-
intestinal sequalae include cellulitis, urinary tract infections (UTI), meningitis and 
endocarditis (Tapia et al., 2015).  
In addition, approximately 2% – 5% of enteric fever patients may become 
chronic carriers, in contrast to 0.15% occurrence rate in patients with NTS (Gunn et 
al., 2014). Chronic carriage incidence is associated with existing gallstone (90% 
prevalence), whereby its presence foster synthesis of Salmonella biofilm (Crawford 
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et al., 2010; Gunn et al., 2014). These asymptomatic carriers are believed to have 
important roles in the maintenance of Salmonella within human populations since the 
first report of the Typhoid Mary in 1939 (Soper, 1939). 
 
1.3.5 Epidemiology 
Enteric fever and iNTS disease are emerging major public health concerns, 
especially in developing countries. The incidences are associated with behavioural, 
environmental and infrastructural factors, especially in areas with inadequate 
sanitation facilities and poor water supply systems (Khan et al., 2016; Phu Huong 
Lan et al., 2016). In many situations, epidemiological data for invasive salmonellosis 
are separated into (i) enteric fever; consist of typhoid fever & paratyphoid fever, and 
(ii) iNTS infections, based on the etiologic agents for each clinical manifestations. 
Worldwide, it was estimated that between 6.9 and 48.4 million cases of 
enteric fever were reported annually (Saad et al., 2018). While S. Typhi accounted 
for  217,000 deaths, S. Paratyphi A, B and C were estimated to cause 0.5% death of 
the total incidence (Buckle et al., 2012). The vast majority (~80%) of this burden 
occurred in Africa and Asia, particularly India, Bangladesh, Nepal, Pakistan, China, 
Laos, Vietnam and Indonesia (Chau et al., 2007; Kothari et al., 2008).  
Meanwhile, 2.1 – 6.5 million iNTS cases were reported worldwide, every 
year.  Of these iNTS cases, approximately 20% were fatal, which were equivalent to 
681,316 (range 415,165 – 1,301,520) deaths, annually (Ao et al., 2015). In other 
studies, case fatality rates (CFR) were estimated between 3% (62,275 – 195,228 
death) and 47% (1,037,912–3,253,800 death). More than 50% of the global cases 
occurred in sub-Saharan African countries, especially among the children (0 – 4 
years) and young adults (30 – 40 years) (Ao et al., 2015). In Malaysia, typhoid and 
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paratyphoid fever are listed as mandatorily notifiable diseases, in which potential 
outbreaks and incidence are monitored continuously. According to the Ministry of 
Health Malaysia, the prevalence of typhoid fever is 0.57 cases per 100,000 
population with 0.01 death per 100,000 population (MOH, 2016). 
 
1.3.6 Risk factors 
Host genetic factors play critical roles in the epidemiology of salmonellosis. 
For instance, individuals with HLA-DRB1*0405 gene within the major 
histocompatibility complex (MHC) region, have 5-fold lower risk of developing 
enteric fever (Dunstan et al., 2014). This resistance may due to the differences in the 
antigen presentation and subsequent immune response. Meanwhile, patients with 
impaired expression of IL-12Rβ1 chain of the interleukin-12 receptor (IL-12R) were 
highly susceptible to Salmonella infections. Deficiency in IL-12R expression impairs 
pro-inflammatory interferon-γ (IFN-γ) production and type 1 helper T cell (TH1) 
responses, which are important in overcoming intracellular infections (de Jong et al., 
1998). In other areas, patients (especially children) with malnutrition, sickle cell 
disease and malarial anaemia were associated with higher incidences of 
salmonellosis (S. C. Wen et al., 2017). In a Malaysian study, 65.5% of iNTS patients 
had at least one underlying immunosuppression, particularly malignancy, AIDS or 
Systemic Lupus Erythematosus (SLE) (Dhanoa and Fatt, 2009). 
Besides, household-related factors, such as unhygienic preparation of food, 
poor hand washing behaviour, and recent Salmonella infections within the family 
members were also associated with salmonellosis (Fangtham and Wilde, 2008). 
Similarly, increased odd-ratios (ORs) were observed in individuals with low score of 
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hand-washing practice (i.e. before eating, after defecating), washing food produce 
before eating and eating lolo (squeeze coconut) (Prasad, 2015). 
In addition to household aspects, increased salmonellosis incidences were 
also associated with environmental factors. For instance, increased rainfall and close 
distance to river increased the risk of salmonellosis (de Alwis et al., 2018). In the 
more temperate area, increase in temperature is associated with higher number of 
cases (Akil et al., 2014). For example, one unit increase in temperature (1 
Fahrenheit) in Maryland, USA was associated with 4% increased risk of 
salmonellosis. At coastal areas of the same state, such an increase in temperature and 
increased rainfall resulted in a higher salmonellosis rate (7.1%) (Jiang et al., 2015). 
Moreover, a high number of salmonellosis incidences were reported following major 
climatic incidences, as seen in 20.5% survivors who reported gastroenteritis and 
diagnosed as salmonellosis, 2 weeks after the catastrophic 2004 Acheh Tsunami 
(Sutiono et al., 2010). 
 
1.3.7 Diagnosis 
Diagnosis of salmonellosis is important for initiation of appropriate treatment 
and control of the disease. To date, the laboratory tests for diagnosis of salmonellosis 
are categorised into; (i) culture methods, (ii) serology method and (iii) molecular 
assays. 
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1.3.7 (a) Culture method 
Isolation of Salmonella colonies from clinical specimens, such as blood, bone 
marrow and stool is a definitive diagnosis of salmonellosis. This method is most 
useful for detection of bloodstream infection during the first two weeks of the disease 
onset. Without prior antibiotic treatment, the sensitivity of Salmonella culture is as 
high as 80%. However, the sensitivity drops to as low as 40% in treated patients 
(Andrews and Ryan, 2015).  
Several culture media can be used for isolation of these non-fastidious Gram-
negative bacilli. For inoculation of non-sterile specimens such as stool, selective 
differential media such as Hektoen (HE) agar and selenite broth with brilliant green 
(Steven and David, 2014). This medium contains (i) bile salts that inhibit certain 
growth of coliforms, (ii) acid fuchsin & bromothymol blue to indicate carbohydrate 
dissimilation and (iii) ferric iron to allow the formation of H2S from thiosulfate. On 
HE agar, Salmonella colonies are blue-green colonies with or without production of 
blackish H2S (Corry, 2003). Meanwhile, for the cultivation of Salmonella from 
sterile specimens, such as blood that contains a low number of the organism (<10 
colonies per ml), enriched media such as blood culture fluid (BD BACTEC and 
BacT/Alert vials) can be used. Following isolation, Salmonella can be screened using 
routine biochemical tests such as Triple Sugar Iron (TSI) agar,  Simmons Citrate 
Agar, urea agar and Motility-Indole-Ornithine (MIO) agar (Mikoleit et al., 2015). 
For definitive identification, commercial API 20E, Remel RapID ONE, Phoenix, 
Vitek 2 and MALDI-TOF mass spectrometry can be used (Wisplinghoff, 2017). 
Complementary serotyping based on the H, O and Vi antigen of the Kauffman-White 
scheme are necessary to confirm the serovars (Mikoleit et al., 2015). 
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1.3.7 (b) Serological diagnosis 
In addition to bacterial culture, the indirect presence of Salmonella can be 
demonstrated by the detection of specific antibodies. In certain regions, the Widal 
test is used to measure agglutination between antibodies (from patient sera) and 
Salmonella antigens, (H and O). Despite its simplicity and inexpensiveness, the 
performance of this test is limited. In an evaluation study, the clinical sensitivity and 
specificity were found between 72% – 80 % and between 51% – 58%, respectively 
(Adhikari et al., 2015). Lower sensitivity (36%) and specificity (58%) were observed 
in a recent study in India (Rao, 2018). Meanwhile, the clinical performance of other 
serological assays, including rapid diagnostic tests (RDTs) and ELISA are listed in 
Table  1.8. 
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Table ‎1.8 Clinical sensitivity & specificity of selected rapid diagnostic tests 
(RDTs) and ELISA for salmonellosis diagnosis 
Kit 
Sensitivity 
(%) 
Specificity 
(%) 
References 
Cromotest® O : semiquantitative  95 4 
(Keddy et al., 
2011) 
Cromotest® H : semiquantitative  80 50 
Cromotest® O: single tube  87 7 
Cromotest® H: single tube  95 14 
Typhidot® IgM 75 61 
Typhidot® IgG 69 70 
MyBioSource ELISA IgM 95 94 (Adhikari et al., 
2015) MyBioSource ELISA IgG 96 95 
Test-It Typhoid 69 90 (Wijedoru et al., 
2017) TUBEX 78 87 
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1.3.7 (c) Molecular diagnosis 
Nucleic acid amplification testing for direct detection of Salmonella DNA has 
been explored since the early 1990s (Song et al., 1993). In the early days, 
conventional PCR was developed against common genes encoding for flagellin or 
more specific genes such as invA and spvC with a sensitivity of approximately 200 – 
250 organisms per reaction. The assays may detect a particular serovar (i.e. S. Typhi 
or S. Typhimurium), a combination of serovars (i.e. S. Typhi & S. Paratyphi A) or a 
particular species (i.e. S. enterica) (Chiu and Ou, 1996; Goay et al., 2016; G. G. 
Stone et al., 1994). 
On the other hand, qPCR (SYBR and TaqMan) are better alternatives, in 
terms of sensitivity and specificity. Example of SYBR qPCR includes the 
Combinatory SYBR®Green qPCR System (CoSYPS) that enables the detection and 
differentiation of Salmonella genus, S. enterica and S. enterica subp. enterica. 
Despite its good analytically sensitivity and specificity, this assay is not validated 
clinically (Barbau-Piednoir et al., 2013). Another instance is clyA-TaqMan qPCR, 
developed for detection of S. Typhi and S. Paratyphi A. However, upon validation on 
blood specimens collected from suspected patients, this assay had clinical sensitivity 
and specificity of 28.6% and 94.7%, respectively. Moreover, this assay also cross-
reacted with diarrheagenic E. coli (Tennant et al., 2015). 
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1.3.8 Management and treatment 
Salmonella gastroenteritis is usually self-limiting and does not require 
antimicrobial treatment. However, antibiotic treatment for this infectious diarrhoea 
remains controversial as more than one organism (i.e. EPEC, Vibrio cholerae) may 
present during the illness. On the other hand, several studies have shown that 
antibiotic treatment in non-typhoidal salmonellosis prolonged NTS shedding in 
faeces and increased risk of relapse (Gillies et al., 2015; Nelson et al., 1980). 
Therefore, antibiotic treatments are recommended for invasive salmonellosis (enteric 
fever and iNTS), as well as for patients who are at high risk of developing invasive 
disease. In the absence of effective therapy, the case-fatality rate is between 10% – 
30%. The fatality is reduced to 1% – 4% when appropriate antibiotic treatment is 
administered (Buckle et al., 2012). 
Both inpatient and outpatients with enteric fever or invasive salmonellosis 
should be monitored for complication. Supportive measures such as electrolyte 
replacement and rehydration should be considered when indicated. While most 
patients can be treated at home, about 10% – 22% may require hospitalisation and 
parenteral antimicrobial treatment (Chen et al., 2013). Table  1.9 summarises WHO 
recommendation for treatment of enteric fever in non-severe and severe cases. 
Meanwhile, the Ministry of Health Malaysia (MOH) further specifies 
treatment based on age groups. Among non-severe cases, ampicillin or ciprofloxacin 
is recommended for adult patients. Meanwhile, for non-severe paediatric cases, third 
generation cephalosporin, ceftriaxone is suggested. Alternatively, chloramphenicol 
can also be considered. Meanwhile, for severe cases, higher doses of respective 
antibiotics should be administered. Details of antibiotic treatment per 
recommendation of MOH are listed in Table  1.10.  
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Table ‎1.9 WHO recommendations of antibiotic treatment in (A) non-severe and 
(B) severe enteric fever  
Optimal therapy Alternative therapy 
(A) 
Susceptibility 
Antibiotic 
Daily 
dose 
mg/kg 
Days Antibiotic 
Daily 
dose 
mg/kg 
Days 
Fully sensitive 
Ciprofloxacin 
Ofloxacin 
15 5-7 
Chloramphenicol 50-75 14-21 
Amoxicillin 75-100 14 
TMP-SMX 8-40 14 
Multidrug 
resistance 
Ciprofloxacin 
15 5-7 Azithromycn 
Cefixime 
8-10 
15-20 
7 
7-14 
Ofloxacin 
Cefixime 15-20 15-20 
Quinolone 
resistant 
Azithromycin 8-10 7 
Cefixime 20 7-14 
Ceftriaxone 75 10-14 
       
Optimal therapy Alternative therapy 
(B) 
Susceptibility 
Antibiotic 
Daily 
dose 
mg/kg 
Days Antibiotic 
Daily 
dose 
mg/kg 
Days 
Fully sensitive Oxofloxacin 15 10-14 
Chloramphenicol 100 14-21 
Amoxicillin 100 14 
TMP-SMX 8-40 14 
Multidrug 
resistance 
Ciprofloxacin 
15 10-14 
Ceftriaxone or 60 
10-14 
Ofloxacin cefotaxime 80 
Quinolone 
resistant 
Ceftriaxone or 60 
10-14 
Ciprofloxacin 
20 7-14 
cefotaxime 80 Ofloxacin 
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Table ‎1.10 MOH recommendations of antibiotic treatment of non-severe and 
severe enteric fever cases 
Cases Antibiotic 
Dose  
(mg per kg) 
Days 
Adult 
(Uncomplicated) 
Ampicillin 500 14 
Ciprofloxacin 750 5-7 
Chloramphenicol 500 14 
Paediatric 
(Uncomplicated) 
Ceftriaxone 60-100 5-7 
Adult 
(Complicated) 
Ceftriaxone 30 5-6 
Ciprofloxacin 200 5-7 
Paediatric 
(Complicated) 
Ceftriaxone 60-100 5-7 
Resistant Depend on sensitivity 
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1.4 Plasmodium and malaria 
Malaria is an infection caused by Plasmodium protozoan parasites. The name 
of the disease originated from ‗mala‘ and ‗aria‘ in Italian which mean ‗bad air‘. The 
discovery of this disease began in 1880, by Alphonse Laveran, who observed black-
pigmented crescentic bodies of the parasites in the blood specimens of malarial 
patients. The organism was named Oscillaria malariae (CDC, 2015). Seventeen 
years later, William MacCallum and Eugene Opie, of the Johns Hopkins University 
discovered sexual stages of Plasmodium. During this period of time, the important 
roles of mosquito vectors; the female Anopheles, in the transmission of Plasmodium, 
were discovered by Sir Ronald Ross. Finally, the complete cycle of this parasite was 
concluded in 1982, when Wojciech Krotoski successfully demonstrated the dormant 
stage of Plasmodium in the liver (Phillips et al., 2017). 
 
1.4.1 Biology of Plasmodium and cultivation 
Plasmodium are eukaryotic protozoa that have complex life cycles, within 
two different hosts. Like other eukaryotes, these malarial pathogens have linear 
genomes and organelles such as ribosomes, mitochondria, enclosed by a plasma 
membrane and pellicular cisterna (Phillips et al., 2017). 
Among all, the Plasmodium merozoites are well characterised. Merozoites are 
oval in shape and are approximately 1.5 µm (in length) and 1 µm (in width). The 
apical end of merozoites contains polar rings and some secretory vesicles that are 
important for cellular invasions. Once released in the blood, merozoites are short-
lived and invade a new erythrocyte for survival. The poor extracellular survival of 
malaria parasite hampered research studies on Plasmodium and dependent of 
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constant need of an animal host for a continuous supply of parasites (Bannister et al., 
2000). 
In vitro cultivation of Plasmodium was pioneered by William Trager and J.B. 
Jensen in 1976 who described artificial media that could support malarial growth 
(Trager and Jensen, 1976). Artificial media for Plasmodium usually consists of a 
minimal tissue culture media i.e. Roswell Park Memorial Institute (RPMI)1640 
medium or MEM medium, seeded with serum and erythrocytes. Culture plates are 
incubated at 38 C with CO2 (2% – 5%), O2 (3% – 18%) and N2 gases (Childs et al., 
2013). The condition of the culture is closely monitored and synchronised to mimic 
original condition in mammalian hosts.  
 
1.4.2 Classification and taxonomy 
Plasmodium are unicellular protozoa which belong to the family 
Plasmodiidae and genus Plasmodia. These obligate intracellular eukaryotes made up 
more than 100 species, of which, five species are capable of infecting humans and 
cause malaria. The clinically important species include Plasmodium falciparum, 
P.malariae, P.ovale, P.vivax and P. knowlesi (zoonotic malaria) (Sherman, 2012).  
Traditionally, Plasmodium are characterised based on its morphology, 
depending on its cycles and species. However, in more recent years, molecular tools 
have been available to explore relatedness of Plasmodium genus. Among the 
commonly used nucleic acid sequences is the mitochondrial genome. Mitochondrial 
genomes have been shown to be unique, different structure, size and organisations. In 
Plasmodium, the mitochondrial genome is linear and consist of distinctive tandem 
repeats (Fuehrer and Noedl, 2014). With the availability of whole-genome 
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sequencing techniques such as next-generation sequencing (NGS) enables 
acceleration of genomic research.  
To date, twenty complete Plasmodium genomes have been described, 
including 5 species that can infect humans. Based on the genomic analysis, malarial 
Plasmodium has three genomes that include (i) a nuclear genome with 14 linear 
chromosomes, (ii) a linear mitochondrial genome and (iii) a vestigial circular plastid 
genome homologous to red-alga‘s chloroplasts. Summary of genomic characteristic 
of five medically important Plasmodium species is listed in Table  1.11. 
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Table  1.11 Characteristic of malaria genomes according to each medically 
important Plasmodium species. Adapted from Antinori et al. (2012).  
Malaria species 
Overall genome 
size (Mb) 
Number of 
genes 
Overall A+T 
content (%) 
Overall G+C 
content (%) 
P. falciparum 23.3 5,403 80.6 19.4 
P. knowlesi 23.5 5,188 62.5 37.5 
P. malariae 31.9 5,930 75.3 24.7 
P. ovalae 35.7 8,421 71.1 28.9 
P. vivax 26.8 5,433 57.7 42.3 
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1.4.3 Pathogenesis 
The life cycles of Plasmodium consist of (i) exogenous sexual phase (named 
sporogony), which take place in Anopheles mosquitoes and (ii) endogenous asexual 
phase (named schizogony), which happen in humans. The latter phase is further 
divided into (a) exo-erythrocytic cycle and (b) erythrocytic cycle. Figure  1.9 
illustrates complete life cycle of Plasmodium parasite. In general, during a blood 
meal, the female Anopheles carrier inoculated sporozoites into humans, marked as 
the start of the exo-erythrocytic cycles (CDC, 2018). Sporozoites remain in the 
parenchyma cells, mature into schizonts and ruptured as merozoites (Phillips et al., 
2017).  
The release of merozoites into bloodstream is the beginning of the 
erythrocytic cycle. Merozoites invade erythrocytes and developed into trophozoites 
and schizonts, which eventually ruptured and release more merozoites. Meanwhile, 
some trophozoites develop into gametocytes. Gametocytes are made of 
microgametocytes (male) and macrogametocytes (female) and ingested by Anopheles 
mosquitos during a blood meal (Cowman et al., 2016).  
Within the vector host, sexual sporogonic cycle begins in which 
microgametes penetrates macrogametes and become ookinetes. Ookinetes develop 
into oocysts in the mosquito midgut wall (Antinori et al., 2012). Eventually, oocysts 
will rupture, release sporozoites that travel to the salivary gland of the mosquitoes, 
ready for inoculation into a new human host (Phillips et al., 2017). Characteristics of 
malaria infections based on respective species are summarised in Table  1.12. 
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Figure ‎1.9 Life cycle of malaria parasites, in mosquito vectors and human hosts. 
Adopted from CDC (2018). 
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Table  1.12 Characteristic of malaria infection according to each medically 
important Plasmodium species. Adapted from Antinori et al. (2012). 
Characteristics P. falciparum P.vivax P.malariae P.ovale P.knowlesi 
Exo-erythrocytic 
stage (days) 
5 – 7 6 – 8 14 – 16 9 8 – 9 
Pre-patent period* 
(days) 
9 – 10 11 – 13 15 – 16 10 – 14 9 – 12 
Erythrocytic cycle 
(hours) 
48 48 72 50 24 
Red cells affected All Reticulocytes 
Mature 
erythrocytes 
Reticulocytes All 
Av. parasitaemia 
(per μl) 
20,000 – 
500,000 
20000 6000 9000 600 – 10,000 
Max. parasitaemia 
(per μl) 
2000000 100000 20000 30000 236000 
Febrile paroxysm 
(hours) 
16 – 36 or 
longer 
8 – 12 8 – 10 8 – 12 8 – 12 
Severe malaria ✓ ✓ X X ✓ 
Relapses from liver 
forms 
X ✓ X ✓ X 
Recurrences 
✓ 
(treatment 
failure) 
✓ 
(treatment 
failure) 
✓ X ✓ 
* Interval period between sporozoites inoculation (during mosquito blood meal) and 
trophozoites detection in blood 
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1.4.4 Malaria in human 
Upon inoculation of malarial parasites by Anopheles into a human host, the 
parasites are detectable in the blood between the first two weeks. This time interval is 
also known as the pre-patent period. During this stage, initial presentation are non-
specific, which include fever (92.5% – 100%), headache (89%), myalgia (58%), 
diarrhoea (20.6% – 72%) and cough (28.8%) (Arévalo-Herrera et al., 2015; Bouyou-
Akotet et al., 2014; Braga et al., 2015; Mutanda et al., 2014). In young children, loss 
of appetite (64%) and vomiting (31%) are also common (Mutanda et al., 2014). 
During uncomplicated malaria, patients may have parasitaemia level between 1,000 
– 50,000 parasites per µl of blood (Phillips et al., 2017). 
Untreated or partially treated patients may develop severe malaria. According 
to the WHO, severe malaria is characterised by impaired consciousness (Glasgow 
coma score <11), generalised weakness, more than two convulsion within 24 hours, 
acidosis, hypoglycaemia (<2.2 mmol/L), severe anaemia, renal impairment, jaundice, 
pulmonary oedema, haemorrhage, compensated shock and hyperparasitaemia (WHO, 
2015). In terms of frequency, approximately 10% of malaria cases developed into 
these severe form (Arévalo-Herrera et al., 2015; Kurth et al., 2017). However, the 
severe rate is significantly higher among children (41.1%) and pregnant women 
(47.7%) (Geleta and Ketema, 2017; Maltha et al., 2014). 
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1.4.5 Epidemiology 
Malaria is a fatal infection caused by Plasmodium parasites that are 
transmitted by infected Anopheles mosquito vectors. According to the WHO, 
between 196 and 263 million people were infected in 2016. Despite a slight decrease 
in death, the mortality number remains steady at 225,000 cases, globally. 
Remarkably, more than 90% of cases and death occurred in Africa, almost entirely 
caused by P. falciparum. Outside Africa, P. vivax is a common cause of malaria in 
Americas (63%), Mediterranean (40%) and South-East Asian (>30%) (WHO, 
2017b). 
In Malaysia, malaria cases must be notified and actively monitored. As shown 
in Figure  1.10, the overall trend of malaria is steadily reducing, from over 7,000 
cases in 2008 to less than 2,500 cases in 2016. Similarly, indigenous cases and 
imported cases of malaria remain low, since the past 6 years (WHO, 2017a). 
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Figure  1.10 Malaria cases in Malaysia, between the year of 2005 and 2016. 
Adapted from WHO (2017a)  
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1.4.6 Risk factors 
Transmissions of malaria are attributed to several aspects that can be 
clustered into (i) human-related factors, (ii) environmental factors and (iii) biological 
factor. In endemic regions, the age of below 40 years was associated with an 
increased risk of malaria (Schwartz et al., 2001). Specifically, WHO estimated that 
285,000 children under 5 years old died due to the severe complication of malaria, 
which includes severe anaemia and cerebral malaria, every year (WHO, 2018). Of 
this young age group, children aged between 6 months and 5 years were most 
susceptible as they have lost maternal immunity, at the same time, specific immunity 
against malaria have not been fully developed (Schumacher and Spinelli, 2012).  
Pregnancy is another risk factor associated with malaria. In Africa alone, 
approximately 200,000 stillbirth cases were due to P. falciparum during pregnancy 
(K. A. Moore et al., 2017). Higher risk of malaria infection during pregnancy may 
due to the hormonal changes, the attractiveness of mosquitoes towards expecting 
mother, as well as the presence of specific receptors such as chondroitin sulphate A 
(CSA) and sequester in the placenta (Takem and D‘Alessandro, 2013). 
In addition to these factors, the density of Anopheles (>1.5 Anopheles per 
house), late outdoor activities, time spent outdoors and lack of preventative measures 
such as indoor residual spraying (IRS) and bed net were also associated with increase 
of malaria cases (Chirebvu et al., 2014; Protopopoff et al., 2009; Roberts and 
Matthews, 2016). Other factors that influence the risk of malaria are illustrated in 
Figure  1.11. 
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Figure  1.11 Factors associated with malaria infections. Adopted from  Protopopoff 
et al. (2009)  
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1.4.7 Diagnosis 
Accurate and prompt diagnosis of malaria significantly reduces mortality and 
morbidity. Similar to leptospirosis, melioidosis and invasive salmonellosis, 
presumptive diagnosis for malaria is challenging due to the lack of pathognomonic 
clinical signs or symptoms. As a result, complementary laboratory diagnosis is 
necessary to confirm the infection. 
 
1.4.7 (a) Microscopic observation 
Microscopic examination of blood smear with Giemsa stain is reference 
standard for diagnosis of malaria. This method allows identification of infecting 
Plasmodium species and quantification of parasitaemia. However, the sensitivity of 
microscopy method is inconsistent (10 – 1000 parasites per µl blood), depending on 
the experience of the laboratory technicians, quality of smear and stains, and 
concentration of parasites (Kakkilaya, 2015; Mukry et al., 2017). Microscopy is less 
reliable at low parasitaemia (<50 parasites per μl) i.e. during pregnancy malaria 
where the parasites sequester at placenta (Fried et al., 2012; Lo et al., 2015). 
Quantitative Buffy Coat (QBC) is another method that is useful for screening 
malaria. This assay utilises staining of the Plasmodium DNA with acridine orange on 
centrifuged blood samples. Unlike Giemsa staining, this assay requires a 
fluorescence microscope, and less convenient for differentiation of infecting malarial 
species (CDC, 2018). 
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1.4.7 (b) Rapid diagnostic test (RDT) 
Several antigen-based tests are available to confirm the presence of 
Plasmodium. Among antigens of interest include histidine-rich protein 2 (HRP2) and 
Plasmodium lactate dehydrogenase (pLDH), utilising immunochromatographic 
lateral flow technology. An FDA-validated test that detects both HRP2 antigen and 
antibodies; BinaxNOW Malaria has sensitivity and specificity of 84% and 99%, 
respectively for non-P. falciparum malaria (Farcas et al., 2003). However, the assay 
was only able to correctly detect 29% of P. knowlesi infections (D. Foster et al., 
2014). 
 
1.4.7 (c) Molecular diagnosis 
Molecular assays generally are superior in terms of sensitivity (and 
specificity). To date, several molecular assays have been described. Such assays 
detect 18S ribosomal RNA (rRNAs), cytochrome C oxidase I gene (cox1) for pan-
detection of Plasmodium genus and/or differentiation of Plasmodium species. In the 
analytical evaluation, the assays had a limit of detections of between 5 – 100 copies 
per reaction (Gruenberg et al., 2018; Kamau et al., 2013).  
Upon evaluation on clinical specimens, certain qPCR assays suffered from 
reduced sensitivity, as low as 62.5%, with apparent evidence of non-specific 
amplicons (Echeverry et al., 2016; Ojurongbe et al., 2013). It is implied that 
differences in the distribution of infecting malarial species negatively affected the 
clinical performance of molecular assays (Gruenberg et al., 2018). 
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1.4.8 Management and treatment 
Prompt diagnosis and appropriate treatment are important for better 
prognosis, as well as reducing the risk of malaria transmission. Currently, 
artemisinin-based combination therapies (ACTs) remain as a core treatment for 
malaria. In uncomplicated P. falciparum malaria, 5 ACTs combination are 
recommended, which include either (i) artemether + lumefantrine, (ii) artesunate + 
amodiaquine, (iii) artesunate + mefloquine, (iv) dihydroartemisinin + piperaquine, or 
(v) artesunate + sulfadoxine-pyrimethamine. Meanwhile, in uncomplicated P. vivax, 
P. malariae, P. ovale or P. knowlesi malaria, treatment with chloroquine or standard 
regime of ACT is recommended. The latter is advocated in areas with prevalent 
chloroquine-resistance (WHO, 2015). In Malaysia, artemether + lumefantrine is the 
first line treatment for uncomplicated P. falciparum malaria (MOH, 2013). 
In severe malaria (i.e. patients with impaired consciousness, acidosis, 
jaundice), intramuscular or intravenous artesunate is recommended for at least 24 
hours. Once patients tolerate orally, treatment is continued with an ACT (WHO, 
2015). 
 
1.5 Laboratory diagnosis of infectious diseases 
For the past two decades, clinical microbiology laboratories have been 
carrying significant roles in determining a plethora aetiologies of infections that are 
paramount to patients‘ well-being and treating physicians (Isenberg, 2003). Since 
then, clinical microbiology laboratories have evolved correspondingly to the clinical 
needs, as well of the technology advancements. The current state-of-the-art, modern 
clinical microbiology laboratories employ a variety of diagnostic platforms, ranging 
from basic staining methods to molecular assays. 
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1.5.1 Conventional method 
Conventional microbiology testing includes microscopy, culture and 
serology. The utilisation of microscopy to demonstrate the direct presence of 
microorganisms remains relevant and are considered as gold-standard in many 
instances, such as stool and malarial parasites (Isenberg, 2003). Moreover, culture 
also remains important as certain organisms are cultivatable in artificial media and 
serve as another method for laboratory diagnosis of bacterial infection. Despite their 
relative simplicity, microscopy and culture are less sensitive when the pathogens 
exist in low number. Moreover, culture is prone to false negativity when organisms 
fail to grow (i.e. due to antibiotic treatment) and require a long incubation period of 
time (Limmathurotsakul et al., 2010).  
Meanwhile, serological assays utilised detection of specific antibodies against 
infecting microorganism, typically produced two weeks after initial exposure. As a 
result, serological tests pose limited usefulness during the acute phase of infections 
(Musso et al., 2013). Alternatively, molecular methods, such PCR and qPCR are 
perceived as powerful choices (in terms of sensitivity & specificity), that can 
potentially be applied for early detection of infection (Laupland and Valiquette, 
2013). 
 
1.5.2 Molecular method 
―Molecular revolution‖ significantly impacts clinical microbiology 
laboratories and gradually replacing conventional methods in many regions (Smith 
and Osborn, 2009). Molecular assays, such as (conventional) PCR utilise Taq 
polymerase for amplification of desired nucleic acid targets, in the presence of at 
least a pair of primers, buffers, salts and dNTPs. In all occasion, results (positivity or 
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negativity) are recognised by the presence (or absence) of PCR products (or 
amplicons) with the correct sizes, achieved after ~ 60 minutes of gel electrophoresis. 
In many diagnostic laboratory settings, conventional PCR successfully replaced 
enzyme immunoassay (EIA) as a reference method i.e. for chlamydia detection 
(Laupland and Valiquette, 2013). However, the compulsory post-PCR 
electrophoresis is laborious and increases the risk of PCR product contamination 
through aerosolisation. 
Simultaneous quantification of amplified PCR products was pioneered by 
Higushi et. al. in 1992. The team included ethidium bromide in the PCR reaction 
which enabled detection of fluorescence increment, proportionately to the amount of 
PCR product, during each cycle. By plotting the fluorescent signals and cycle 
number, a complete graph with real-time detection of the amplification product can 
be produced. This technology omits requirement of post-amplification gel 
electrophoresis (Patrinos and Ansorge, 2005).  
Since then, the real-time PCR (qPCR) technology evolves rapidly, producing 
many derivative applications with different types of fluorescent dyes. These real-time 
molecular assays are grouped based on the fluorescent agents used; (i) intercalating 
dyes and (ii) fluorophores attached to oligonucleotides. The latter group can be 
further divided into (i) primer-probe (probe functions as a primer), (ii) hydrolysis 
probe and (iii) nucleic acid analogues. Figure  1.12 summarises types of qPCR assays 
based on their respective fluorescent agents. 
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Figure  1.12 Types of qPCR assays based on the fluorescent agent used. 
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SYBR® Green I is commonly used intercalating dye. The structure is based 
on cyanine dye (2-[N-(3-dimethylaminopropyl)-N-propylamino]-4-[2,3- dihydro-3-
methyl-(benzo-1,3-thiazol-2-yl)-methylidene]-1-phenyl-quinolinium). Under thermal 
cycling condition, the dye is positively charged (2+) which will bind to the minor 
groove of dsDNA with strong affinity. This dsDNA-SYBR complex absorbs and 
emits lights (λmax) at 497 nm and 520 nm, respectively (Arya et al., 2005). In 
addition to SYBR, more recent intercalating dyes include EvaGreen, a more stable 
dye, useful for  high-resolution melt (HRM) analysis. Despite the possibility to 
analyse the melting temperature of resulting PCR products, the risk of false positivity 
due to primer-dimerisation cannot be fully excluded (Sánchez et al., 2017). 
Moreover, multiplexing in SYBR/EvaGreen (to detect more than one target) is 
challenging, rely solely on the difference in the melting peaks (Navarro et al., 2015). 
Another qPCR group employs fluorophores (also called as dye), that are 
attached to oligonucleotides. Fluorophores are small fluorescent molecules, made up 
of reporter and quencher, which are attached to oligonucleotides function as probes. 
During absorbance, ‗ground state‘ reporter fluorophore absorbs energy from light 
and become to an ‗excited state‘. To return to the ‗ground state‘, reporter fluorophore 
will emit energy (emission) as fluorescence. The emitted light from a donor has 
lower energy, lower frequency and longer wavelength than the absorbed light. 
Therefore, if another quencher fluorophore presents in close distance (10 to 100 Å), 
it can absorb the emitted light from the reporter fluorophore. This transfer is 
expressed as Fluorescence Resonance Energy Transfer (FRET) (Crisalli and Kool, 
2011).  
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Primer-probe is the first group of qPCR platform that utilises fluorophores. 
Primer-probe is a fragment of oligonucleotides that acts as both primer and probe. 
These oligonucleotides have conjugated fluorophores. Fluorescence is measured 
when primer-probe oligonucleotides are linearised during PCR amplification 
(Navarro et al., 2015). Primer-probes can be further divided into (i) hairpins primer-
probes (i.e. Scorpion, Amplifluor®, LUX), (ii) Cyclicon primer-probe and (iii) 
Angler® primer-probes. Details of primer-probes are illustrated in Figure  1.13. 
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Figure  1.13 Action mechanism of primer-probes. Adopted from Navarro et al. 
(2015). 
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Probe is the second group of qPCR platform that utilises fluorophores. Unlike 
primer-probe that serves a dual function, the probe is a single-stranded 
oligonucleotide with a reporter fluorophores and/or a quencher. The probe is further 
categorised into (i) hydrolysis probe and (ii) hybridisation probe. Hydrolysis probe 
utilises 5‘ – 3‘ exonuclease activity of Taq polymerase enzyme (Holland et al., 
1991). It can be further divided into (a) TaqMan probe and (b) Snake assay. 
Mechanism of TaqMan probe is detailed in section  1.6. Meanwhile, the mechanism 
of snake assay is similar to TaqMan probe except that the complementary primer 
contains special sequence (snake primer). Following amplification, this special 
sequence will self-hybridise to form a small loop. The probe will bind next to this 
loop and get hydrolysed. Details of the snake assay are illustrated in Figure  1.14. 
Hybridisation probe also utilises hydrolysis probe and quencher. The 
differences are the location of fluorophores (either on the same oligonucleotide or 
different oligonucleotides), the location of reporter dye (at 5‘-end, 3‘-end or in the 
middle), the presence of loop, as well as the presence of  a 3′-end blocker (3′-
octanediol or phosphate). Hybridisation probe includes Hybprobes/FRET probe, 
Molecular Beacon probe, HyBeacons probe, MGB-probes, ResonSense® probe 
and Yin-Yang probe (Kong et al., 2007). 
The last category of qPCR utilises nucleic acid analogue, which resembles 
DNA, but contains alteration at their phosphate DNA backbone and pentose sugar 
substitution, as shown in Figure  1.15. Once paired with a fluorophore, nucleic acid 
analogue can serve as probes. This nucleic acid analogues are more stable at a low 
salt concentration of PCR buffer, resistant to nucleases and bind strongly to 
complementary DNA templates  Examples of nucleic acid analogue include peptide 
nucleic acids (PNA), locked nucleic acids (LNA) and zip nucleic acids (ZNA) (Bala 
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et al., 2016). Figure  1.16 illustrates the mechanism of ZNA. In this ZNA assay, a 
probe conjugated with cationic spermine unit is attracted to the negatively charged 
DNAs. Hybridisation happens once the probe binds to its complementary sequence 
located on the DNA target (Navarro et al., 2015). 
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Figure  1.14 Mechanism of snake assay that utilises hydrolysis probe. Adopted 
from Navarro et al. (2015). 
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 Figure  1.15 Comparison of chemical structures between a nucleic acid analogue, 
PNA and  DNA. Adopted from Navarro et al. (2015). 
 
 
 
Figure  1.16 Binding of a nucleic acid analogue, ZNA to DNA template during 
PCR amplification. Adopted from Navarro et al. (2015). 
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In addition to conventional PCR and qPCR, isothermal amplification has 
been used to amplify nucleic acid from pathogens at a single temperature, with or 
without additional digestive enzyme such as helicase (Zhao et al., 2015). To date, at 
least, 15 different isothermal amplifications have been described and can be 
classified according to the reaction kinetics; (i) exponential amplification, (ii) linear 
amplification and (iii) cascade amplification. 
The exponential amplification group consists of nucleic acid sequence-based 
amplification (NASBA), exponential strand displacement amplification (E-SDA), 
exponential rolling circle amplification (E-RCA), loop-mediated isothermal 
amplification (LAMP), Helicase-Dependent Amplification (HDA) and recombinase 
polymerase amplification (RPA). Moreover, exponential isothermal amplification 
also includes exponential amplification reaction (EXPAR), whole genome 
amplification (WGA) and emerging exponential isothermal amplification, such as 
smart amplification process version 2 (SMAP 2) and Beacon-assisted detection 
amplification. These methods rely on exponential DNA replication hence pose high 
amplification efficiency and good sensitivity (Asiello and Baeumner, 2011). 
However, some assays suffer from non-specific amplification (production of multiple 
bands) and challenging in the design.  
Alternatively, linear isothermal amplifications are simpler and fast. This 
method includes linear SDA, linear RCA, transcription-based amplification and 
signal amplification strategies (Zheng et al., 2016). Yet, due to linear amplification 
strategy, some assays may have a weak signal and false negativity when the initial 
amount of template is low. To overcome these limitations, cascade amplifications 
have been introduced. In cascade amplification, enhancers such as DNAzyme, 
nucleases and NEase are included to improve the sensitivity of the assays (Zhu et al., 
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2017). Examples of commonly used isothermal amplification and their 
characteristics are listed in Table  1.13. 
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Table  1.13 Characteristic of commonly used isothermal amplification. Adapted 
from Navarro et al. (2015).  
Method 
Enzyme 
(required) 
Primer 
# 
Temp. 
(°C) 
Incubation 
(h) 
Template Amplicon 
E-SDA 
DNA polymerase 
and NEase 
2 or 4 37 2 DNA dsDNA 
EXPAR 
DNA polymerase 
and NEase 
0 ∼60 < 0.5 
short 
DNA/RNA 
DNA 
HDA 
DNA polymerase 
and helicase 
2 37−65 0.5−2 DNA DNA 
HRCA 
DNA polymerase 
and ligase 
2 60 1.5 DNA/RNA DNA 
LAMP DNA polymerase 4 60−65 < 1 DNA DNA 
MDA DNA polymerase 
rando
m 
primer
s 
30−37 > 8 DNA DNA 
NASBA 
Reverse 
transcriptase & 
RNA polymerase 
2 ∼41 1.5−2 RNA/DNA 
RNA, 
DNA 
PG-RCA 
DNA polymerase 
and NEase 
0 60 1−3 DNA/RNA DNA 
pWGA 
DNA polymerase 
and T7 gp4 
primase 
0 37 0.5−2 DNA DNA 
RPA 
DNA polymerase 
and recombinase 
2 37−42 0.5−1.5 DNA DNA 
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1.6 Hydrolysis probe-based qPCR 
The construction of hydrolysis TaqMan probe in 1988 and the discovery of 5‘ 
exonuclease activity of Taq DNA polymerase that was capable to degrade 
fluorophores‘ of a probe in 1991 marked as important milestones in molecular 
research (Cardullo et al., 1988; Holland et al., 1991). By combining these 
fundamental findings together, two related research teams from Genetech, USA 
successfully developed "real-time" quantitative PCR methods that were able to 
measure accurate and reproducible expressions of human -actin gene and cystic 
fibrosis transmembrane transductance regulator (CFTR) mRNA (Gibson et al., 1996; 
Heid et al., 1996). 
The principle of hydrolysis probe-based qPCR (or TaqMan qPCR) relies on 
hydrolysis probe (also known as a TaqMan probe) and 5‘ exonuclease activity of Taq 
polymerase, or any other polymerase with equivalent activity, such as Tth and Tfl 
polymerase (Ishino and Ishino, 2014). 
Structurally, a hydrolysis probe is a short fragment of sequence-specific 
oligonucleotides of (25 – 30 bp), double labelled with a reporter dye at 5‘ end and 
another quencher at the 3‘ end. Some probe manufacturers offer additional internal 
quencher, located in the middle of the probe to further reduce the effect of 
unnecessary ‗noise‘. In its intact form, probe does not emit detectable signal because 
the emitted energy from reporter dye is absorbed by the quencher, in a reaction called 
FRET (Crisalli and Kool, 2011). Figure 1.17 illustrates typical structure of a TaqMan 
hydrolysis probe. 
Availability of various reporter dyes with distinctive emission and absorbance 
ranges enable multiplexing in TaqMan qPCR. Numbers of PCR target that can be 
detected by a TaqMan qPCR depends on the quantity of channel/detectors of the 
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real-time thermal cycler. To date, almost a dozen companies have developed real-
time thermal cyclers. The companies are (according to seniority in the market) 
Applied Biosystems, Roche, Qiagen, BioGene, Bioneer, Bio-Rad, Cepheid, Corbett 
Research, Idaho Technology, MJ Research and Stratagene (Tajadini et al., 2014). For 
instance, Bio-rad CFX96 Touch™ Real-Time PCR Detection System enables 
simultaneous detection of five different targets and do not require any reference dye, 
such as ROX (for calibration purpose) (Jordan and Kurtz, 2010). List of reporter dyes 
and quenchers available in the market, as well as their characteristics are included in 
Table 1.14.  
In order to utilise all channel available within a real-time thermal cycle, 
reporter dyes and quenchers must be carefully selected. Such reporter dye ideally 
should have distinctive emission and absorbance range to avoid cross-talk. Crosstalk 
is an undesired phenomenon where fluorescence signal from a reporter dye is 
detected by more than 1 channel and results in false-positivity (Weidmann et al., 
2008). 
During amplification, probe and two other primers hybridise to the 
complementary DNA targets. Elongation of amplicon will happen from the 5‘end to 
the 3‘ end, of each primer. Once the new strand reaching the probe, the 5‘ 
exonuclease activity of Taq polymerase will cleave the reporter dye, releasing them 
from the probe. When free and no longer in close proximity with a quencher, the 
emitted energy of the reporter dye is detectable. This process happens in every 
amplification cycle. As the PCR products accumulate exponentially, stronger signals 
will be detected by the real-time PCR machine. Accumulation of ‗free‘ reporter dye 
does not inhibit PCR amplification (Navarro et al., 2015). Figure  1.18 illustrates 
amplification of DNA targets in a TaqMan qPCR assay. To date, several multiplex 
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TaqMan qPCR assays have been reported, for the detection of periodontal pathogens 
such as Fusobacterium nucleatum, Porphyromonas gingivalis and Treponema 
denticola and foodborne pathogens such as Listeria monocytogenes, Giardia lamblia, 
Yersinia enterocolitica and Enterovirus (Coffey et al., 2016; Morrison et al., 2015). 
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Table  1.14 Types of primer-probe used in qPCR. Adopted from 
http://www.genelink.com/oligo_modifications_reference/  
 
  
Quencher & Dye Selct ion Guide 
Dye Name Excitation 
Yellow-Green 
Yellow 
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Figure  1.17 Typical structure of TaqMan hydrolysis probe. Reporter dye (red 
circle) and quencher (black circle) located in close proximity within an 
oligonucleotide (blue line). 
 
 
 
Figure  1.18 Amplification of DNA targets in TaqMan hydrolysis probe-based 
qPCR. 
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1.7 Rationale of the study 
Leptospirosis, melioidosis, invasive salmonellosis and malaria are important 
causes of morbidity and mortality, worldwide, especially among those of the tropical 
and subtropical regions (WHO, 2014). Altogether, these communicable diseases 
accounted for 243.7 million cases and more than 1.4 million deaths, annually (Costa 
et al., 2015; Crump et al., 2015; Greenwood, 2017; Limmathurotsakul et al., 2016).  
Early detection enables prompt diagnosis and initiation of appropriate 
treatment. Subsequently, it increases patients‘ prognosis, reduces the risk of death, 
the burden of diseases and potential economic loss (Colzani et al., 2017; Nii-Trebi, 
2017). However, during the early phase of infection, patients develop febrile 
illnesses, together with other non-specific clinical features such as malaise, cough 
and diarrhoea, that perplexes clinical diagnosis (Beresford and Gosbell, 2016). As a 
result, complementary laboratory tests are required in order to confirm the diagnosis. 
Currently, each of these infectious diseases is detected by a different 
conventional laboratory test. In leptospirosis case, the existing gold standard, MAT 
has inconsistent sensitivity & specificity and less useful during the early phase of 
infection (Limmathurotsakul et al., 2012). Meanwhile, conventional culture for B. 
pseudomallei and Salmonella are laborious and time-consuming, requires more than 
24 hours incubation (Hemarajata et al., 2016). Microscopy examination for malarial 
parasites is specific, but less sensitive during low-level parasitaemia and entails 
experienced technicians (Lo et al., 2015). In undesired circumstances, potential 
misdiagnosis happens when either of the laboratory tests is requested or available. 
On top of that, there is no laboratory test that can simultaneously detect Leptospira, 
B. pseudomallei, Salmonella and Plasmodium in a single reaction. 
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To address the urgent needs of a reliable diagnostic assay for early diagnosis 
of leptospirosis, melioidosis, invasive salmonellosis and malaria, this study is 
designed to exploit the flexible platform of hydrolysis probe-based qPCR for the 
detection of pathogens‘ DNA from clinical specimens. This assay will detect nucleic 
acids of pathogens, which usually exist during the first two weeks of infection, at 
high sensitivity and specificity. In addition to these four pathogenic targets, an extra 
built-in internal amplification control (IAC) is also included to exclude potential 
false negativity due to PCR inhibitors and others. This important IAC function is 
often omitted and unavailable in many reported molecular assays. 
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1.8 Objective of the study 
General objective: 
To develop a sensitive and specific multiplex qPCR for the detection of 
pathogens associated with four common febrile infections (leptospirosis, melioidosis, 
invasive salmonellosis and malaria) simultaneously. 
 
Specific objectives: 
1. To design specific probes and primers, and optimize the developed multiplex 
qPCR. 
2. To optimize the incorporation of internal amplification control (IAC) in the 
developed assay. 
3. To perform the analytical evaluation (sensitivity & specificity) of the 
developed multiplex qPCR. 
4. To evaluate the stability and clinical performance of the developed multiplex 
qPCR.  
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1.9 Overview of the study 
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CHAPTER 2 
MATERIALS AND METHODS 
 
2.1 General materials and equipment 
2.1.1 Chemical and reagents  
Details of chemicals and reagents used in the study are listed in Table  2.1. 
2.1.2 Consumables and kits  
Details of consumables and commercial kits used in the study are listed in 
Table  2.2 and Table  2.3. 
2.1.3 Equipment 
Details of the equipment used in the study are listed in Table  2.4. 
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Table ‎2.1 List of chemicals and reagents used in this study  
Name Source 
5-fluorouracil Merck, Germany 
Absolute ethanol Merck, Germany 
Agarose powder First Base Laboratories, Malaysia 
Ampicillin Sigma Aldrich, USA 
Bacteriological agar Oxoid, UK 
Benzyl alcohol Sigma Aldrich, USA 
Deoxycholate Citrate Agar (DCA) Oxoid, UK 
Deoxyribonucleoside triphosphate (dNTPs) Fermentas, Lithuania 
Ethylenediaminetetraacetic acid (EDTA) Sigma Aldrich, USA 
GeneRuler™ 1 kb DNA Ladder Thermo Scientific, USA 
GeneRuler™ 100bp Plus DNA Thermo Scientific, USA 
Glycerol Merck, Germany 
Hydrochloric acid (HCL) Merck, Germany 
Leptospira Enrichment EMJH Difco, USA 
Leptospira Medium Base EMJH Difco, USA 
MacConkey No.3 powder  Oxoid, UK 
Magnesium chloride (MgCl2) Sigma Aldrich, USA 
Magnesium sulphate (MgSO4) Sigma Aldrich, USA 
Mineral oil Sigma Aldrich, USA 
Mueller Hinton (MH) agar powder Oxoid, UK 
Mueller Hinton (MH) broth powder Oxoid, UK 
Oligonucleotides Integrated DNA Technologies, Singapore 
Orange G Sigma Aldrich, USA 
PCR grade water Sigma Aldrich, USA 
Proteinase K Merck, Germany 
Raffinose BDH, UK 
RedSafe™ Nucleic Acid Staining Solution   iNtRON Biotechnology, Korea 
Sodium bicarbonate (NaHCO3) Sigma Aldrich, USA 
Sodium carbonate (Na2CO3) Sigma Aldrich, USA 
Sodium chloride (NaCl) Merck, Germany 
Sodium citrate (C6H5O7Na3) Merck, Germany 
Sodium dihydrogen phosphate (NaH2PO4) Sigma Aldrich, USA 
Sodium hydroxide (NaOH) Merck, Germany 
Taq DNA polymerase Fermentas, Lithuania 
Trehalose Merck, Germany 
Tris-base Merck, Germany 
Tris-hydrochloride (Tris-HCl) Invitrogen, USA 
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Table ‎2.2 List of kits used in this study 
Name Source 
NucleoSpin® Blood QuickPure Macherey Nagel, Germany 
NucleoSpin® Tissue Macherey Nagel, Germany 
SsoAdvanced™ universal probes supermix Bio-Rad Laboratories, USA 
 
Table ‎2.3 List of consumables used in this study 
Name Source 
Aluminium foil Diamond, USA 
Conical polypropylene tube Corning, USA 
CryoBeads™ Hardy Diagnostics, USA 
Disposable Petri dish Corning, USA 
Disposable surgical face mask Medicos, Malaysia 
Filtered pipette tips Axygen, USA & GoldenGate Bioscience, USA 
Gloves Iron Skin, Malaysia 
Microcentrifuge tube Axygen, USA 
N95 Mask 3M, Korea 
UV/Vis cuvette Eppendorf, Germany 
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Table ‎2.4 List of equipment used in this study 
Name  Source 
Autoclave (Tomy ES-315) Tomy Seiko, Japan 
Balance (CPA225D) Sartorius, Germany 
Biological safety cabinet (E-series) Esco Technologies, USA 
Microcentrifuge (5424) Eppendorf, Germany 
Refrigerated centrifuge (5920) Kubota, Japan 
Microcentrifuge (Force 7) Denver Instruments, USA 
Centrifuge (Hettich Mikro 22R) Hettich, Germany 
Centrifuge (Micro 1730R) LaboGene, Denmark 
Chiller (Chill-1050) Tech-Lab Scientific, Malaysia 
Darkfield microscope (BX51) Olympus, Japan 
Dry cabinet (TD-100) Eureka, Taiwan 
Freezer -20 °C (LY350LT) Snow, Malaysia 
Freezer -20 °C (MDF-436) Sanyo, Japan 
Freezer -80 °C (VIP® Series) Sanyo, Japan 
Gel imaging system (Chemilmager 5500) Alpha Innotech, USA 
Heating block (IC-20) Cole-Parmer, USA 
Gel electrophoresis (Owl Separation Systems) Thermo Scientific, USA 
Ice maker (AF100) Scotsman, USA 
Incubator (IN260) Memmert, Germany 
Incubator Shakers (Innova 40) New Brunswick, USA 
Light microscope (CX31) Olympus, Japan 
Lyophiliser (Heto Lyolab 3000) Thermo Scientific, USA 
pH meter (CyberScan pH 510) Thermo Scientific, USA 
Pipettes (Pipetman) Gilson, USA 
Spectrophotometer (UV-Vis 1201) Shimadzu, Japan 
Spectrophotometer (BioPhotometer) Eppendorf, Germany 
Thermocycler  – qPCR (CFX96) Bio-Rad Laboratories, USA 
Thermocycler – Conventional PCR (Mastercycler)  Eppendorf, Germany 
Vacuum centrifugal concentrator (Heto) Thermo Scientific, USA 
Vacuum pump (RZ 6 rotary vane pump) VacuuBrand, Germany 
Vortex mixer (IKA® MS 3) Mason Technology, Ireland 
Water bath (TE-10A thermoreulator) Techne, USA 
Water distiller (W4L) Favorit, UK 
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2.2 Preparation of chemical stocks, buffers and media 
2.2.1 Preparation of buffer and stock solutions 
2.2.1 (a) 5-Fluorouracil (5-FU) solution, 10 mg/ml 
This stock solution was prepared by dissolving 1 g 5-FU antibiotic powder in 
100 ml 0.02 M phosphate buffer, pH 7.4, followed by sterilisation using 0.2 m 
syringe filter. The solution was stored at room temperature until further use. 
 
2.2.1 (b) Hydrochloric acid (HCl) solution, 1 M 
This solution was prepared by adding 41.7 ml 36% HCl into 300 ml distilled 
water. Following gentle mixture, solution mixture was adjusted to 500 ml using 
distilled water. 
 
2.2.1 (c) Orange G, 0.2% 
One gram Orange G powder was dissolved in 500 ml distilled water and 
sterilised using 0.2 m syringe filter. The solution was stored at 4 – 8 C until further 
use. 
 
2.2.1 (d) Sodium hydrochloride (NaOH) solution, 1 N 
This solution was prepared by adding 20 g NaOH into 500 mL distilled 
water, mixed well until complete dissolve and stored at room temperature. 
 
2.2.1 (e) Tris-HCl solution, 0.1 M, pH 7.4 
To prepare this solution, 7.88 g Tris-HCl was dissolved in 500 ml distilled 
water. The pH was adjusted to 7.4 using HCl. The solution was sterilised using 0.2 
m syringe filter and stored at room temperature until further use. 
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2.2.1 (f) Glycerol stock, 15% (v/v) 
Fifteen ml glycerol was dissolved in 85 ml distilled water, mixed and 
sterilised at 121 °C for 15 minutes. The solution was stored at 4 – 8 C until further 
use. 
 
2.2.2 Preparation of culture media 
2.2.2 (a) Liquid Ellinghausen-McCullough-Johnson-Harris (EMJH) 
This leptospiral growth media was prepared by dissolving 2.3 g Leptospira 
medium base in 900 ml distilled water, with frequent stirring. Upon complete 
dissolution, the solution was autoclaved and allowed to cool. Next, 100 ml 
Leptospira enrichment EMJH and 200 g/ml 5-FU were added, mixed thoroughly 
and dispensed into 15 ml polypropylene conical tubes, at a volume of approximately 
8 ml. The aliquots were stored at 4 – 8 C until further use. 
 
2.2.2 (b) Semisolid EMJH 
The steps were similar to the preparation of liquid EMJH, except additional 
0.5 g bacteriological agar was added, together with 2.3 g Leptospira medium base in 
900 ml distilled water. 
 
2.2.2 (c) MH agar  
Nineteen gram MH agar powder was dissolved in 500 ml distilled water and 
boiled. Following autoclaving at 121 °C for 15 minutes, the sterilised medium was 
poured into sterile disposable Petri dishes. 
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2.2.2 (d) MH broth  
A mixture of 10.5 g MH broth powder in 500 ml distilled water was prepared 
and autoclaved at 121 °C for 15 minutes. The medium was allowed to cool down and 
aliquoted into sterile tubes. 
 
2.2.2 (e) MacConkey No.3 agar 
To prepare this agar, 25.75 g MacConkey agar powder was dissolved in 500 
ml distilled water, boiled and autoclaved at 121 °C for 15 minutes. The medium was 
poured into sterile disposable Petri dishes. 
 
2.2.2 (f) Deoxycholate Citrate Agar (DCA) 
To prepare this agar, 24.25 g DCA was dissolved in 500 ml distilled water 
and boiled by frequent agitation using flame. As a precaution, the agar was not 
autoclaved or heated. The medium was poured into sterile disposable Petri dishes. 
 
2.2.2 (g) Todd-Hewitt broth 
Fifteen-gram Todd-Hewitt powder was dissolved in 500 ml distilled water 
and autoclaved at 121 °C for 15 minutes. Cool sterilised media were then transferred 
into sterile tubes.  
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2.3 Development of TaqMan qPCR assay 
2.3.1 Designing of synthetic DNA for IAC target 
Unlike the other microbial targets (Leptospira, B. pseudomallei, Salmonella 
and Plasmodium) that relied on genomic DNA as templates, synthetic double-
stranded DNA (dsDNA) or gBlocks® Gene Fragments was used as the PCR target 
for IAC. The synthetic DNA was designed based on a fusion of Mycobacterium 
tuberculosis rpoB gene (Accession no. NC_000962.3: 759807-763325) and 83-110 
bp region of Entamoeba histolytica HLY5mc1 gene (Accession no. Z29969.1) 
(https://sg.idtdna.com/pages/products/genes/gblocks-gene-fragments/). 
 
2.3.2 Designing of oligonucleotides 
Primers and probes were designed using the online IDT PrimerQuest tool 
(https://sg.idtdna.com/Primerquest/Home/Index). A total of sixty-four nucleotide 
sequences of Leptospira rrs genes, B. pseudomallei orf2 genes, Salmonella StyR-3 
gene, Plasmodium 18S ribosomal RNA (18S rRNA) genes and human GAPDH gene 
were retrieved from the National Center for Biotechnology Information (NCBI) 
database and used for the oligonucleotides designing.  
The sequences‘ compositions were; 24 Leptospira rrs genes (as listed in 
Table  2.5),  10 B. pseudomallei orf2 genes (as listed in  Table  2.6), 15 Salmonella  
StyR-3 gene (as listed in Table  2.7), 14 Plasmodium 18S rRNA genes (as listed in  
Table  2.8) and one human GAPDH gene (NC_000012.12, from 6534405 bp to 
6538375 bp). The sequences were aligned using VectorNTI software and visualised 
using GeneDoc software to determine the conserved region. For the exogenous IAC, 
the respective oligonucleotides were designed against the synthetic DNA as 
described in section  2.3.1. 
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Initial specificities of the designed oligonucleotides were checked using 
online Basic Local Alignment Search Tool (BLAST) by the NCBI 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi). 
 
2.3.3 Bioinformatics characterisation of oligonucleotides 
Characteristic of the designed primers and probes were checked using online 
IDT OligoAnalyzer tool (https://sg.idtdna.com/calc/analyzer) for potential hairpin 
formation and primer dimerisation. Standard pre-set qPCR parameters were used 
during the bioinformatics analysis (50 mM Na
+
, 3 mM Mg
2+
 and 0.8 mM dNTPs). 
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Table ‎2.5 List of accession numbers of Leptospira rrs gene sequences used for 
designing of primers and probe 
No Accession number Location of gene Species Serovar Group 
1 AY631880 1 to 1432 L. alexanderi Manhao Pathogenic 
2 AOHD02000026 296 to 1806 L. alstonii Pingchang Pathogenic 
3 AM050581 1 to 1318 L. borgpetersenii Ballum Pathogenic 
4 AY996794 1 to 1431 L. interrogans Australis Pathogenic 
5 AY996791 1 to 1431 L. interrogans Autumnalis Pathogenic 
6 EF536987 1 to 1385 L. interrogans Bataviae Pathogenic 
7 DQ991476 1 to 1319 L. kirschneri Agogo Pathogenic 
8 AHMP02000003 562206 to 563714 L. kmetyi Malaysia Pathogenic 
9 KJ847187 1 to 1313 L. mayottensis N/A Pathogenic 
10 AHOP02000022 21126 to 22634 L. noguchii Autumnalis Pathogenic 
11 AY461889 1 to 1181 L. santarosai N/A Pathogenic 
12 AY631877 1 to 1431 L. weilii Celledoni Pathogenic 
13 AY792329 1 to 1431 L. broomii N/A Intermediate 
14 AY996789 1 to 1464 L. fainei Hurstbridge Intermediate 
15 AY631891 1 to 1431 L. inadai Aguaruna Intermediate 
16 EF612278 1 to 1348 L. licerasiae Varillal Intermediate 
17 EF025496 1 to 1318 L. wolffii Khorat Intermediate 
18 AY631876 1 to 1422 L. biflexa Patoc Saprophytic 
19 AB721966 1 to 1443 L. idonii N/A Saprophytic 
20 AY631889 1 to 1422 L. meyeri Hardjo Saprophytic 
21 AY631888 1 to 1422 L. terpstrae Hualin Saprophytic 
22 AY631897 1 to 1422 L. vanthielii Holland Saprophytic 
23 AY631879 1 to 1422 L. wolbachii Codice Saprophytic 
24 AY631882 1 to 1422 L. yanagawae Saopaulo Saprophytic 
 
Table ‎2.6 List of accession numbers of B. pseudomallei TTSS-orf2 gene 
sequences used for designing of primers and probe 
No Accession number Location of gene 
1 AF074878.2 25391 to 26344 
2 CP018404.1 2131427 to 2132380 
3 CP018402.1 2693333 to 2694286 
4 CP018388.1 2406331 to 2407284 
5 LK936443.1 1885696 to 1886649 
6 BX571966.1 1919731 to 1920690 
7 AY626775.1 1 to 891 
8 HM235938.1 1 to 131 
9 CP004043.1 1726185 to 1727138 
10 CP008891.1 1977666 to 1978619 
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Table ‎2.7 List of accession numbers of Salmonella StyR-3 gene sequences used 
for designing of primers and probe 
No 
Accession 
number 
Location of gene Organism Serovar Strain 
1 AL513382 622812 to 623305 S. enterica Typhi CT18 
2 CP012151 1761103 to 1761596 S. enterica Typhi B/SF/13/03/195 
3 LT906560 4137882 to 4138375 S. enterica Typhi OVG_041 
4 LT904870 1639553 to 1640046 S. enterica Typhi SGB90 
5 LT904881 3025972 to 3026465 S. enterica Typhi UI2120 
6 CP009049 2860086 to 2860579 S. enterica Paratyphi A CMCC 50973 
7 CP023508 2376776 to 2377269 S. enterica Paratyphi A FDAARGOS_368 
8 CP000886 2486471 to 2486964 S. enterica Paratyphi B SPB7 
9 CP000857 630078 to 630571 S. enterica Paratyphi C RKS4594 
10 CP019177 3323035 to 3323528 S. enterica Albany ATCC 51960 
11 CP007639 677299 to 677792 S. enterica Choleraesuis C500 
12 CP018657 3841800 to 3841951 S. enterica Enteritidis 92-0392 
13 CP015924 3453164 to 3453315 S. enterica Newport Levine 15 
14 CP022168 3417343 to 3417494 S. enterica Typhimurium WW012 
15 CP014996 3538585 to 3539078 S. enterica Weltevreden 1655 
 
Table ‎2.8 List of accession numbers of Plasmodium 18S rRNA gene sequences 
used for designing of primers and probe 
No Accession number Location of gene Species 
1 NC_004325.1 474888 to 477036 P. falciparum 
2 XR_002273095.1 1 to 2149 P. falciparum 
3 AL844501.2 473739 to 475887 P. falciparum 
4 CP016991.1 474581 to 476729 P. falciparum 
5 KF018657.1 1 to 2096 P. ovale 
6 KF219559.1 1 to 2094 P. ovale 
7 AB182493.1 1 to 2094 P. ovale 
8 LT727657.1 74467 to 75768 P. knowlesi 
9 LT727650.1 964364 to 965664 P. knowlesi 
10 M54897.1 999 to 2319 P. malariae 
11 LT594624.1 1104390 to 1105716 P. malariae 
12 LT615240.1 136671 to 137951 P. vivax 
13 LT615257.1 166254 to 167528 P. vivax 
14 U07367.1 789 to 2063 P. vivax 
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2.3.4 Reconstitution of oligonucleotides stock solutions 
Primers and probes were synthesised by Integrated DNA Technologies (IDT), 
Singapore and purified using standard desalting procedure by the same manufacturer. 
Upon arrival, the lyophilised primers and probes were centrifuged at 10, 000 × g for 
3 minutes. One hundred µM oligonucleotides stocks were prepared by adding an 
appropriate amount of water (or TE buffer, for probes) to the lyophilised nucleotides. 
The reconstituted oligonucleotides were vortexed for 5 – 10 minutes, briefly 
centrifuged and stored at -20 °C until further use. 
 
2.3.5 Preparation of oligonucleotides working solutions 
Primers working stocks and probes working stocks were prepared in 20 µM 
concentration in water (or TE buffer, for probes). An appropriate amount of water of 
TE buffer was added to reach the desired concentration based on the          
equation. The diluted oligonucleotides were briefly vortexed, centrifuged and stored 
at -20 °C until further use. 
 
2.3.6 TaqMan qPCR assay 
To determine the functionality of the designed oligonucleotides, TaqMan 
qPCR mixtures were prepared. Reactions consisting 1 × SsoAdvanced Universal 
Probes Supermix, 50 – 600 nM primers, 50 – 200 nM probes, 2 – 8 µl DNA template 
and water, adjusted to 20 µl, was prepared. The reactions were subjected to thermal 
cycling program as listed in Table  2.9.  
Data from the assay were analysed using Biorad CFX Manager software. 
Baseline threshold was set at 25 RFU for FAM signal and 50 RFU for Texas Red, 
HEX, Cy5 and Cy5.5 signals. Any Cq ≤40 is considered positive (Bustin et al., 2009).  
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Table ‎2.9 TaqMan qPCR cycling condition 
Mode Temperature (°C) Time Cycle 
Initial denaturation 95 3 min 1 
Denaturation 95 15 sec 
50 
Annealing & elongation 61.3 30 sec 
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2.3.7 Optimisation of PCR parameters 
2.3.7 (a) Optimisation of oligonucleotides’‎concentrations 
To determine the optimal concentration of primers that result in the lowest 
Cq, PCR reactions were prepared as described in section  2.3.6. The primers 
concentrations were adjusted to 100 nM, 200 nM, 300 nM, 400 nM, 500 nM and 600 
nM. The reactions were subjected to thermal cycling program as listed in Table  2.9.  
Once optimal primers concentrations were determined, additional PCR 
reactions were prepared to define optimal probes concentration. Probes 
concentrations were adjusted to 50 nM, 100 nM, 150 nM, 200 nM. The reactions 
were subjected to thermal cycling program as listed in Table  2.9. 
 
2.3.7 (b) Optimisation of unconjugated universal primer concentration 
Presence of unconjugated universal primer may improve PCR efficiency 
(Yuan et al., 2009). To determine the optimal concentration of unconjugated 
universal primer, PCR reactions were prepared as described in section  2.3.6, using 
the previously determined optimal conditions. Additional unconjugated universal 
primer was added, at concentration of 100 nM, 200 nM, 300 nM and 400 nM. The 
reactions were subjected to thermal cycling program as listed in Table  2.9.  
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2.4 Analytical evaluation of the developed TaqMan qPCR assay 
2.4.1 Reference strains 
Microorganisms used for this study were divided into two categories; clinical 
isolates and environmental isolates. Of these isolates, L. interrogans serovar 
Canicola strain UPM, B. pseudomallei local strain (USM BUPS 15/07/A), S. enterica 
serovar Typhi (ATCC 7251) and P. falciparum (ATCC PRA¬405D) were used as 
reference strains. 
 
2.4.2 Clinical isolates and ATCC strains 
A total of 253 clinical isolates and ATCC strains, consisted of 27 Leptospira, 
105 B. pseudomallei, 44 Salmonella, 31 Plasmodium and 46 other organisms were 
used in this study. The strains were obtained from the Department of Medical 
Microbiology & Parasitology, School of Medical Sciences, Universiti Sains 
Malaysia, Hospital Raja Perempuan Zainab II (HRPZII), Kota Bharu, Malaysia, 
Institute for Medical Research (IMR), Malaysia, Malaysia, Hospital Sultanah Nur 
Zahirah (HSNZ), Kuala Terengganu, Malaysia, Department of Veterinary Medicine, 
Universiti Putra Malaysia (UPM), Malaysia, Belgian Coordinated Collections of 
Microorganisms (BCCM), Belgium, London School of Hygiene & Tropical 
Medicine (LSHTM), England, American Type Culture Collection (ATCC), National 
Collection of Type Cultures (NCTC), London, United Kingdom and National 
Autonomous University of Mexico (UNAM), Mexico. Details of clinical and ATCC 
strains used in this study are listed in Table  2.10. 
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2.4.3 Environmental Leptospira isolates 
A total of 104 environmental Leptospira isolates were obtained from 
Department of Medical Microbiology & Parasitology, School of Medical Sciences, 
Universiti Sains Malaysia and from peridomicilar area of leptospirosis patients 
residences (Azali et al., 2016; M. R. M. R. Mohd Ali, Mohamad Safiee, Yusof, et al., 
2017). Details of environmental Leptospira isolates used in this study are listed in 
Table  2.11.  
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Table ‎2.10 List of clinical isolates and ATCC strains used in this study 
Organism (n = 253) Source 
No. of 
strains  
Acinetobacter baumanii  USM, Malaysia 1 
Acinetobacter baumanii (ATCC 19606) ATCC, USA 1 
Aeromonas hydrophilia USM, Malaysia 1 
Aspergillus fumigatus USM, Malaysia 1 
Bacillus subtilis USM, Malaysia 1 
Burkholderia cepacia USM, Malaysia 6 
Burkholderia pseudomallei USM, Malaysia 95 
Burkholderia pseudomallei HSNZ, Malaysia 10 
Burkholderia thailandensis USM, Malaysia 1 
Campylobacter jejuni USM, Malaysia 1 
Candida albicans USM, Malaysia 1 
Citrobacter freundii USM, Malaysia 1 
Entamoeba dispar UNAM, Mexico 1 
Entamoeba histolytica UNAM, Mexico 1 
Entamoeba moshkovskii LSHTM, England 1 
Enterococcus avium (LMG 10744) BCCM, Belgium 1 
Enterococcus faecalis USM, Malaysia 1 
Enterococcus faecalis (LMG 16216) BCCM, Belgium 1 
Enterococcus faecium  USM, Malaysia 1 
Enterococcus faecium (LMG 16200) BCCM, Belgium 1 
Enterococcus gallinarum USM, Malaysia 1 
Enterococcus hirae (LMG 6399) BCCM, Belgium 1 
Enterohemorrhagic Escherichia coli (EHEC) IMR, Malaysia 1 
Enteroinvasive Escherichia coli (EIEC) IMR, Malaysia 1 
Enteropathogenic Escherichia coli (EPEC) IMR, Malaysia 1 
Enterotoxigenic Escherichia coli (ETEC) IMR, Malaysia 1 
Haemophilus influenzae USM, Malaysia 1 
Klebsiella oxytoca USM, Malaysia 1 
Klebsiella ozaenae USM, Malaysia 1 
Klebsiella pneumoniae USM, Malaysia 1 
Leptospira biflexa serovar Patoc IMR, Malaysia 1 
Leptospira biflexa serovar Patoc UPM, Malaysia 1 
Leptospira borgpetersenii Celledoni IMR, Malaysia 1 
Leptospira borgpetersenii serovar Ballum UPM, Malaysia 1 
Leptospira fainei serovar Hurtsbridge IMR, Malaysia 1 
Leptospira fainei serovar Hurtsbridge UPM, Malaysia 1 
Leptospira interrogans serovar Australis UPM, Malaysia 1 
Leptospira interrogans serovar Autumnalis IMR, Malaysia 1 
Leptospira interrogans serovar Bataviae IMR, Malaysia 1 
Leptospira interrogans serovar Bataviae UPM, Malaysia 1 
Leptospira interrogans serovar Canicola UPM, Malaysia 1 
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Organism (n = 253) Source 
No. of 
strains  
Leptospira interrogans serovar Copenhageni IMR, Malaysia 1 
Leptospira interrogans serovar Djasiman IMR, Malaysia 1 
Leptospira interrogans serovar Hardjoprajitno IMR, Malaysia 1 
Leptospira interrogans serovar Hebdomadis UPM, Malaysia 1 
Leptospira interrogans serovar 
Icterohaemorrhagiae RGA 
UPM, Malaysia 1 
Leptospira interrogans serovar Javanica IMR, Malaysia 1 
Leptospira interrogans serovar Pomona IMR, Malaysia 1 
Leptospira interrogans serovar Pomona UPM, Malaysia 1 
Leptospira interrogans serovar Pyrogenes IMR, Malaysia 1 
Leptospira interrogans serovar Pyrogenes UPM, Malaysia 1 
Leptospira interrogans serovar Tarassovi IMR, Malaysia 1 
Leptospira licerasiae serovar Varillal IMR, Malaysia 2 
Leptospira meyeri serovar Semaranga IMR, Malaysia 2 
Leptospira wolffii IMR, Malaysia 1 
Listeria monocytogenes UPM, Malaysia 1 
Plasmodium falciparum 
MKA Kota Bharu, 
Malaysia 
10 
Plasmodium falciparum (ATCC PRA405D) ATCC, USA 1 
Plasmodium knowlesi 
MKA Kota Bharu, 
Malaysia 
10 
Plasmodium vivax 
MKA Kota Bharu, 
Malaysia 
10 
Proteus vulgaris USM, Malaysia 1 
Proteus mirabilis USM, Malaysia 1 
Providencia stuartii IMR, Malaysia 1 
Salmonella  Agona (ATCC 51957) ATCC, USA 1 
Salmonella  Albany USM, Malaysia 1 
Salmonella  Bordeaux  USM, Malaysia 1 
Salmonella  Braenderup (ATCC BAA-664) ATCC, USA 1 
Salmonella  Emek USM, Malaysia 1 
Salmonella  Enteritidis (ATCC 13076) ATCC, USA 1 
Salmonella  Hadar USM, Malaysia 1 
Salmonella  Heidelberg (ATCC 8326) ATCC, USA 1 
Salmonella  Java USM, Malaysia 1 
Salmonella  Kibi USM, Malaysia 1 
Salmonella  Kissi USM, Malaysia 1 
Salmonella  Newport USM, Malaysia 1 
Salmonella  Paratyphi A (ATCC 9150) ATCC, USA 1 
Salmonella  Paratyphi B (ATCC BAA 1250) ATCC, USA 1 
Salmonella  Paratyphi C (ATCC 9068) ATCC, USA 1 
Salmonella  Poona  USM, Malaysia 1 
Salmonella  Regent USM, Malaysia 1 
Salmonella  Richmond USM, Malaysia 1 
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Organism (n = 253) Source 
No. of 
strains  
Salmonella  Tshiongwe  USM, Malaysia 1 
Salmonella  Typhi  ATCC, USA 10 
Salmonella  Typhi (ATCC 7251) USM, Malaysia 1 
Salmonella  Typhimurium (ATCC 14028) ATCC, USA 1 
Salmonella  Uppsala USM, Malaysia 1 
Salmonella  Virchow USM, Malaysia 1 
Salmonella  Weltevreden (NCTC 6534) NCTC, London 1 
Salmonella spp. USM, Malaysia 10 
Shigella boydii IMR, Malaysia 1 
Shigella dysenteriae IMR, Malaysia 1 
Shigella flexneri IMR, Malaysia 1 
Shigella sonnei IMR, Malaysia 1 
Staphylococcus aureus  USM, Malaysia 1 
Staphylococcus epidermidis USM, Malaysia 1 
Staphylococcus saprophyticus USM, Malaysia 1 
Vibrio cholerae IMR, Malaysia 1 
Vibrio parahaemolyticus IMR, Malaysia 1 
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Table ‎2.11 List of environmental Leptospira isolates used in this study 
Organism (n = 104) Isolation location No. of isolates  
Pathogenic group 
  L. alstonii Pasar Wakaf Che Yeh 1 
L. kmetyi Jeram Linang 13 
L. kmetyi Kelantan & Terengganu 7 
   
Intermediate group 
  L. fainei  Jeram Linang 2 
L. fainei  
Kelantan or Terengganu 
(Unspecified) 
1 
L. inadai Jeram Linang 2 
L. inadai 
Kelantan or Terengganu 
(Unspecified) 
1 
L. licerasiae  Jeram Linang 3 
L. licerasiae  Kelantan & Terengganu 2 
L. wolffii Jeram Linang 26 
L. wolffii Pasar Wakaf Che Yeh 3 
L. wolffii Pasar Siti Khadijah 2 
L. wolffii Kelantan & Terengganu 3 
   
Saprophytic group 
  L. idonii Jeram Linang 1 
L. meyeri  Pasar Wakaf Che Yeh 18 
L. meyeri  Jeram Linang 13 
L. meyeri  Pasar Siti Khadijah 2 
L. meyeri  Kelantan & Terengganu 4 
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2.4.4 Cultivation and maintenance of organisms 
Liquid and semi-solid EMJH media were prepared for cultivation and short-
term maintenance of Leptospira, respectively. For non-leptospiral bacteria, strains 
were cultured in MH broth. More fastidious bacteria, such as Streptococcus and 
Haemophilus were cultivated on enriched growth media such as Todd-Hewitt broth 
and commercial chocolate blood agar (CBA). Selective media such as MacConkey 
agar and DCA were also used for Enterobacteraciae. CryoBeads™ and/or 15% (v/v) 
glycerol stocks were used for long-term preservation of bacteria, stored at -80°C. 
Procedures for preparation of culture media were described in section  2.2.2. 
Bacteria were revived by inoculating the stock into EMJH media (for 
Leptospira) or MH broth (for non-fastidious organism) or enriched growth media 
(for Streptococcus and Haemophilus) or other selective media. Inoculated EMJH 
media were incubated at 30°C, for 7 days on a shaker at 40 rpm and examined under 
dark field microscope for their presumptive hooked-ends, helical coils and motility. 
Other media were incubated at 37°C for 24 – 48 hours. Fresh cultures were used for 
subsequent genomic DNA extraction. 
 
2.4.5 Genomic DNA extraction 
Genomic DNA from clinical isolates were used in specificity testing. The 
extractions of the genomic DNA were performed using NucleoSpin® Tissue kit 
DNA from fresh bacterial cultures. Briefly, one millilitre of fresh bacterial culture 
was centrifuged at 8, 000 × g for 5 minutes. The supernatant was discarded and the 
pellet was re-suspended in 180 µl buffer T1, mixed, added with 25 µl Proteinase K, 
briefly centrifuged and incubated at 56 °C until complete lysis (at least 1 – 3 hours, 
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or overnight). Sample was vortexed, added with 200 µl buffer B3 and incubated at 70 
°C for 10 minutes.  
Following the addition of 210 µl absolute ethanol and vigorous vortex, 
sample was placed into column and collection tube and centrifuged at 11, 000 × g for 
1 minute. Column was placed into a new collection tube, added with 500 µl buffer 
BW and centrifuged at 11, 000 × g for 1 minute. Column was placed into a new 
collection tube, added with 600 µl buffer B5 and centrifuged at 11, 000 × g for 1 
minute. Column was placed into a new collection tube and centrifuged at 11, 000 × g 
for 1 minute. Next, the column was placed in a 1.5 ml microcentrifuge tube, applied 
with 100 µl of pre-warmed buffer BE (70 °C). Following incubation at room 
temperature for 10 minutes, DNA was eluted by centrifugation at 11, 000 × g for 1 
minute. Dilution of DNA was carried out when necessary and stored at -20 °C. 
 
2.4.6 Quantification and quality analysis of DNA 
2.4.6 (a) DNA quantitation  
DNA was quantitated using dsDNA program of Biophotometer at 260 nm 
wavelength. Fifty microliter elution buffer was used as a blank. Before sample 
reading, 2 µl DNA was added to 48 µl elution buffer. The purity of the diluted 
samples was also checked at the wavelengths of 230 nm, 280 nm and 320 nm. 
 
2.4.6 (b) Agarose gel electrophoresis 
Agarose gel electrophoresis was performed to determine the intactness and 
quality of the extracted genomic DNA or PCR products, when applicable. Briefly, 
0.8% – 2% (w/v) agarose powder was dissolved in 0.5 × TE buffer, by heating the 
mixture in a microwave for 2 – 3 minutes. After the mixture was cooled to the 
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temperature of approximately 50 °C, 1 × RedSafe™ Nucleic Acid Staining Solution 
was homogeneously added. The gel was cast and allowed to solidify. Then, the gel 
was placed in the tank, emerged with 0.5 × TE buffer. Five microliter of DNA or 
PCR product was mixed with 1 µl 6 × Orange G loading dye and loaded to respective 
well of the gel. GeneRuler 100 bp Plus DNA Ladder was included to enable size 
estimation of the DNA or PCR product. The bands were separated by subjecting the 
gel to 150 V for 5 minutes and subsequent 100 V for 45 minutes. The bands were 
visualised using Alpha Innotech Chemi Imager 5500. 
 
2.4.7 Analytical sensitivity 
A set of 10-fold dilution of DNA templates from the reference strains were 
prepared, ranging from 10 ng µl
-1
 to 1 fg µl
-1
. PCR reactions were prepared as 
described in section  2.3.6. Two microliter of each dilution was used, in triplicates. 
Standard curves were constructed based on the mean of Cq values and log10 (DNA 
copies). Copy numbers were calculated using an online tool by the URI Genomics & 
Sequencing Center (http://cels.uri.edu/gsc/cndna.html). The genome sizes for 
Leptospira, B. pseudomallei, Salmonella and Plasmodium are 4,627,366 bp 
(Nascimento et al., 2004), 7,247,547 Mbp (Holden et al., 2004), 4,809,037 bp 
(Parkhill et al., 2001) and 22,853,764 bp (Gardner et al., 2002), respectively. When 
specified, a 500 bp synthetic DNA was used to substitute Plasmodium DNA. 
Linearity and efficiency are calculated from logarithmic standard curves using 
Microsoft Excel. 
Analytical sensitivity is defined by the lowest amount of DNA detectable by 
at least one of the replicates. Meanwhile, a more stringent definition was used for 
LOD, exemplified as the lowest concentration of DNA template detectable at 95% 
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likelihood (Bustin et al., 2009). Twenty four replicates were performed in three 
occasions, using bacterial genomic DNA concentration of 80 fg, 40 fg, 20 fg, 5 fg 
and 2 fg per reaction and 20 ag, 10 ag, 5 ag, 2 ag and 0.2 ag of Plasmodium synthetic 
DNA per reaction. 
 
2.4.8 Analytical specificity 
Analytical specificity testing was carried out on reference strains, clinical 
isolates and environmental isolates as listed in Table  2.10 and Table  2.11. Twenty-
nanogram DNA of each isolate was used as templates, unless specified otherwise. 
PCR reactions were prepared as described in section  2.3.6. 
 
2.4.9 Assay precisions 
2.4.9 (a) Repeatability (Intra-assay evaluation) 
Repeatability is defined by the variation of replicates within the same run. 
PCR assays were prepared, as described in section  2.3.6, in triplicates. Standard 
deviation (SD) of the Cqs was calculated using Microsoft Excel. Two different 
template concentrations, 200 pg and 200 fg were used. 
 
2.4.9 (b) Reproducibility (Inter-assay evaluation) 
Reproducibility is defined by the variation of replicates between different 
runs. PCR assays were prepared, as described in section  2.3.6, in triplicates, for two 
different days. Standard deviation (SD) of the Cqs was calculated using Microsoft 
Excel. Two different template concentrations, 200 pg and 200 fg were used. 
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2.4.10 Stability of TaqMan qPCR assay 
Lyophilisation of the multiplex assay was performed using Heto LyoLab 
3000 freeze-dryer connected to a vacuum concentrator. Master mix solutions 
containing optimised amount oligonucleotides, 10% (w/v) trehalose and water were 
prepared, aliquoted into 0.5 ml microcentrifuge tubes, and lyophilised at 8 × 10
-2
 
mBar for 2 hours. The tubes containing dried pellets were capped, sealed and kept in 
designated temperatures (4 °C, 25 °C, 37 °C and 45 °C) at different days until 
subsequent use. Appropriate controls such as pre-lyophilised master mix solutions 
were also included.  
To test the lyophilised oligonucleotides, pellets were dissolved in water, 
added with 1 × SsoAdvanced Universal Probes Supermix and 2 – 8 µl DNA 
template. The assays were then subjected to thermal cycling condition as listed in 
Table  2.9.  
The shelf-life was estimated using equations by (Clark, 1991); 
                      (      
          ))             , where  
D = duration at elevated temperature 
Q10 = rate of chemical reaction 
AAT = accelerated ageing temperature 
AT = ambient temperature 
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2.5 Clinical evaluation of the developed TaqMan qPCR assay 
Performance of the developed multiplex assays was evaluated on 
retrospective and prospective clinical samples. Retrospective samples were 
previously confirmed by gold standard methods or reference methods; leptospirosis – 
MAT/PCR/culture, melioidosis – culture, invasive salmonellosis – culture and 
malaria – BFMP/PCR. Meanwhile, prospective samples were collected from febrile 
patients presented to the Department of Emergency Medicine, Hospital Universiti 
Sains Malaysia. 
 
2.5.1 Ethical approval 
Prior to recruitments of patients, ethical approvals were obtained from 
appropriate ethical committees. This study protocol has been approved by the Human 
Ethics Committee of Universiti Sains Malaysia (Protocol code: 
USM/JEPeM/16080260) and the Medical Research and Ethics Committee (MREC) 
of the Ministry of Health Malaysia (Protocol code: NMRR-16-2117-33181) 
(Appendix A and B). 
 
2.5.2 Sample size calculation 
Sample sizes were calculated using public spreadsheet developed by Dr Wan 
Nor Arifin, from Universiti Sains Malaysia (Wan Nor Arifin, 2017). Sample size for 
retrospective specimens was estimated based on sensitivity & specificity formula by 
Buderer study (1996). Prevalence of leptospirosis, melioidosis, salmonellosis and 
malaria in the febrile patients were assumed to be 8.4% (Rafizah et al., 2013), 5% 
(Berger, 2018), 7.4% (Brown et al., 1984) and 6.2% (Berger, 2018), respectively. 
Expected sensitivity & specificity was set to 98% (Liesenfeld et al., 2014). Precision 
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was set at 10% with an alpha error of 0.05. Additional 10% drop-out was also 
included. 
Meanwhile, the sample size for prospective specimens was calculated using 
the prevalence formula;   
       )
  
 by (Naing, 2003). Where n = sample size, Z = 
Z statistic corresponding to 95% confidence (1.96), P = expected prevalence (8.4%), 
and d = precision (0.05). 
Details of sample sizes calculation (for both retrospective and prospective 
specimens) were listed in Appendix C. 
 
2.5.3 Clinical samples collection 
Retrospective clinical samples were collected based on the estimated sample 
sizes. EDTA blood samples from confirmed leptospirosis and malaria status were 
collected from the Makmal Kesihatan Awam Kota Bharu, Kelantan. The samples 
were previously tested for leptospiral DNA using GenoAmp® Real-Time PCR 
Leptospirosis kit or for malarial DNA using abTES™ Malaria qPCR I Kit. Besides, 
EDTA blood samples from confirmed melioidosis and invasive salmonellosis status 
were collected from the Department of Haematology and Department of Medical 
Microbiology & Parasitology, School of Medical Sciences, USM. The collected 
EDTA blood samples had parallel samples tested for viable organisms (i.e. B. 
pseudomallei isolated, S. Typhi isolated, no growth) through blood culture method. 
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Meanwhile, prospective EDTA blood samples from febrile patients with 
unknown status of leptospirosis, melioidosis, salmonellosis and malaria were 
collected from the Emergency Department, HUSM.  
The inclusion criteria for prospective patients were: 
 Aged more than 18 years old and 
 Has fever with temperature more than 38 °C and/or 
 Has suspected or proven severe infection or sepsis  
Meanwhile, prospective patients with these conditions were excluded; 
 Has suspected or proven healthcare-associated pneumonia (HAP/HCAP) 
and/or ventilator-associated pneumonia (VAP) and/or 
 Has proven disease/s other than leptospirosis, melioidosis, invasive 
salmonellosis and malaria. 
Clinical evaluation was carried out by preparing multiplex TaqMan qPCR as 
described in section 2.3.6. For each assay, eight microliter DNA template was used. 
Reactions were subjected to the cycling condition as described previously. 
 
2.5.4 Genomic DNA extraction from clinical samples 
Genomic DNA from clinical specimens was used for clinical evaluation. 
Total genomic DNA from blood specimens was extracted using NucleoSpin® Blood 
QuickPure kit. Briefly, 200 µl blood, 200 µl lysis buffer BQ1 and 25 µl Proteinase K 
were mixed and incubated at 70 °C for 10 – 15 minutes. Following the addition of 
200 µl absolute ethanol, the sample was mixed, vortexed, applied onto the column 
and centrifuged at 11, 000 × g for 1 minute. Then 350 µl buffer BQ3 was added to 
the column and centrifuged at 11, 000 × g for 3 minutes. Another 200 µl buffer BQ3 
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was added to the column, followed by centrifugation at 11, 000 × g for 1 minute. The 
column was placed in a 1.5 ml microcentrifuge tube, applied with 50 µl of pre-
warmed buffer BE (70 °C). Following incubation at room temperature for 10 
minutes, DNA was eluted by centrifugation at 11, 000 × g for 1 minute. Eluted DNA 
samples were stored at -20 °C until further use. 
Meanwhile, other clinical specimens, DNA were extracted using 
NucleoSpin® Tissue kit. Depending on the sample type, pre-treatment was necessary 
and performed according to the manufacturer‘s recommendations. For urine sample, 
1 ml of the sample was centrifuged at 13, 000 × g for 30 minutes, followed by 
removal of the supernatant. This step was repeated three times. Then, the pellet was 
re-suspended in 180 µl buffer T1 and 25 µl Proteinase K. The subsequent steps were 
similar to the section  2.4.5. 
In addition, blood culture fluid (BCF) samples were treated according to the 
M5 method of a previous study (Villumsen et al., 2010). A hundred microliter of 
BCF was added to 100 µl lysis buffer (5 M guanidine hydrochloride in 100mM Tris-
HCl, pH 8.0) and 10 µl proteinase K (20 mg/ml). Following incubation at room 
temperature for 10 minutes, 600 µl ultrapure water and 800 µl ˃99% benzyl alcohol 
were added to the mixture. Samples were mixed and centrifuged at 20, 000 × g for 5 
minutes at room temperature. Two hundred microliter of the supernatant were 
collected and added to 200 µl of BQ1 buffer and 200 µl absolute ethanol, and were 
processed according to procedures for the blood specimens, using NucleoSpin® 
Blood QuickPure kit, as described previously.  
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2.5.5 Sequencing of PCR products 
Any retrospective sample with a discordant result (negative by the reference 
method, positive by multiplex qPCR) was confirmed by sequencing. Briefly, another 
reaction tube containing 0.75 unit of Taq Polymerase, 1× PCR buffer, 
0.16 mM dNTP, 2.5 mM MgCl2, 200 nM of respective forward and reverse primers 
and five microliter PCR products. The reaction was adjusted to 20 µl using water. 
The mixture was then subjected to a primary denaturation at 95 °C for 3 minutes, 
followed by 40 cycles of; 94 °C for 30 seconds, 60 °C for 30 seconds, 72 °C for 30 
seconds; and a final elongation at 72°C for 5 minutes. Subsequently, PCR products 
purification and sequencing were outsourced to Integrated DNA Technologies, 
Singapore. 
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CHAPTER 3 
RESULTS AND DISCUSSION 
 
3.1 Preparation of genomic DNA templates  
L. interrogans serovar Canicola strain UPM, B. pseudomallei local strain 
(USM BUPS 15/07/A), S. enterica serovar Typhi (ATCC 7251) and P. falciparum 
(ATCC PRA¬405D) were used as reference strains. The remaining clinical isolates 
and environmental isolates were used in the subsequent analytical specificity 
analysis. Genomic DNA templates were extracted following cultivation of respective 
microorganisms using commercial extraction kits. 
Quantity and quality of the extracted genomic DNA from reference strains 
were determined using UV spectroscopy. Ratios of absorbance at the wavelength of 
A260/A280 and A260/A230 were used as indicator of purity. Ideally, the ratio at 
A260/A280 should lie between 1.8 and 2, which is accepted indicator for pure DNA. 
Ratio outside this range may indicate protein or RNA contamination. Meanwhile, 
ratio at A260/A230 should ideally lies within 1.8 and 2.2 and is useful to indicate 
contamination by residual phenol, salt, protein, polysaccharide or guanidine, usually 
originating from the extraction reagent (Olson and Morrow, 2012). 
Residual contamination may affect the spectrophotometric measurements. To 
further confirm the quality of the DNA, extracted samples were analysed using gel 
electrophoresis (Didelot et al., 2013). This method provides an important indication 
of DNA intactness, as well as further estimation of the DNA quantity and sizes. A 
single high molecular band without smear indicated intact extracted genomic DNA, 
as well as two smaller bands at ~500 bp and ~250 bp which represented the 
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Plasmodium synthetic DNA and IAC synthetic DNA. (Figure  3.1 and Figure  3.2). 
Meanwhile, the presence of low molecular band may indicate RNA contamination.  
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Figure ‎3.1 Gel electrophoresis of purified genomic DNA from L. interrogans 
(Lane 1), B. pseudomallei (Lane 2) and S. Typhi (Lane 3) and 2 other organisms 
(Lane 4 and 5). Lane L contained GeneRuler 100 bp Plus DNA Ladder. 
 
 
 
Figure ‎3.2 Gel electrophoresis of purified P. falciparum genomic DNA (Lane 1), 
IAC synthetic DNA (Lane 2) and Plasmodium synthetic DNA (Lane 3). Lane L 
contained GeneRuler 100 bp Plus DNA Ladder.  
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3.2 Preparation of synthetic DNA fragment as IAC template and 
Plasmodium DNA substitute 
IAC was designed synthetically against a fusion of M. tuberculosis rpoB gene 
and 83-110 bp region of E. histolytica HLY5mc1 gene (later will be denoted as IAC 
synthetic DNA or IAC target). Full sequence of the IAC synthetic DNA is listed in 
Figure 3.3. The quality of synthetic DNA fragment, also known as gBlocks® Gene 
Fragment (rpoB-EH synthetic DNA) was measured using UV spectrophotometer, as 
well as gel electrophoresis. A single molecular band at ~250 bp indicated intact 
synthetic DNA fragment (Figure  3.2). 
In certain circumstances, Plasmodium synthetic DNA was used to substitute 
commercially purified P. falciparum strain 3D7 ATCC® PRA-405D. The 495-bp 
Plasmodium synthetic DNA was designed based on partial sequence of P. falciparum 
18S rRNA gene. Full sequence of Plasmodium synthetic DNA is listed in Figure 3.4. 
Quality of the synthetic DNA was measured using UV spectrophotometer and gel 
electrophoresis. Figure  3.2 illustrated size and intactness of Plasmodium synthetic 
DNA, at a molecular band size of approximately 500 bp. 
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Figure ‎3.3 Sequence of IAC synthetic DNA used in this study. The locations of 
forward (green), reverse (red) primers and probe (brown) are highlighted in 
respective colours. 
 
 
Figure ‎3.4 Sequence of Plasmodium synthetic DNA used in this study. The 
locations of forward (green), reverse (red) primers and probe (brown) are highlighted 
in respective colours. 
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3.3 Oligonucleotides design 
3.3.1 Selection of target genes and sequence alignments  
Selection of the target gene is an important initial step for designing and 
validating PCR assays. A target gene can be a specific gene for a particular microbial 
species or a functional gene coding for a protein or non-protein coding (NPC) 
sequences from a similar genus (Hanna et al., 2005). Sometimes, a target gene can be 
selected from a polymorphic area of a common housekeeping gene (Adékambi et al., 
2009; Bondoso et al., 2013; J. T. Foster et al., 2008). The nature of the target gene is 
exploited in order to be used for broad detection of a particular microbial species or 
targeting a particular species or strain, depending on the study interest (Kumar and 
Chordia, 2015). 
Several genes have been described and used for the detection of Leptospira 
spp.. Among the widely used genes is lipL32 that encodes for a 32 kDa outer 
membrane lipoprotein, highly conserved among pathogenic leptospiral species (D A 
Haake et al., 2000; Nurul Najian et al., 2016). As increasing number of studies have 
reported the detection of intermediate and saprophytic Leptospira from human 
patients (Arzouni et al., 2002; Chiani et al., 2016; Krogfelt et al., 2001), this study 
utilised rrs gene as PCR target for Leptospira genus. Twenty four rrs gene sequences 
from 22 Leptospira species have been retrieved from the NCBI database and aligned. 
L. interrogans serovar Bataviae (Accession no. EF536987) was selected as the 
reference sequence. From the alignment, a region between nucleotides 246 and 424 
was selected due to high similarity among the leptospiral species (Figure  3.5). 
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Meanwhile, the B. pseudomallei type III secretion system (TTSS) genes 
cluster has been extensively studied and associated with the pathogenicity of the 
bacteria. This gene cluster encodes for more than 30 proteins, and several open 
reading frames (ORFs) (Gong et al., 2015). Among the ORFs, orf2 was selected as 
the target gene due to its uniqueness to the B. pseudomallei. A sequence from the 
AF074878.2 was used as the reference. Alignment of ten orf2 genes revealed a 
region between nucleotides 554 and 651 that is conserved among the sequences, as 
shown in Figure  3.6.  
Next, StyR-3 gene was used as the Salmonella target. This non-protein coding 
(npc) gene is unique to the Salmonella genus (Chinni et al., 2010). Fifteen StyR-3 
gene sequences from 10 serovars were retrieved and aligned. Sequence from 
AL513382 was set as the reference. A conserved region between nucleotide 161 and 
312 was determined and used for oligonucleotide designing (Figure  3.7). 
Another potential target, the 18S rRNA gene is a common house-keeping in 
eukaryotes, including Plasmodium. Fourteen 18S rRNA gene sequences were 
retrieved and aligned to determine specific malarial region. Sequence from 
NC_004325.1, of P. falciparum was used as the reference. A conserved region, 
specific to Plasmodium were found, located at nucleotide 1945 and 2097, as shown 
in Figure  3.8. 
In the fifth target; IAC, a fusion of M. tuberculosis rpoB gene and 83-110 bp 
region of E. histolytica HLY5mc1 gene was designed as PCR template. The template 
was ordered as a synthetic DNA fragment as illustrated in Figure 3.3. 
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Figure ‎3.5 Alignment of selected Leptospira rrs gene sequences. Shaded areas 
represent forward (green), reverse (red) primers and probe (brown). 
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Figure ‎3.6 Alignment of selected B. pseudomallei orf2 sequences. Shaded areas 
represent forward (green), reverse (red) primers and probe (brown). 
 
 
Figure ‎3.7 Alignment of selected Salmonella StyR-3 sequences. Shaded areas 
represent forward (green), reverse (red) primers and probe (brown). 
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Figure ‎3.8 Alignment of selected Plasmodium 18S rRNA sequences. Shaded 
areas represent forward (green), reverse (red) primers and probe (brown). 
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3.3.2 Primers designs and characteristics 
Following the identification of target region of the selected genes, primers 
were designed using IDT PrimerQuest tool. The sequences of the developed primers 
were listed in Table 3.1. Locations of primers on the respective gene alignments are 
shown in Figure  3.5 - Figure  3.8. Degenerative nucleotides were used when area of 
polymorphism occurred in the target. 
In addition, a CT-rich universal adapter was added to each primer (except 
IAC), as a previous study had shown that modification at 5‘ end of primers may 
increase PCR efficiency (Yuan et al., 2009). The sequences of modified primers 
(also denoted as primer with universal adapter or UN-primers) are listed in Table  3.2. 
Several parameters have been reported as optimal oligonucleotides characteristics. In 
terms of length, desirable primers should contain 18 – 35 bp (Basu, 2015). Some 
authors suggested slightly shorter ones, between 16 – 24 bp (J. Lim et al., 2011). 
Without the addition of a universal adapter, the non-modified primers‘ lengths were 
still within the recommended range, 19 – 24 bp. 
Conversely, following the addition of universal adapter, the length increased 
by 17 bp. Though this modification caused the primers‘ length to fall outside the 
optimal range, during the initial annealing and elongation, only the microbial-
specific sequence will bind to the complementary target, leaving the adapter hanging. 
Full sequence of modified primers would play their roles in the subsequent cycles 
(Arif and Ochoa-Corona, 2013). Furthermore, previous studies have shown that this 
strategy may improve PCR efficiency (Afonina et al., 2007; Yuan et al., 2009). 
Therefore, in vitro validation is important in order to verify this hypothesis. 
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Another important primer characteristic is the GC content. Prior to the 
addition of universal adapter, all primers had GC% between 31.2% and 57.9%, 
except the IAC reverse primer that contained 64.7% (Table 3.1). This value is 
slightly higher than the GC% recommendation; 40 – 60% (Basu, 2015). Some 
guidelines tolerate much higher upper limit, up to 80% (Rodríguez et al., 2015). 
Following addition of the universal adapter, the GC% increased to 46.4% and 62.2% 
(Table  3.2). Careful caution should be taken into consideration because high GC% 
and lengthy primer will increase melting temperature, which subsequently reduce 
PCR amplification efficiency and denaturation (J. Lim et al., 2011). In the modified 
primer, the melting temperature range was 73.6 °C to 77.6 °C. It is anticipated that 
the melting temperature will increase proportionately to the oligonucleotide lengths 
(Arif and Ochoa-Corona, 2013).  
Potential formation of secondary hairpin structure of primers was investigated 
using online OligoAnalyzer 3.1 software using default qPCR parameter setting. 
Ideally, hairpin structure should be avoided. However, its presence may be 
acceptable when the structure is readily denatured (or linearised) at low temperature. 
Table  3.3 summarises the potential hairpin formation of the developed primers and 
their melting temperatures. Without modification at 5‘ end, all primers have no 
potential formation of hairpin at ≥60 °C.  
Meanwhile, additions of universal adapter to the primer affect hairpin 
structure slightly differently, as listed in Table  3.4, in which, the additional universal 
adapter to the forward primer of B. pseudomallei may result in hairpin formation, 
possible melts at 61.3 °C. Meanwhile, the other modified primers did not form 
hairpin structure at ≥60 °C.  
  
 145 
Table ‎3.1 List of primers used in this study and respective characteristics 
Organism 
Primer 
type 
Sequences‎(5’‎→ 3’‎end) Length (bp) 
GC 
(%) 
Tm 
(°C) 
Leptospira 
F ACTGAGACACGGTCCATACT 20 50.0 62.3 
R TAGTTAGCYGGTGCTTTAGGYA 22 45.5 63.2 
B. 
pseudomallei 
F CCTGGGAGAGCGAGATGTT 19 57.9 63.1 
R GCTGGATGAGAAGAAAGTCC 20 50.0 60.1 
Salmonella 
F TCACTCATAATCAAGGGCTGC 21 47.6 62.3 
R CCTCTATCAAACTCGTCAGCG 21 52.4 62.1 
Plasmodium 
F GATTGTGCTGACTACGTCCC 20 55.0 62.2 
R CCTTTAAAAGATAGGATTTACRGT 24 31.2 59.7 
IAC 
F AAGGAGTTCTTCGGCACCA 19 52.6 63.5 
R GGCGCTTGTGGGTCAAC 17 64.7 63.3 
 
Table ‎3.2 List of primers with 5' end modification (UN-primers) used in this 
study and respective characteristics. Letters in brown represent 
universal sequences used as an adapter or an universal primer. 
Organism 
Primer 
type 
Sequences‎(5’‎→ 3’‎end) 
Length 
(bp) 
GC 
(%) 
Tm 
(°C) 
Leptospira 
UN-F 
CCTTCCTTCCTTCCCCCC- 
ACTGAGACACGGTCCATACT 
38 57.9 76.1 
UN-R 
CCTTCCTTCCTTCCCCCC- 
TAGTTAGCYGGTGCTTTAGGYA 
40 55.0 75.9 
B. pseudomallei 
UN-F 
CCTTCCTTCCTTCCCCCC- 
CCTGGGAGAGCGAGATGTT 
37 62.2 77.6 
UN-R 
CCTTCCTTCCTTCCCCCC- 
GCTGGATGAGAAGAAAGTCC 
38 57.9 75.6 
Salmonella 
UN-F 
CCTTCCTTCCTTCCCCCC- 
TCACTCATAATCAAGGGCTGC 
39 56.4 75.6 
UN-R 
CCTTCCTTCCTTCCCCCC- 
CCTCTATCAAACTCGTCAGCG 
39 59.0 76.0 
Plasmodium 
UN-F 
CCTTCCTTCCTTCCCCCC- 
GATTGTGCTGACTACGTCCC 
38 60.5 76.4 
UN-R 
CCTTCCTTCCTTCCCCCC- 
CCTTTAAAAGATAGGATTTACRGT 
42 46.4 73.6 
Universal UN CCTTCCTTCCTTCCCCCC 18 66.7 63.3 
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Table ‎3.3 Summary of hairpin structure presence among primers at 60 °C and 
other temperatures 
Organism Primer type 
Presence of hairpin 
at‎≥‎60‎°C at < 60 °C 
Leptospira 
Forward No Yes, 32 °C 
Reverse No Yes, 44.7 °C 
B. pseudomallei 
Forward No Yes, 13.4 °C 
Reverse No Yes, 31.2 °C 
Salmonella 
Forward No Yes, 16.5 °C 
Reverse No Yes, 35.4 °C 
Plasmodium 
Forward No Yes, 24.2 °C 
Reverse No Yes, 31.9 °C 
IAC 
Forward No Yes, 29.4 °C 
Reverse No Yes, 32 °C 
Universal UN No No 
 
Table ‎3.4 Summary of hairpin structure among UN-primers at 60 °C and other 
temperatures 
Organism Primer type 
Presence of hairpin 
at‎≥‎60‎°C at < 60 °C 
Leptospira 
UN-Forward No Yes, 32.0 °C 
UN-Reverse No Yes, 43.3 °C 
B. pseudomallei 
UN-Forward Yes, 61.3 °C Yes, 54.3 °C 
UN-Reverse No Yes, 39.8 °C 
Salmonella 
UN-Forward No Yes, 51.8 °C 
UN-Reverse No Yes, 35.4 °C 
Plasmodium 
UN-Forward No Yes, 32.7 °C 
UN-Reverse No Yes, 39.7 °C 
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3.3.3 Probes designs and characteristic 
Probes were designed using IDT PrimerQuest tool, located between the 
developed forward and reverse primers. The sequences of the developed probes were 
listed in Table  3.5. Ideally, the melting temperature should be 6 – 10 °C higher than 
the primers. In comparison to the unmodified primers, the Tm differences were in 
parallel to the recommendation. However, following the addition of universal 
adapter, the modified primers had higher Tm than the probes. This less desired 
scenario might affect PCR because there is possible tendency where the modified 
primers will hybridise earlier to the target DNA than the probe. As a result, 
amplification might happen without probes which subsequently reduce the PCR 
performance. Careful optimisation and in vitro validation should be carried out to 
rule out these undesirable possibilities.  
Similarly, potential formation of secondary hairpin structure of probes was 
investigated using online OligoAnalyzer 3.1 software using default qPCR parameter 
setting. Even though hairpin structure may compromise PCR, its existence may be 
acceptable when the structure is readily denatured (or linearised) at low temperature. 
Table  3.6 summarises the potential hairpin formation of the developed probes and 
their melting temperature. At the temperature of 60°C and higher, the probes did not 
form any hairpin. 
In addition, autolysis of probe may happen in the event where the 5‘ of the 
probe contain guanine. In the designed probes, no guanine base is located at the 
mentioned location. 
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Table ‎3.5 List of probes used in this study and respective characteristics 
Organism Sequences‎(5’‎→ 3’‎end) 
Size 
(bp) 
GC 
(%) 
Tm 
(°C) 
Leptospira FAM-ACGGGAGGCAGC-ZEN-AGTTAAGAATCTTGC-IBFQ 27 51.9 69.9 
B. pseudomallei TexRed-CCACGCACGGCGGAGATTCT-IBRQ 20 65.0 68.6 
Salmonella HEX-AGGCCATGCGAT-ZEN-AAGCTGTCTCAC-IBFQ 24 54.2 68.1 
Plasmodium Cy5-CCCGTCGCTCCT-TAO-ACCGATTGAAAG-IBRQ 24 58.3 67.9 
IAC Cy5.5-TTCCTGCTATTCTCATTCGCATCCATGT-IBRQ 28 42.9 67.9 
 
Table ‎3.6 Summary of hairpin structure presence among probes at 60 °C and 
other temperatures 
Organism 
Presence of hairpin 
at‎≥‎60‎°C at < 60 °C 
Leptospira No Yes, 36.4 °C 
B. pseudomallei No Yes, 56.5 °C 
Salmonella No Yes, 46.4 °C 
Plasmodium No Yes, 31.2 °C 
IAC No Yes, 31.0 °C 
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3.3.4 Self- and hetero-dimerisation activities between oligonucleotides 
Dimerisation of primers also may affect PCR amplification. Generally, ∆G 
value of ≤9 kcal mole-1 should be avoided and are deemed to favour production of 
dimerisation product. To determine the possible dimerisation, the sequences of 
oligonucleotides were analysed using IDT OligoAnalyzer using default qPCR 
parameters. The ∆G values of each primer pairs were listed in Table  3.7. Noticeably, 
three primer pairs had ∆G values of between 9.61 and -12.3 kcal mole-1.  
Meanwhile, the ∆G values of each probe versus primer or probe were listed 
in Table  3.8 and Table  3.9, respectively. Four probe-primer and four probe-probe pairs 
had ∆G value of less than -9 kcal mole-1. Analytical performance should be 
performed in order to validate the functionality of these primers and probes in the 
multiplex reaction. In contrast to primers, probes are less susceptible to dimerisation 
due to the presence of reporter dyes and quenchers in close proximity that may affect 
its structure (Johansson, 2006).  
Furthermore, the effects of additional universal adapter to each primer were 
also investigated. Summary of potential primer dimerisation was listed in Table  3.10. 
Following addition of universal adapter to primers, three more primer pairs had ∆G 
values of less than -9 kcal mole
-1
. Similarly, extra four pairs of probe versus UN-
primers had ∆G values of more than -9 kcal mole-1 (Table  3.11). It is anticipated that 
addition of universal adapter will affect the ∆G values (Arif and Ochoa-Corona, 
2013). 
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Table ‎3.7 Potential dimerisations between primers used in this study. The ∆G 
values (kcal mole
-1
) were coloured in gradient, from green (the highest value) to red 
(the lowest value).  
Primers interaction 
(Primer vs. primer) 
L
ep
to
sp
ir
a
 
B
. 
p
se
u
d
o
m
a
ll
ei
 
S
a
lm
o
n
el
la
 
P
la
sm
o
d
iu
m
 
IA
C
 
F
 
R
 
F
 
R
 
F
 
R
 
F
 
R
 
F
 
R
 
Leptospira 
F -3.61          
R -6.68 -8.19         
B. pseudomallei 
F -5.02 -5.47 -3.61        
R -6.6 -5.49 -4.74 -4.64       
Salmonella 
F -5.13 -7.07 -4.74 -6.6 -3.14      
R -5.13 -8.26 -6.78 -6.69 -6.69 -3.61     
Plasmodium 
F -4.95 -4.74 -7.71 -4.64 -6.14 -9.61 -6.3    
R -4.89 -5.49 -4.67 -5.49 -6.61 -5.61 -4.95 -8.74   
IAC 
F -4.64 -12.3 -5.19 -8.64 -5.09 -6.46 -6.44 -6.61 -3.61 
 
R -5.02 -5.47 -8.35 -3.54 -5.5 -8.35 -4.61 -4.12 -5.02 -9.89 
 
Table ‎3.8 Potential dimerisations between primers and probes used in this study. 
The ∆G values (kcal mole-1) were coloured in gradient, from green (the highest 
value) to red (the lowest value).  
Oligonucleotides interaction 
(Primer vs. probe) 
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Leptospira 
F -4.89 -4.64 -10 -8.02 -6.7 
R -6.69 -8.26 -7.07 -7.19 -5.85 
B. pseudomallei 
F -4.67 -6.75 -5.02 -11.5 -8.33 
R -6.69 -5.12 -6.7 -4.64 -10.1 
Salmonella 
F -9.83 -5.09 -6.21 -6.14 -5.09 
R -6.24 -6.75 -6.69 -8.35 -6.75 
Plasmodium 
F -8.65 -6.44 -4.74 -4.95 -5.09 
R -6.59 -3.61 -4.89 -8.02 -6.24 
IAC 
F -7.06 -3.61 -6.21 -8.26 -6.24 
R -4.74 -6.75 -6.75 -6.75 -6.75 
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Table ‎3.9 Potential dimerisations between probes used in this study. The ∆G 
values (kcal mole
-1
) were coloured in gradient, from green (the highest value) to red 
(the lowest value).  
Oligonucleotides interaction 
(Probe vs. probe) 
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Leptospira Probe -5.12     
B. pseudomallei Probe -9.77 -6.75    
Salmonella Probe -6.69 -8.7 -9.28   
Plasmodium Probe -11.1 -8.02 -8.33 -5.19 
 
IAC Probe -8.29 -6.75 -11.8 -5.19 -5.38 
 
Table ‎3.10 Potential dimerisations between modified primers used in this study. 
The ∆G values (kcal mole-1) were coloured in gradient, from green (the highest 
value) to red (the lowest value).  
Oligonucleotides interaction 
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Leptospira 
UN-F -3.61 
          
UN-R -6.68 -8.19 
         
B. pseudomallei 
UN-F -8.09 -7.71 -7.71 
        
UN-R -6.68 -5.85 -8.35 -5.12 
       
Salmonella 
UN-F -6.61 -7.74 -7.74 -6.61 -7.74 
      
UN-R -5.13 -8.26 -7.71 -10.3 -7.74 -3.61 
     
Plasmodium 
UN-F -6.68 -5.85 -7.71 -5.12 -6.61 -9.61 -6.3 
    
UN-R -6.24 -6.24 -7.71 -6.68 -9.68 -6.24 -6.68 -8.74 
   
IAC 
F -8.19 -12.3 -8.19 -8.64 -8.19 -8.19 -8.26 -8.19 -3.61 
  
R -9.43 -6.14 -8.35 -6.75 -6.14 -8.35 -6.14 -6.14 -5.02 -9.89 
 
Universal primer UN -3.07 -4.67 -7.71 -5.12 -6.61 -1.94 -1.57 -6.24 -8.19 -6.14 0 
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Table ‎3.11 Potential dimerisations between modified primers and probes used in 
this study. The ∆G values (kcal mole-1) were coloured in gradient, from green (the 
highest value) to red (the lowest value).  
Oligonucleotides interaction 
(Between UN-primers and probes) 
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Leptospira 
UN-F -7.71 -4.64 -10 -8.02 -6.7 
UN-R -7.71 -9.82 -6.68 -8.02 -5.7 
B. pseudomallei 
UN-F -7.71 -6.75 -5.02 -11.5 -8.33 
UN-R -9.75 -9.82 -6.75 -4.64 -10.1 
Salmonella 
UN-F -9.83 -5.09 -6.21 -6.14 -5.09 
UN-R -7.71 -6.75 -6.69 -8.35 -6.75 
Plasmodium 
UN-F -9.75 -6.68 -4.74 -5.19 -5.19 
UN-R -7.71 -4.64 -4.89 -8.02 -6.24 
IAC 
F -7.06 -3.61 -6.21 -8.26 -6.24 
R -4.74 -6.75 -6.75 -6.75 -6.75 
Universal primer UN -7.71 -4.64 -4.67 -3.54 0 
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3.3.5 Amplicon sizes and characteristics 
PCR product or amplicon is also another important factor for successful PCR. 
Ideally, amplicon size should be between 50 and 150 bp. Even though shorter 
amplicon is desired, ones with less than 400 bp can be amplified efficiently 
(Rodríguez et al., 2015). In addition, CG content should remain moderate because 
high GC content (˃80%) can potentially reduce or cause unsuccessful PCR 
amplification (Naz and Fatima, 2013). In this assay, the amplicon sizes are less than 
250 bp (107 – 215 bp) and contain between 40.7% and 58.5% GC (Table  3.12). 
Theoretically, at 95 °C, all amplicons are readily denatured. 
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Table ‎3.12 Amplicon sizes and respective characteristics 
Organism Target gene Length (bp) GC content (%) Tm (°C) 
Leptospira 16S rRNA 215 58.5 76.1 
B. pseudomallei TTSS-orf2 135 53.0 79.4 
Salmonella StyR-3 188 51.6 78.0 
Plasmodium 18S rRNA 189 40.7 79.9 
IAC rpoB-HLY5mc1 fusion 107 55.1 81.0 
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3.4 Development of monoplex TaqMan qPCR for the detection of Leptospira 
spp., B. pseudomallei, Salmonella spp. and Plasmodium spp. DNA 
3.4.1 Functionality of each monoplex TaqMan qPCR  
Following in silico validation of respective primers and probes, the developed 
oligonucleotides were tested in vitro to confirm their functionality. PCR reactions 
consisted 1 × SsoAdvanced Universal Probes Supermix, 200 nM primers of each 
primer pair, 100 nM probe, 2 µl DNA template (10 – 20 ng µl-1) and water were 
prepared and subjected to thermal cycling condition as described in Table  2.9. 
 
3.4.1 (a) Functionality of monoplex assay for detection of Leptospira spp. DNA 
Functionality of primers pair and probe for the detection of Leptospira on 
real-time PCR platform was investigated. Selected strains from pathogenic, 
intermediate and saprophytic Leptospira group were used as PCR template.   
Amplification of desired products was observed at first channel of the CFX 
machine, which captured signal of 450 - 730 nm wavelengths. For the leptospiral 
probe, FAM probe was used (Wavelength: 450 – 490 nm). As shown in Figure  3.9, 
the developed monoplex assay was able to amplify all of the tested leptospiral strains 
which included the L. interrogans serovar Canicola strain UPM strains and five other 
Leptospira spp. with Cq values ranged from 18 to 20. Next, the preliminary 
specificity of the developed assay on B. pseudomallei, Salmonella sp., Plasmodium 
sp. and healthy human DNA was investigated. 
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3.4.1 (b) Functionality of monoplex assay for detection of B. pseudomallei DNA 
Functionality of primers pair and probe for the detection of B. pseudomallei 
on real-time PCR platform was investigated. Several B. pseudomallei isolates were 
used as PCR template. Amplification of PCR products was expected at wavelength 
of 560 – 590 nm, through the Texas Red channel. As shown in Figure  3.10, the 
developed monoplex assay was able to amplify B. pseudomallei reference strain 
(USM BUPS 15/07/A) and six other B. pseudomallei isolates with Cq values 
between 26 and 28. Next, the preliminary specificity of the developed assay on L. 
interrogans, Salmonella sp., Plasmodium sp. and healthy human DNA was 
investigated.   
 
3.4.1 (c) Functionality of monoplex assay for detection of Salmonella spp. DNA 
Functionality of the developed primers and probe for detection of Salmonella 
in monoplex assay were tested against selected Salmonella strains. Specific HEX-
labelled probe, detectable at wavelength of 515 – 535 nm was selected.  
As shown in Figure  3.11, the developed assay was able to amplify the tested 
Salmonella Typhi reference strains and other Salmonella isolates with Cq values 
ranging from 25 to 27. Next, the preliminary specificity of the developed assay on L. 
interrogans, B. pseudomallei, Plasmodium sp. and healthy human DNA was 
investigated.   
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3.4.1 (d) Functionality of monoplex assay for detection of Plasmodium spp. 
DNA 
Functionality of the designed oligonucleotides for amplification of malarial 
nucleic acid was determined using P. falciparum reference strain (ATCC 
PRA¬405D), synthetic Plasmodium DNA and three other Plasmodium strains. A 
Cy5-labelled probe, detectable at wavelength 620 – 650 nm was used. As shown in 
Figure  3.12, the designed primers and probe was able to amplify the entire tested 
malarial DNA. Next, the preliminary specificity of the developed assay on L. 
interrogans, B. pseudomallei, Salmonella sp. and healthy human DNA was 
investigated.   
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Figure ‎3.9 Amplification of Leptospira spp. rrs genes in the monoplex assay 
 
 
Figure ‎3.10 Amplification of B. pseudomallei TTSS-orf2 genes in the monoplex 
assay 
 
 
 
Leptospira DNAs 
B. pseudomallei DNAs 
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Figure ‎3.11 Amplification of Salmonella StyR-3 genes in the monoplex assay 
 
  
Figure ‎3.12 Amplification of Plasmodium 18S rRNA genes in the monoplex assay 
 
  
Plasmodium DNAs 
Salmonella DNAs 
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3.4.2 Preliminary specificity testing of the developed monoplex TaqMan qPCR 
Prior to optimisation of assays, potential cross-amplification of the developed 
monoplex assay was tested on Leptospira spp., B. pseudomallei, S. Typhi, P. 
falciparum and healthy human DNA. As shown in Figure  3.13 - Figure  3.16, the 
monoplex assays exclusively amplified their desired target, respectively. No cross 
amplification was observed on other organisms. This preliminary specificity results 
suggest that the primers are specific for individual detection of Leptospira, B. 
pseudomallei, Salmonella and Plasmodium respectively, hence can be potentially 
used in real-time PCR platform. 
For example, as illustrated in Figure  3.13, the monoplex leptospiral qPCR 
assay only amplified Leptospira spp. DNA. No signal was observed in the other 
tested organism. Similarly, the monoplex qPCR assays for B. pseudomallei 
(Figure  3.14), Salmonella spp. (Figure  3.15) and Plasmodium spp, (Figure  3.16) only 
amplified B. pseudomallei, Salmonella spp. and Plasmodium spp. DNA, respectively. 
No cross-amplification of non-related organisms was observed. 
These results are consistent with the BLAST analysis that found that the 
designed oligonucleotides have high specificity to their particular targets. Further 
extended empirical specificity on wider spectrum of microorganism would be carried 
out, once a multiplex qPCR assay is successfully developed. Subsequently, the 
optimal primers and probe concentrations for each monoplex qPCR assays were 
determined, individually.  
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Figure ‎3.13 Preliminary specificity testing of the monoplex Leptospira qPCR 
 
 
Figure ‎3.14 Preliminary specificity testing of the monoplex B. pseudomallei qPCR 
  
Leptospira DNAs 
B. pseudomallei DNAs 
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Figure ‎3.15 Preliminary specificity testing of the monoplex Salmonella qPCR 
 
 
Figure ‎3.16 Preliminary specificity testing of the monoplex Plasmodium qPCR 
Plasmodium DNAs 
Salmonella DNAs 
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3.4.3 Optimisations of primer concentrations of the developed monoplex 
TaqMan qPCR  
Following preliminary specificity analysis, optimal primer concentration that 
resulted in the lowest (earliest) Cq value was determined. Respective monoplex 
qPCR reactions using different primer concentration were assayed. 
 
3.4.3 (a) Optimisation of primer concentrations for monoplex Leptospira qPCR 
assay 
Leptospiral primers at 100 nM, 200 nM, 300 nM, 400 nM, 500 nM and 600 
nM were tested. As shown in Table  3.13, the mean of Cq increased proportionately 
to the increase of primers concentration. Even though the differences were close, 
especially at concentration of 100 – 300 nM, 200 nM resulted in the lowest Cq. 
 
3.4.3 (b) Optimisation of primer concentrations for monoplex B. pseudomallei 
qPCR assay 
Next, the optimal concentration of B. pseudomallei primers was determined 
(Table  3.14). No significant changes in the Cq values were seen across the tested 
primer concentration (100 nM – 600 nM). The Cq differences between primer 
concentrations lied between 0.35 and 0.57. Primer concentration of 200 nM was 
chosen as the optimal concentration. 
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3.4.3 (c) Optimisation of primer concentrations for monoplex Salmonella 
qPCR assay 
Optimal concentration of Salmonella primers was determined by testing the 
concentrations at 100 nM until 600 nM. As shown in Table  3.15, the difference of Cq 
value ranged closely, between 0.05 to 0.54, relative to the lowest Cq value, achieved 
at primer concentration of 200 nM. 
 
3.4.3 (d) Optimisation of primer concentrations for monoplex Plasmodium 
qPCR assay 
Optimal concentration of primers was determined by testing the assay at 
different concentration of oligonucleotides, ranging between 100 nM and 600 nM. 
As shown in Table  3.16, primer concentration of 400 nM resulted in the lowest Cq. 
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Table ‎3.13 Leptospira primers optimisation 
Primers concentration Mean Cq Cq difference (Cqlowest – Cqany) 
100 nM 15.34 + 0.04 
200 nM 15.30 0 
300 nM 15.71 + 0.41 
400 nM 16.01 + 0.71 
500 nM 16.05 + 0.75 
600 nM 16.41 + 1.11 
 
Table ‎3.14 B. pseudomallei primers optimisation 
Primers concentration Mean Cq Difference (Cqlowest – Cqany) 
100 nM 19.08 + 0.35 
200 nM 18.73 0 
300 nM 19.04 + 0.31 
400 nM 19.23 + 0.50 
500 nM 19.14 + 0.41 
600 nM 19.3 + 0.57 
 
Table ‎3.15 Salmonella primers optimisation 
Primers concentration Mean Cq Difference (Cqlowest – Cqany) 
100 nM 17.73 0.51 
200 nM 17.22 0 
300 nM 17.47 0.25 
400 nM 17.27 0.05 
500 nM 17.76 0.54 
600 nM 17.67 0.45 
 
Table ‎3.16 Plasmodium primers optimisation 
Primers concentration Mean Cq Difference (Cqlowest – Cqany) 
100 nM 22.78 + 1.91 
200 nM 21.27 + 0.40 
300 nM 20.93 + 0.05 
400 nM 20.87 0 
500 nM 21.05 + 0.18 
600 nM 20.88 + 0.01 
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3.4.4 Optimisations of probe concentrations of the developed monoplex 
TaqMan qPCR 
Leptospira monoplex qPCR assay used FAM-labelled probe, detectable at 
channel 1, wavelength of 520 nm. Meanwhile, Salmonella monoplex qPCR assay 
used HEX-labelled probe, detectable at channel 2, wavelength of 555 nm. B. 
pseudomallei and Plasmodium monoplex qPCR assays utilised Texas Red-labelled 
probe and Cy5-labelled probe, respectively. The probes are detectable separately at 
channel 3, wavelength of 617 nm and channel 4, wavelength of 668 nm.  
Optimal probe concentration that resulted in the lowest (earliest) Cq value 
was determined by testing the monoplex qPCR assay at different concentration. 
Unlike primer, probes are significantly expensive, hence should be utilised 
judiciously (Tajadini et al., 2014). During this study, TaqMan hydrolysis probes cost 
between RM 1600 to RM 2300 per tube (data not shown). Therefore, in this 
optimisation steps, Cq differences of approximately 0.5 is considered less significant. 
Therefore, lowest possible concentration of probe that resulted ±0.5 Cq difference 
will be selected. 
 
3.4.4 (a) Optimisation of probe concentrations for monoplex Leptospira qPCR 
assay 
Optimal probe concentration was determined, between 50 and 200 nM. As 
shown in Table 3.17, the Cq decreased as the probe concentration increased. In 
contrast to selection of primer where the concentration that produces the lowest Cq is 
selected, differences between the lowest Cq values, as well as their respective probe 
concentration were carefully considered. In this optimisation, probe at 200 nM 
resulted in the lowest Cq. However, another probe concentration, the 100 nM was 
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chosen because the Cq difference is less than 0.5 from the 200 nM, hence will save 
the cost by approximately 50%. 
 
3.4.4 (b) Optimisation of probe concentrations for monoplex B. pseudomallei 
qPCR assay 
Optimal B. pseudomallei probe concentration was determined by testing the 
monoplex assay using different concentration of Texas Red probe (Table  3.18). 
Higher concentration of probe decreased Cq value of the assay. Probe concentration 
of 100 nM was selected as the Cq difference was close to 0.5. 
 
3.4.4 (c) Optimisation of probe concentrations for monoplex Salmonella qPCR 
assay 
Four different probe concentrations (50 nM, 100 nM, 150 nM and 200 nM) 
were tested. Generally, increase of probe concentration resulted in lower Cq value 
(Table  3.19). Probe concentration of 100 nM was used as it produced the Cq within 
0.4 Cq difference from the 200 nM. 
 
3.4.4 (d) Optimisation of probe concentrations for monoplex Plasmodium 
qPCR assay 
Optimal malarial probe concentration was determined by testing the 
monoplex assay using different concentration of Cy5-labelled probe. Probe 
concentration of 200 nM produced the lowest Cq, as compared to other tested 
concentration. However, probe concentration of 100 nM was chosen in subsequent 
analysis as the Cq difference was less than 0.5 from the lowest Cq value 
(Table  3.20). 
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Table ‎3.17 Optimisation of Leptospira probe 
Probe concentration Mean Cq Cq difference 
50 nM 15.41 0.77 
100 nM 15.12 0.48 
150 nM 14.98 0.34 
200 nM 14.64 0 
 
Table ‎3.18 Optimisation of B. pseudomallei probe 
Probe concentration Mean Cq Cq difference 
50 nM 19.26 1.29 
100 nM 18.51 0.54 
150 nM 18.11 0.13 
200 nM 17.97 0 
 
Table ‎3.19 Optimisation of Salmonella probe 
Probe concentration Mean Cq Difference 
50 nM 18.08 1.03 
100 nM 17.45 0.40 
150 nM 17.12 0.07 
200 nM 17.05 0 
 
Table ‎3.20 Optimisation of Plasmodium probe 
Probe concentration Mean Cq Cq difference 
50 nM 22.71 0.92 
100 nM 22.28 0.49 
150 nM 21.98 0.19 
200 nM 21.79 0 
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3.4.5 Effect of universal adapter to PCR amplification 
Additions of unique nucleotides to the 5‘ end of primers, also known as 
adapter or flap, have been reported to improve PCR efficiency. To date, several 
universal adapters have been reported and utilised in molecular platform (Afonina et 
al., 2007; Yuan et al., 2009). In this study, the effect of universal adapter/conjugated-
primers (UN-primers) on PCR performance was investigated.  
 
3.4.5 (a) Performance of Leptospira monoplex qPCR assay using primer 
with/without universal adapter. 
As shown in Table  3.21, the PCR efficiency of primer with the presence of 
universal adapter was 96.9%, almost 2% better than primer without additional 
adapter. In terms of analytical sensitivity, the primer with universal adapter was more 
sensitive, able to amplify as low as 20 fg of leptospiral DNA, as compared to the 
primer without universal adapter. As the Leptospira DNA was diluted, the Cq 
increased proportionately (Table  3.22). Standard curves were constructed based on 
the mean Cq and log10 (copies number). The linearity of the assays, denoted by the 
R
2
 values was close to 1. 
 
3.4.5 (b) Performance of B. pseudomallei monoplex qPCR assay using primer 
with/without universal adapter. 
Performance of qPCR utilising primer with universal adapter was compared 
with primer without universal adapter. As shown in Table  3.23, both primer types 
had comparable PCR efficiency, 93.9% and 93.4%, respectively. In terms of 
sensitivity (Table  3.24), both assays could detect as low as 20 fg B. pseudomallei 
DNA per reaction. For subsequent optimisation, primer with universal adapter was 
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chosen to allow standardisation of primers, as well as due to its potential in 
improving PCR efficiency in the multiplex assay. 
 
3.4.5 (c) Performance of Salmonella monoplex qPCR assay using primer 
with/without universal adapter. 
Effect of universal adapter on PCR performance was compared with primer 
that did not contain universal adapter. As shown in Table  3.25, presence of universal 
adapter slightly increased the PCR efficiency, by 0.2%. In terms of linearity and 
sensitivity (Table  3.26), both types of primer had comparable performance, linearity 
of close to 1, and sensitivity of as low as 20 fg of Salmonella DNA. 
 
3.4.5 (d) Performance of Plasmodium monoplex qPCR assay using primer 
with/without universal adapter. 
PCR performance of assay utilising standard primers was compared with 
primers conjugated with universal adapter. As shown in Table  3.27, the presence of 
conjugated universal primer significantly improved PCR efficiency to 94.2%, as 
compared to assay without universal adapter which scored 87.2%. In terms of 
linearity and sensitivity (Table  3.28), both assays had R
2
 values of close to 1, and 
were able to amplify as low as 200 ag Plasmodium synthetic DNA. 
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Table ‎3.21 Performance of Leptospira monoplex qPCR assay using primer 
without adapter and primer with adapter 
Parameter 
Leptospira qPCR 
without UN-adapter with UN-adapter 
Slope -3.4454 -3.3982 
PCR efficiency 95.1% 96.9% 
Linearity, R
2 0.9976 0.9942 
 
Table ‎3.22 Sensitivity of Leptospira monoplex qPCR assay using primer without 
adapter and primer with adapter 
Amount of Leptospira DNA 
per reaction (pg) 
Mean Cq 
Primer without UN-adapter  Primer with UN-adapter  
20000 17.69 19.72 
2000 21.22 23.63 
200 25.19 27.65 
20 28.44 30.78 
2 31.95 34.68 
0.2 34.72 37.33 
0.02 - 39.96 
0.002 - - 
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Table ‎3.23 Performance of B. pseudomallei monoplex qPCR assay using primer 
without adapter and primer with adapter 
Parameter 
B. pseudomallei qPCR 
without UN-adapter with UN-adapter 
Slope -3.475 -3.489 
PCR efficiency 93.9% 93.4% 
Linearity, R
2 0.9991 0.9993 
 
Table ‎3.24 Sensitivity of B. pseudomallei monoplex qPCR assay using primer 
without adapter and primer with adapter 
Amount of B. pseudomallei  DNA Mean Cq 
per reaction (pg) Primer without UN-adapter  Primer with UN-adapter  
20000 18.36 17.96 
2000 22.07 21.33 
200 25.35 24.53 
20 28.75 28.16 
2 32.37 31.65 
0.2 35.38 35.60 
0.02 39.58 38.65 
0.002 - - 
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Table ‎3.25 Performance of Salmonella monoplex qPCR assay using primer 
without adapter and primer with adapter 
Parameter 
Salmonella qPCR 
without UN-adapter with UN-adapter 
Slope -3.172 -3.168 
PCR efficiency 106.7% 106.9% 
Linearity, R
2 0.996 0.994  
 
Table ‎3.26 Sensitivity of Salmonella monoplex qPCR assay using primer without 
adapter and primer with adapter 
Amount of Salmonella  DNA Mean Cq 
per reaction (pg) Primer without UN-adapter  Primer with UN-adapter  
20000 17.03 18.35 
2000 20.18 21.53 
200 23.63 25.13 
20 27.14 28.54 
2 30.31 32.14 
0.2 33.51 34.63 
0.02 35.52 36.85 
0.002 - - 
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Table ‎3.27 Performance of Plasmodium monoplex qPCR assay using primer 
without adapter and primer with adapter 
Parameter 
Plasmodium qPCR 
without UN-adapter with UN-adapter 
Slope -3.673 -3.469 
PCR efficiency 87.2% 94.2% 
Linearity, R
2 0.9999 0.9977 
 
Table ‎3.28 Sensitivity of Plasmodium monoplex qPCR assay using primer 
without adapter and primer with adapter 
Amount of Plasmodium synthetic DNA Mean Cq 
per reaction (pg) 
Primer without UN-
adapter  
Primer with UN-adapter  
20 17.50 17.97 
2 21.26 21.50 
0.2 24.94 25.30 
0.02 28.44 28.90 
0.002 32.15 32.30 
0.0002 35.98 35.05 
0.00002 - - 
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3.5 Development of monoplex TaqMan qPCR for the detection of IAC 
3.5.1 Functionality of monoplex assay 
Following the designing of primers and probe against rpoB-EH IAC synthetic 
DNA, functionality of the oligonucleotides was evaluated. Amplification of desired 
product was observed at channel Cy5.5 that detect wavelength of 694 nm. As shown 
in Figure  3.17, the developed IAC monoplex assay was able to amplify rpoB-EH 
IAC synthetic DNA.  
 
3.5.2 Preliminary specificity testing 
The preliminary specify of the IAC oligonucleotides was also tested against 
L. interrogans, B. pseudomallei, S. Typhi, P. falciparum and human DNA. As shown 
in Figure  3.18, no undesired cross amplification was observed in the unrelated DNA 
templates.  
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Figure ‎3.17 Amplification of IAC rpoB-EH fusion target in the monoplex assay 
 
 
 
Figure ‎3.18 Preliminary specificity testing of the IAC monoplex assay  
  
IAC target 
IAC targets  
(triplicates) 
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3.5.3 Optimisation of IAC template concentrations 
Competitive amplification strategy where all targeted pathogens and IAC 
were amplified within the same reaction was implemented. This strategy enabled 
more accurate determination of (true) negative specimen; that may also be caused by 
the presence of inhibitor, sub-optimal polymerase enzyme activity or imprecise PCR 
mixture within a single tube, as compared to the non-competitive strategy. Moreover, 
competitive strategy is more cost-effective as only a single reaction tube is needed. 
However, careful assay design should be carried out as competitive may in strategy 
favour to biased amplification, and subsequent false negativity. 
Ideally, to reduce the possibility of primers competition between IAC and 
pathogenic targets, the IAC primers concentration should be lower than the 
pathogen-specific primers (Hoorfar et al., 2004). Therefore, in this study, the 
concentration of IAC primers was reduced to 50% - 75% of the pathogen-specific 
primers, set at 100 nM and 50nM, for forward primer and reverse, respectively. This 
strategy was implemented to favour amplification of the desired microbial targets. 
Meanwhile, IAC probe concentration was maintained at 100 nM to maximize the 
signal strength. 
Another important parameter is the IAC target concentration. Too high IAC 
target may compete with pathogen DNA or may not be able to detect low presence of 
inhibitor. To determine the optimal concentration of IAC, a set of IAC template (2 pg 
– 2 ag per reaction) was tested. As shown in Figure  3.19 IAC target concentration of 
2 fg was chosen as it gave the Cq value of approximately 32. 
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3.5.4 Linearity, efficiency and limit of detection (LOD) 
Based on the previous data (as illustrated in Figure  3.19), the analytical 
performance of the IAC qPCR was determined. The PCR efficiency was 76.9% and 
linearity value of 0.9975 (Table  3.29). Even though the efficiency is lower than the 
other microbial targets, it is anticipated due to low primer concentrations used.  
Another study that had similar assay efficiency and linearity reported that such 
conditions did not affect the assays‘ reproducibility (Coffey et al., 2016). Besides, 
the developed assay was able to detect as low as 20 ag of IAC synthetic DNA 
(Table  3.30). These parameters would be used in the multiplex qPCR assays in order 
to favour amplification of Leptospira, B. pseudomallei, Salmonella and Plasmodium. 
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Figure ‎3.19 Optimisation of IAC template concentrations 
 
Table ‎3.29  Performance of IAC monoplex qPCR assay 
Parameter IAC qPCR 
Slope -4.035 
PCR efficiency 76.9% 
Linearity 0.9975 
 
Table ‎3.30  Sensitivity of IAC monoplex assay 
Amount of IAC synthetic DNA Mean 
Cq per reaction (pg) 
2 20.17 
0.2 24.37 
0.02 28.01 
0.002 32.53 
0.0002 35.67 
0.00002 40.73 
0.000002 - 
 
  
2pg    200pg  20pg  2pg  200fg   2 fg 
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3.6 Development of multiplex TaqMan qPCR for the detection of Leptospira, 
B. pseudomallei, Salmonella and Plasmodium DNA with the incorporation 
of IAC. 
3.6.1 Functionality of the multiplex assay 
Following the development of separate monoplex qPCR assays for detection 
of individual microbial target and IAC, all primer pairs and probes were multiplexed 
into a single reaction. Preliminary functionality of the multiplex reaction was 
investigated. As illustrated in Figure  3.20, all of the targets, Leptospira, B. 
pseudomallei, Salmonella, Plasmodium and IAC were successfully amplified. 
Next, the concentration of unconjugated universal primer would be optimised, 
followed by performance comparisons of the multiplex qPCR assay versus monoplex 
qPCR assays. 
  
 181 
 
Figure ‎3.20 Functionality test of the developed multiplex qPCR 
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3.6.2 Optimisation of un-conjugated universal primers concentration 
Effect of additional unconjugated universal primer (UN) to PCR was 
investigated at concentrations of 100 nM – 400 nM. As shown in Table  3.31, 
addition of unconjugated universal primer reduced the Cq values by 0.58 and 0.6 for 
B. pseudomallei and Plasmodium targets, respectively. For remaining targets, the 
Leptospira and Salmonella, additional un-conjugated universal primers resulted in 
slightly reduced Cq, of approximately 0.2. In the subsequent multiplex qPCR assays, 
200 nM unconjugated universal primer will be added to the reactions, as it resulted in 
the lowest Cq values, in B. pseudomallei, Salmonella and Plasmodium targets. 
Mechanisms of actions of unconjugated universal primer (UN) and universal adapter 
are illustrated in Appendix D. 
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Table ‎3.31  Optimisation of un-conjugated universal primers concentration 
Target Sample Mean Cq Difference 
Leptospira 
0 nm UN 16.13 0.22 
+ 100 nM UN 15.93 0.02 
+ 200 nM UN 16.03 0.12 
+ 300 nM UN 16.11 0.2 
+ 400 nM UN 15.91 0 
B. pseudomallei 
0 nm UN 18.78 0.58 
+ 100 nM UN 18.49 0.29 
+ 200 nM UN 18.20 0 
+ 300 nM UN 18.4 0.2 
+ 400 nM UN 18.34 0.14 
Salmonella 
0 nm UN 18.31 0.16 
+ 100 nM UN 18.17 0.02 
+ 200 nM UN 18.15 0 
+ 300 nM UN 18.19 0.04 
+ 400 nM UN 18.19 0.04 
Plasmodium 
0 nm UN 17.63 0.6 
+ 100 nM UN 17.33 0.3 
+ 200 nM UN 17.03 0 
+ 300 nM UN 17.26 0.23 
+ 400 nM UN 17.37 0.34 
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3.6.3 Efficiency and linearity of multiplex versus monoplex qPCR 
Standard curves were constructed using amplification data of the developed 
multiplex qPCR assay, as well as data from the monoplex qPCR assays. As shown in 
Table 3.32, the PCR efficiency of the multiplex qPCR versus Leptospira monoplex 
qPCR assay was 91.04% versus 95.09%, respectively. It is expected that PCR 
efficiency can be affected once a monoplex assay is combined into a multiplex assay 
(Deng et al., 2013; Jin et al., 2017). Some groups reported that PCR efficiency can 
be reduced as many as 13% in a multiplex platform (Giry et al., 2017). In this study, 
the 91.04% PCR efficiency of the multiplex assay for the leptospiral target is still 
within the acceptable range; of 90% efficiency and above (Z. Pang et al., 2014; Svec 
et al., 2015).   
In the next target; the B. pseudomallei DNA (Table  3.33), the multiplex qPCR 
had considerably higher efficiency (103.26%) than the monoplex assay (93.43%). 
Similarly, for the detection of malarial DNA (Table  3.35), the multiplex qPCR assay 
had slightly higher efficiency (95.22%) than the monoplex assay (94.22%). 
Meanwhile, Salmonella multiplex and monoplex qPCR assays had comparable 
efficiency of 105.3% and 106.3%, respectively (Table  3.34). Overall, the multiplex 
qPCR assays scored more than 90% efficiency for all of the desired microbial 
targets.  
In terms of analytical sensitivity, the multiplex assays had comparable 
sensitivity with the monoplex assay (Figure  3.21-Figure  3.24). Noticeably, regardless 
of the lower PCR efficiency of the leptospiral multiplex qPCR assay, the multiplex 
assay also had similar analytical sensitivity with the leptospiral monoplex assay 
(Figure  3.21). Similarly, in terms of linearity, all multiplex and monoplex assays had 
R2 values between 0.9868 and 0.9986; very close to 1. 
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Table ‎3.32  Comparison of performance between monoplex and multiplex qPCR 
assays for detection of Leptospira DNA 
Parameter 
Leptospira qPCR 
Multiplex Monoplex 
Slope -3.5571 -3.3111 
PCR efficiency 91.04% 100.45% 
Linearity 0.9980 0.9957 
 
 
 
Figure ‎3.21 Standard curve of the developed qPCR for the detection of Leptospira 
DNA. Multiplex (blue) versus monoplex (red) assays. 
  
 186 
Table ‎3.33  Comparison of performance between monoplex and multiplex qPCR 
assays for detection of B. pseudomallei DNA 
Parameter 
B. pseudomallei qPCR 
Multiplex Monoplex 
Slope -3.2461 -3.4904 
PCR efficiency 103.26% 93.43% 
Linearity 0.9958 0.9993 
 
 
 
Figure ‎3.22 Standard curve of the developed qPCR for the detection of B. 
pseudomallei DNA. Multiplex (blue) versus monoplex (red) assays. 
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Table ‎3.34  Comparison of performance between monoplex and multiplex qPCR 
assays for detection of Salmonella DNA 
Parameter 
Salmonella qPCR 
Multiplex Monoplex 
Slope -3.2011 -3.1682 
PCR efficiency 105.30% 106.85% 
Linearity 0.9868 0.9940 
 
 
 
Figure ‎3.23 Standard curve of the developed qPCR for the detection of Salmonella 
DNA. Multiplex (blue) versus monoplex (red) assays. 
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Table ‎3.35  Comparison of performance between monoplex and multiplex qPCR 
assays for detection of Plasmodium DNA 
Parameter 
Plasmodium qPCR 
Multiplex Monoplex 
Slope -3.4421 -3.4686 
PCR efficiency 95.22% 94.22% 
Linearity 0.9986 0.9977 
 
 
 
Figure ‎3.24 Standard curve of the developed qPCR for the detection of 
Plasmodium DNA. Multiplex (blue) versus monoplex (red) assays. 
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3.6.4 Limits of detection (LOD) 
The limits of detection (LOD) of the developed multiplex qPCR assays were 
determined using Probit nonlinear-regression model, based on data of 24 replicates, 
targeting 5 different DNA copy numbers and distributed across different days. LOD 
is defined by the lowest DNA copies at which 95% of the samples were positive. 
Details of replicates positivity rate and amount of DNA in each reaction were listed 
in Table  3.36. Respective Probit analysis graphs were constructed from the data. 
As shown in Figure  3.25, the LOD of the multiplex qPCR assay for the 
detection of Leptospira DNA was approximately 5.61 copies per reaction. The LOD 
is comparable to other reported molecular assays which detected 1 – 10 leptospiral 
DNA copies per reaction (Ahmed et al., 2009; Bedir et al., 2010; Bourhy et al., 
2011; Levett et al., 2005; Merien et al., 2005; A. Slack et al., 2007; Thaipadungpanit 
et al., 2011). 
The LOD of the multiplex qPCR assay for the detection of another target, the 
B. pseudomallei DNA was ~ 8.24 DNA copies per reaction (Figure  3.26). Similarly, 
the LOD is analogous to previously described hydrolysis probe-based molecular 
assays that can amplify 5 – 10 copies B. pseudomallei DNA per reaction (Al-
Marzooq and Mustafa, 2011; Kaestli et al., 2012; Novak et al., 2006; B. Zhang et al., 
2012). 
Meanwhile, the LOD of the multiplex qPCR assay for the Salmonella target 
was around 19.3 DNA copies per reaction (Figure  3.27). In comparison to other 
studies, the reported LODs were comparable, ranging from 40 to 1000 DNA copies 
per reaction (González-escalona et al., 2012; Maurischat et al., 2015). In many 
instances, the reported molecular assays require pre-enrichment prior to the DNA 
extraction (Reynisson et al., 2006; G. G. Stone et al., 1994). 
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The fourth target of the multiplex qPCR assay; Plasmodium; had LOD of 
approximately 18.1 copies per reaction (Figure  3.28). As the target gene presents in 5 
copies per malarial genome, the calculated LOD could be around 3.7 organisms per 
reaction (Gonçalves et al., 2012; Mangold et al., 2005). Relative to other studies, the 
reported LOD was between 40.3 and 250 copies per reaction (Divis et al., 2010; 
Pholwat et al., 2017). Other assays that targeted 18S rRNA gene had reported LOD 
of 5 to 50 copies per reaction (Mangold et al., 2005; Rougemont et al., 2004). 
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Table ‎3.36  Testing of multiplex qPCR assays on 80 fg - 2 fg bacterial DNA and 
20 ag – 0.2 ag Plasmodium DNA 
Organism DNA amount DNA copies # Positive # Replicates Positivity % 
Leptospira 
80 fg 16 24 24 100% 
40 fg 8 23 24 96% 
20 fg 4 22 24 92% 
5 fg 1 4 24 17% 
2 fg 0.4 0 24 0% 
B. pseudomallei 
80 fg 10.24 24 24 100% 
40 fg 5.12 21 24 88% 
20 fg 2.56 15 24 63% 
5 fg 0.64 7 24 29% 
2 fg 0.256 1 24 4% 
Salmonella 
80 fg 15.24 24 24 100% 
40 fg 7.62 18 24 75% 
20 fg 3.81 13 24 54% 
5 fg 0.9525 4 24 17% 
2 fg 0.38 2 24 8% 
Plasmodium 
20 ag 37.1 24 24 100% 
10 ag 18.55 23 24 96% 
5 ag 9.275 18 24 75% 
2 ag 3.71 9 24 38% 
0.2 ag 0.371 0 24 0% 
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Figure ‎3.25 Probit nonlinear regression analysis of the developed multiplex qPCR  
for the detection of Leptospira DNA 
 
 
 
Figure ‎3.26 Probit nonlinear regression analysis of the developed multiplex qPCR 
for the detection of B. pseudomallei DNA 
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Figure ‎3.27 Probit nonlinear regression analysis of the developed multiplex qPCR 
for the detection of Salmonella DNA 
 
 
 
Figure ‎3.28 Probit nonlinear regression analysis of the developed multiplex qPCR 
for the detection of Plasmodium synthetic DNA. 
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3.6.5 Amplification of microbial target in the presence of IAC 
Simultaneous amplification of IAC and microbial targets (titred close to the 
LOD) were investigated. As shown in Table  3.37, the means Cq of Salmonella target 
(HEX probe) without and with amplification of IAC targets were comparable, 35.53 
and 35.91, respectively. Similarly, the means Cq of Plasmodium, in the presence and 
absence of IAC were analogous, 38.61 and 38.20 each.  
Meanwhile, the means Cq of individual Leptospira and B. pseudomallei 
target were lower than the Leptospira and B. pseudomallei with IAC, by more than 1 
Cq. This result may due to the competitive amplification between Leptospira or B. 
pseudomallei with IAC or potential dimerisation between Leptospira and IAC 
primers, as well as potential dimerisation between B. pseudomallei and IAC primers 
which had ∆G values of -10.3 and -12.3 kcal mole-1as shown in section  3.3.4. 
Remarkably, if the latter factor is significant, sensitivity and amplification efficiency 
of multiplex qPCR should be lower than the monoplex qPCR. As shown previously 
in the section  3.6.3, both monoplex and multiplex qPCR assay had similar 
sensitivity. In terms of amplification efficiency, in contrast to leptospiral target, B. 
pseudomallei multiplex qPCR assay had higher PCR efficiency than the monoplex 
assay. Other factors such as Poisson distribution effect of DNA targets and random 
pipetting error might also affect the variations.  
Meanwhile, the IAC (Cy5.5 probe) had very stable Cq in all reaction. The 
recorded IAC Cq values were approximately 32, with and without co-amplification 
of the microbial target. In this sectional analysis, it is found that the multiplex qPCR 
assay was able to simultaneously amplify both microbial and IAC target, at low copy 
numbers albeit increased in the Cq values in certain targets. As there is a possibility 
that certain sensitivity of the assay may be affected by amplification competition 
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between IAC and low concentration microbial targets (Flores et al., 2009), further 
study can evaluate the oligonucleotides competition effects on the assays LOD. 
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Table ‎3.37  Amplification of microbial targets in the absence or presence of IAC 
target 
Target 
Specific probe 
(FAM/HEX/TexRed/Cy5) 
IAC probe (Cy5.5) 
Mean Cq SD CV% Mean Cq SD CV% 
Leptospira 36.57 1.26 3.4 - - - 
Leptospira          +  IAC 37.62 0.32 0.8 32.46 1.07 3.3 
B. pseudomallei 36.24 0.52 1.4 - - - 
B. pseudomallei  +  IAC 37.74 1.10 2.9 32.38 0.43 1.3 
Salmonella 35.53 1.29 3.6 - - - 
Salmonella          +  IAC 35.91 0.54 1.5 32.09 0.48 1.5 
Plasmodium 38.20 0.34 0.9 - - - 
Plasmodium        +  IAC 38.61 0.80 2.1 32.07 0.38 1.2 
IAC - - - 32.36 0.2 0.6 
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3.6.6 Analytical specificity of the multiplex assay 
Extended analytical specificity testing was carried out on 357 microbial 
isolates, consisted of 131 leptospiral strains, 105 B. pseudomallei isolates, 44 
Salmonella isolates, 31 Plasmodium strains and 46 other organisms. As shown in 
Table  3.38, the developed multiplex qPCR assay was able to detect and differentiate 
the entire organisms of interest, in particular Leptospira (100% detection by the 
FAM channel), B. pseudomallei (100% detection by the Texas Red channel), 
Salmonella spp. (100% detection by the HEX channel) and Plasmodium spp. (100% 
detection by the Cy5 channel). No other organism was detected by any of the 
mentioned channels.  
For the IAC (denoted by the Cy5.5 probe), the signals were detected in other 
organisms, suggesting successful PCR / absence of PCR inhibitors. In the desired 
microbial targets, the IAC might not be amplified perhaps due to primers-targets 
competition, in which the target DNA presents in a proportionally larger amount than 
the IAC (Hoorfar et al., 2004). 
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Table ‎3.38  Summary of analytical specificity of the developed multiplex qPCR 
assay on extended spectrum of microorganisms 
Organisms tested # strains 
# positive in Multiplex qPCR 
Total Leptospira 
(FAM) 
B. pseudomallei 
(Texas Red) 
Salmonella 
(HEX) 
Plasmodium 
(Cy5) 
IAC 
(Cy5.5) 
Leptospira spp. 131 131 - - - - 131 
B. pseudomallei 105 - 105 - - - 105 
Salmonella spp. 44 - - 44 - - 44 
Plasmodium spp. 31 - - - 31 - 31 
Other organisms 46 - - - - 46 46 
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3.6.7 Intra- and inter-assay variation 
Precision of the developed multiplex qPCR assays was determined based on 
intra-assay variation (repeatability) and inter-assay variation (reproducibility) (Bustin 
et al., 2009). In this study, two different DNA concentrations; 200 pg and 0.2 pg 
were used. 
Overall, the coefficients of variations (CV) of intra-assays were between 
0.1% and 2.8% (Table  3.39). For the leptospiral target, the coefficient of variation 
(CV) of the first and second runs was 0.1% and 0.7%. Similarly, the Salmonella, 
Plasmodium and IAC targets also had CV% between 0.1% and 0.2%. Slightly higher 
CV% values were observed in 0.2 pg B. pseudomallei targets in which, each run 
scored 2.8% and 1.8% respectively. 
For inter assays variation, as shown in Table  3.39, the CV% of for each 
microbial targets were less than 4%. Most microbial targets had CV of 2.0% and 
below, except slightly higher CV% were observed in 0.2 pg B. pseudomallei target 
(3.7%) and 0.2 pg of Plasmodium target (2.7%).  
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Table ‎3.39  Precision of the developed multiplex qPCR assay represented by the 
intra- and inter-assay variations 
Organism 
Amount 
of DNA 
(pg) 
Run 1  Run 2 Inter-
assay  
CV% Mean SD CV%  Mean SD CV% 
Leptospira 
200 22.31 0.02 0.1  23.01 0.07 0.3 1.7 
0.2 33.74 0.15 0.4  34.45 0.25 0.7 1.3 
B. pseudomallei 
200 26.66 0.16 0.6  26.91 0.22 0.8 0.8 
0.2 36.76 1.03 2.8  37.12 0.66 1.8 3.7 
Salmonella 
200 25.73 0.09 0.4  26.07 0.01 0.1 0.8 
0.2 35.43 0.43 1.2  36.57 0.27 0.7 2.0 
Plasmodium 
200 24.61 0.14 0.6  24.94 0.27 1.1 1.0 
0.2 31.39 0.29 0.9  32.92 0.12 0.5 2.7 
IAC 0.002 32.36 0.20 0.6  32.38 0.28 0.9 0.7 
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3.6.8 Preliminary stability testing of lyophilised oligonucleotide mixture 
Lyophilisation (also known as freeze-drying or thermo-stabilisation improve 
molecular assays‘ stability (Foo et al., 2017; Nagaraj et al., 2018; Nurul Najian et al., 
2016). However, during lyophilisation, some PCR component may be negatively 
affected and resulted in reduced molecular performances. Some lyoprotectants such 
as trehalose, raffinose and several others have been utilised to preserve PCR 
components, as well as improving the molecular performance.  
In this study, real-time stability of lyophilised multiplex oligonucleotides 
mixtures was investigated, with and without addition of lyoprotectant. Five per cent 
trehalose has been chosen in this preliminary testing, as reported by previous assays 
(Gaertig et al., 2015; Klatser et al., 1998; S. V Lee et al., 2011; Nagaraj et al., 2018). 
Briefly, wet mixtures and lyophilised mixtures (with and without 5% trehalose) were 
stored at three different temperatures (-20 °C, 25 °C and 37 °C) and tested every 
week. 
Table  3.40 - Table  3.44 and Figure  3.29 - Figure  3.33 portrayed the mean Cq 
value and stability trends of the respective mixtures tested on different occasions. In 
general, no significant Cq differences were observed in the wet oligonucleotides 
mixtures and lyophilised oligonucleotides mixtures, tested across the stipulated 
period of 28 days.  
However, in terms of CV%, the Texas Red (B. pseudomallei) signals in wet 
oligonucleotides mixtures, stored at 25 °C and 37 °C had CV% of 4.7% and 8.9%, 
respectively. The other Texas Red parallel thermo-stabilised mixture (with or without 
trehalose) scored slightly lower CV% values (3.0% - 4.3%) (Table  3.41). 
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In addition, it is noticeable that the Cy5 (Plasmodium) signals in the 
lyophilised mixture that did not contain additional trehalose had the highest CV% 
(~6%) as compared to the other mixtures‘ (0.8% - 1.8%) (Table  3.43). This 
observation suggests that lyophilisation process possibly had slightly negative effect 
on the amplification of Plasmodium target. García-Ruíz et al. (2016) had reported 
reduced fluorescence signals and delayed Cq following lyophilisation (García-Ruíz 
et al., 2016). In addition, another study also reported that the Cy5 probe was more 
susceptible to post-lyophilisation prolonged storage, even in the presence of 
lyoprotectants, as compared to FAM, HEX and Texas Red probes (Rombach et al., 
2014). It is suggested that further sensitivity/LOD analysis using extended dilutions 
of DNA templates should be carried to confirm this inference, with appropriate 
controls and settings. 
Meanwhile, the FAM (Leptospira), HEX (Salmonella) and Cy5.5 (IAC) 
signals, from wet and lyophilised mixtures scored CV% values between 1.0% and 
3.8% during the 28-day evaluation time, consistent with a previous report (Rombach 
et al., 2014). Figure  3.29, Figure  3.31 and Figure  3.33 provide overall trends of 
probes‘ stabilities at different form, stabiliser status and temperature storage. 
Shelf life of the lyophilised multiplex oligonucleotides mixture was estimated 
using Q10 accelerated ageing technique (Clark, 1991). Based on the calculation, the 
estimated shelf life of the dried mixture is 84.7 days at ambient temperature. Given 
that the Cq was still stable after 28 days, further study can investigate the lyophilised 
mixture stability after 12 months, as recommended the UNICEF (Rombach et al., 
2014; UNICEF, 2014).  
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Calculation of the estimated shelf life of the dried mixture is as follow; 
Accelerated study   
Q10     = 1.8 
Storage temperature, Te = 37 °C  
Ambient temperature, Ta = 25 °C  
Length of time at elevated temperature       = 28 days 
                        (          ))          
                                                     
                                                 at 25 °C 
 
In summary, it is found that the multiplex oligonucleotides mixture was 
readily stable in wet form, as well as in the lyophilised form. Further study should 
test its stability at long period of time i.e. 12 months, using different concentration of 
targets. 
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Table ‎3.40  Stability of wet and lyophilised multiplex oligonucleotides mixtures, 
with and without stabiliser at different temperature and length of times – FAM-
labeled probe (Leptospira) 
Dye 
Storage 
temp. 
Lyo-
philisation 
Amount 
of 
stabiliser 
Mean Cq 
Mean SD 
CV 
% Day 
0 
Day  
7 
Day 
14 
Day 
21 
Day 
28 
FAM 
25 °C 
- - 15.63 16.21 16.15 16.23 15.72 15.99 0.29 1.8 
Yes - 15.18 15.82 16.68 16.46 15.72 15.97 0.60 3.8 
Yes 5% 16.02 16.01 16.3 16.66 15.53 16.10 0.42 2.6 
37 °C 
- - 15.63 16.09 16.04 16.22 15.5 15.90 0.31 2.0 
Yes - 15.18 16.05 16.05 16.30 15.88 15.89 0.43 2.7 
Yes 5% 16.02 15.97 16.17 15.62 15.62 15.88 0.25 1.6 
- 20 °C - - 15.63 16.17 14.70 14.4 15.94 15.37 0.78 5.1 
 
 
 
 
Figure ‎3.29 Trends of FAM probe stability at different form, stabiliser status and 
temperature 
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Table ‎3.41  Stability of wet and lyophilised multiplex oligonucleotides mixtures, 
with and without stabiliser at different temperature and length of times – Texas Red-
labeled probe (B. pseudomallei) 
Dye 
Storage 
temp. 
Lyo-
philisation 
Amount 
of 
stabiliser 
Mean Cq 
Mean SD 
CV 
% Day 
0 
Day  
7 
Day 
14 
Day 
21 
Day 
28 
Texas 
Red 
25 °C 
- - 19.73 19.17 20.50 18.06 19.90 19.47 0.92 4.7 
Yes - 19.59 19.35 20.91 19.87 20.21 19.99 0.61 3.0 
Yes 5% 20.25 19.18 20.83 19.68 19.59 19.91 0.64 3.2 
37 °C 
- - 19.73 19.03 20.90 16.31 19.38 19.07 1.70 8.9 
Yes - 19.59 19.11 20.85 20.54 20.04 20.03 0.70 3.5 
Yes 5% 20.25 19.14 20.63 18.55 19.88 19.69 0.84 4.3 
- 20 °C - - 19.73 19.70 20.66 21.09 20.13 20.26 0.60 3.0 
 
 
 
 
Figure ‎3.30 Trends of Texas Red probe stability at different form, stabiliser status 
and temperature 
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Table ‎3.42  Stability of wet and lyophilised multiplex oligonucleotides mixtures, 
with and without stabiliser at different temperature and length of times – HEX- 
labelled probe (Salmonella) 
Dye 
Storage 
temp. 
Lyo-
philisation 
Amount 
of 
stabiliser 
Mean Cq 
Mean SD 
CV 
% Day 
0 
Day  
7 
Day 
14 
Day 
21 
Day 
28 
HEX 
25 °C 
- - 18.76 18.24 19.00 18.56 18.64 18.64 0.28 1.5 
Yes - 18.76 18.40 19.08 18.59 18.70 18.71 0.25 1.3 
Yes 5% 19.06 18.27 18.68 18.86 18.49 18.67 0.31 1.7 
37 °C 
- - 18.76 18.4 19.01 18.72 18.32 18.64 0.28 1.5 
Yes - 18.76 18.49 19.02 18.47 18.65 18.68 0.23 1.2 
Yes 5% 19.06 18.27 18.89 18.75 18.68 18.73 0.30 1.6 
- 20 °C - - 18.76 18.74 19.12 18.59 18.71 18.78 0.20 1.1 
 
 
 
 
Figure ‎3.31 Trends of HEX probe stability at different form, stabiliser status and 
temperature 
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Table ‎3.43  Stability of wet and lyophilised multiplex oligonucleotides mixtures, 
with and without stabiliser at different temperature and length of times – Cy5- 
labelled probe (Plasmodium) 
Dye 
Storage 
temp. 
Lyo-
philisation 
Amount 
of 
stabiliser 
Mean Cq 
Mean SD 
CV 
% Day 
0 
Day  
7 
Day 
14 
Day 
21 
Day 
28 
Cy5 
25 °C 
- - 18.18 18.1 17.66 17.39 17.85 17.84 0.32 1.8 
Yes - 20.78 18.22 18.17 18.25 17.79 18.64 1.21 6.5 
Yes 5% 18.13 18.35 18.04 17.96 18.09 18.11 0.15 0.8 
37 °C 
- - 18.18 18.12 18.01 17.44 18.09 17.97 0.30 1.7 
Yes - 20.78 18.19 18.56 17.86 18.00 18.68 1.20 6.4 
Yes 5% 18.13 18.14 18.01 18.11 17.78 18.03 0.15 0.8 
- 20 °C - - 18.18 18.05 18.13 18.16 17.71 18.05 0.19 1.1 
 
 
 
 
Figure ‎3.32 Trends of Cy5 probe stability at different form, stabiliser status and 
temperature 
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Table ‎3.44  Stability of wet and lyophilised multiplex oligonucleotides mixtures, 
with and without stabiliser at different temperature and length of times – Cy5.5- 
labelled probe (IAC) 
 
Dye 
Storage 
temp. 
Lyo-
philisation 
Amount 
of 
stabiliser 
Mean Cq 
Mean SD 
CV 
% Day 
0 
Day  
7 
Day 
14 
Day 
21 
Day 
28 
Cy5.5 
25 °C 
- - 19.87 19.92 19.63 20.35 20 19.95 0.26 1.3 
Yes - 20.08 20.26 20 20.67 19.93 20.19 0.30 1.5 
Yes 5% 19.65 19.5 19.23 20.31 20.02 19.74 0.43 2.2 
37 °C 
- - 19.87 20.12 20.33 20.31 20.33 20.19 0.20 1.0 
Yes - 20.08 19.96 21.16 19.67 20.11 20.20 0.57 2.8 
Yes 5% 19.65 19.84 21.05 19.6 20.18 20.06 0.60 3.0 
- 20 °C - - 19.87 19.78 20.21 19.7 20.02 19.92 0.20 1.0 
 
 
 
Figure ‎3.33 Trends of Cy5.5 probe stability at different form, stabiliser status and 
temperature 
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3.6.9 Clinical evaluation of the developed multiplex TaqMan qPCR assay 
3.6.9 (a) Retrospective samples 
Clinical validation of the developed multiplex qPCR assay was carried out 
using 518 clinical samples that were previously tested with respective gold standard / 
conventional tests. Of that, 100 leptospirosis-suspected samples were initially 
confirmed using GenoAmp® Real-Time PCR Leptospirosis kit. Meanwhile, 282 
melioidosis- and salmonellosis-suspected clinical samples were cultured beforehand 
in BD BACTEC™ blood culture system. The remaining 136 clinical samples were 
previously tested using abTES™ Malaria qPCR I Kit. 
As shown in Table  3.45, the multiplex qPCR assay correctly amplified all 
confirmed specimens. Among the negative specimens, one sample was amplified by 
the multiplex qPCR assays. While there was no evidence of cross-contamination, the 
PCR product was sent out for sequencing. BLAST analysis of the sequencing result 
showed that the sequences resembled those of L. interrogans and L. kirschneri. This 
finding had been reported in Molecular & Cellular Probe journal (M. R. Mohd Ali et 
al., 2018). This discordant result may due to the differences of sensitivity of the 
qPCR assays, compounded by the nature of the Leptospira rrs gene that presents in 
two copies per genome (Bourhy et al., 2013). In addition, any leptospirosis caused by 
intermediate or saprophytic (rare) Leptospira strains, which does not have pathogenic 
genes may be undetectable by the GenoAmp® Real-Time PCR Leptospirosis kit, as 
the kit is exclusive for the pathogenic Leptospira counterparts. The remaining 
negative samples had identical results as the developed multiplex qPCR assays. 
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Clinical performance of the developed multiplex qPCR assay was calculated 
and summarised in Table  3.46. Overall, the developed assay had 100% clinical 
sensitivity in detecting samples with positive Leptospira, B. pseudomallei, 
Salmonella and Plasmodium. Similarly, high clinical specificity was observed in all 
targets. PPV and NPV were also very high. In leptospiral target, 95.2% PPV 
recorded due to a single discordant where leptospiral DNA was amplified by the 
multiplex qPCR assay from one negative specimen, as mentioned previously. 
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Table ‎3.45  Summary of clinical evaluation of the developed multiplex qPCR 
assay using confirmed clinical specimens 
Targets 
Conventional assay  
positive 
 
Conventional assay 
negative 
Multiplex 
qPCR + 
Multiplex 
qPCR - 
 
Multiplex 
qPCR + 
Multiplex 
qPCR - 
Leptospira (n = 100) 20 0  1 79 
B. pseudomallei (n = 168) 20 0  0 148 
Salmonella (n = 114) 20 0  0 94 
Plasmodium (n = 136) 50 0  0 86 
 
Table ‎3.46  Clinical sensitivity, specificity, Positive Predictive Value (PPV) and 
Negative Predictive Value (NPV) of the developed multiplex qPCR assay 
Targets 
Sensitivity 
 
Specificity 
 
PPV 
 
NPV 
% 95% CI (%) 
 
% 95% CI (%) 
 
% 
 
% 
Leptospira 100 83.2 to 100 
 
98.8 93.2 to 99.9 
 
95.2 
 
100 
B. pseudomallei 100 83.2 to 100 
 
100 97.5 to 100 
 
100 
 
100 
Salmonella 100 83.2 to 100 
 
100 96.2 to 100 
 
100 
 
100 
Plasmodium 100 92.9 to 100 
 
100 95.8 to 100 
 
100 
 
100 
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3.6.9 (b) Prospective prevalence study 
Lastly, the developed multiplex qPCR assays were tested prospectively on 
155 patient samples with febrile symptom. Of that, 102 were males and 53 were 
females. The overall age average was 37.7 ± 20.2 years. Based on gender, the 
average age for males and females were 35.9 ± 18.9 years and 41 ± 22.8 years, 
respectively. 
Of the 155 samples, 16 had detectable Leptospira DNA (10.32%), 4 had 
detectable B. pseudomallei DNA (2.58%), one sample was positive for malarial 
DNA (0.65%) and none for Salmonella. In addition, two samples were positive for 
both Leptospira and B. pseudomallei DNA (1.29%). However, the findings were not 
compared with concurrent diagnostic microbiological investigations because most of 
the samples were not tested for all diseases of interest (leptospirosis, melioidosis, 
invasive salmonellosis and malaria). Feasibly, a further retrospective study can be 
carried out to ideally compared the performance of this multiplex qPCR assay with 
MAT/leptospiral qPCR, culture and BFMP/malarial PCR on patients with unknown 
febrile illness.  
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CHAPTER 4 
GENERAL DISCUSSION 
 
The difficulties in timely diagnosis of leptospirosis, melioidosis, invasive 
salmonellosis and malaria remain as perplexing problems, especially to clinicians of 
the endemic areas. This is attributed to the lack of specific disease characteristics of 
each particular organism and their infections share a common clinical spectrum of 
signs and symptoms. Due to these reasons, leptospirosis, melioidosis and malaria are 
referred as the Great Mimicker (Ghosh and Nicolson, 1977; Izurieta et al., 2008; 
Meumann et al., 2012). The title can be expanded to invasive salmonellosis, as this 
infection also share overlapping clinical manifestations (Crump et al., 2015).  
During acute phase of leptospirosis, melioidosis, invasive salmonellosis and 
malaria, the most common presenting symptom is fever. For example, 91% - 99% of 
leptospirosis patients reported of having elevated temperature within the first week of 
infection (De Francesco Daher et al., 2017). Similarly, 94.2% of patient with 
salmonellosis had fever of between 38 C - 40 C after seven to fourteen days of 
infection (Tapia et al., 2015). For malaria and melioidosis, fever was reported in 96% 
and 96.8% of the cases, respectively (D‘Acremont et al., 2002; Vidyalakshmi et al., 
2012). Other common signs and symptoms include diarrhoea, myalgia, lethargy and 
pulmonary involvements, such as cough. While some infections are asymptomatic 
and do not require hospitalisation (i.e. patients may seek treatments from primary 
care facilities and been prescribed with general medications), in other cases, the 
infection may progress to severe forms of potentially fatal diseases. 
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Several misdiagnoses have been reported worldwide because leptospirosis, 
melioidosis, invasive salmonellosis and malaria were mistakenly diagnosed as other 
diseases (Kishimoto et al., 2004; A. N. Rafizah et al., 2012; Y.-M. Wen et al., 2009). 
For example, only approximately one-third of MAT positive patients were diagnosed 
as leptospirosis during discharge (A. N. Rafizah et al., 2012). In other circumstances, 
definitive diagnosis becomes more complicated when more than one organism infect 
the same patient. To date, several studies have reported leptospirosis-melioidosis co-
infection (Hin et al., 2012; Lu and Tseng, 2005; M. R. M. R. Mohd Ali, Mohamad 
Safiee, Thangarajah, et al., 2017; Sapian et al., 2012), leptospirosis-malaria co-
infection (Srinivas et al., 2007; Yong and Koh, 2013) and malaria-Salmonella co-
infections (Keong and Sulaiman, 2006). Even though co-infections are uncommon, 
such cases are possible because of the similarity of the organisms geographical 
distribution. In addition, these infections are potentially under-diagnosed when 
clinical suspicion is lacking and reliable laboratory tests are limited or not available. 
Due to the challenges in the clinical diagnosis, clinicians rely on laboratory 
test for confirmation. Currently, the gold standard test for diagnosis of leptospirosis 
is MAT and EMJH culture. The MAT utilises detection of host antibodies against 
Leptospira, which are typically produced after two weeks of infection, hence is less 
useful during acute leptospirosis (Suneth B. Agampodi et al., 2016). Meanwhile, the 
fastidious nature of leptospiral growth leads to delay of positive culture, which 
usually requires several weeks of incubation, sometimes longer for pathogenic strains 
of Leptospira (Cameron, 2015). In addition, both methods are also laborious and 
suffer from inconsistent sensitivity and specificity. 
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Similarly, B. pseudomallei and Salmonella spp. are routinely detected by 
conventional culture method. Isolation of the bacteria requires more than 24 hours, 
followed by another 24 – 48 hours for biochemical identification (Andrews and 
Ryan, 2015; Lau et al., 2015). Potential misidentification of the organism may 
happen due to inexperienced laboratory technologist or high genome plasticity and 
diverse phenotypic characteristic of the bacteria (Zong et al., 2012). Based on the 
Bayesian model, the estimated culture sensitivity for B. pseudomallei and Salmonella 
was between 60.2% and 75% (Limmathurotsakul et al., 2010; Parry et al., 2011; 
Wilkins, 2009). In addition, blood culture requires large amount of samples; 
approximately 20 – 30 ml blood sample per patient, and is challenging for neonates 
and elderly (Kaur et al., 2018). 
Meanwhile, the current gold standard detection for Plasmodium is 
microscopy. Following Giemsa staining, blood smear is examined under the light 
microscope. Apart from low sensitivity, potential misdetection may happen due to 
inexperienced laboratory technologist (Joveen-Neoh et al., 2011; Ting Goh et al., 
2013). The microscopic detection limit is between 10 – 50 trophozoites/μl (Trampuz 
et al., 2003). 
Unavailability of useful tool for early detection and differentiation of these 
important tropical infections lead to risk of misdiagnosis or under-diagnosis. Over 
the past 20 years, increasing number of real-time molecular assays have been 
reported worldwide, developed for many applications including pathogen detections 
(Huggett et al., 2015; Pabinger et al., 2014). Of these, hydrolysis or TaqMan probe is 
widely used due to its high specificity, simplicity and multiplexing flexibility, owing 
to the strict requirement of two primers and an additional probe for a positive 
amplification (Navarro et al., 2015). Following total hybridization of primers and 
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probe, elongation of PCR product takes place. Upon reaching the probe, the 5‘ end 
exonuclease activity of the polymerase will cleave the previously coupled probe-
quencher resulting in freeing of the detectable emitting probe (Navarro et al., 2015). 
Many hydrolysis qPCR assays have been described for individual detection of 
leptospirosis, melioidosis, salmonellosis and malaria causative agents (Divis et al., 
2010; Kaestli et al., 2012; Stoddard et al., 2009; Villumsen et al., 2012; Woods et 
al., 2008). However, to date, there is no diagnostic assay that can simultaneously 
detect and differentiate Leptospira, B. pseudomallei, Salmonella and Plasmodium in 
a single tube. 
This study is aimed to acknowledge the urgent need for a laboratory assay 
that enables simultaneous diagnosis of leptospirosis, melioidosis, salmonellosis and 
malaria. The developed multiplex TaqMan qPCR for Leptospira, B. pseudomallei, 
Salmonella and Plasmodium DNA was designed according to the MIQE Guidelines: 
Minimum Information for Publication of Quantitative Real-Time PCR Experiments‖. 
This guideline was introduced to promote standardisation of reporting and 
consistencies inter laboratories (Bustin et al., 2009). Recommendations from the 
MIQE guidelines were divided into (i) experimental design, (ii) sample, (iii) nucleic 
acid extraction, (iv) qPCR target information, (v) qPCR oligonucleotides, (vi) qPCR 
protocol, (vii) qPCR validation and (viii) qPCR data analysis. This present study 
adheres to the recommendations, albeit the developed multiplex assay is more 
qualitative, rather than quantitative. 
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4.1 Analytical sensitivity 
Definitions of analytical sensitivity or LOD also vary between publications. 
Traditionally, LOD (or analytical sensitivity) is defined as the lowest amount of 
target that can be detected as positive in all replicates, or as low as one of them 
(Apfalter et al., 2003; Augustin et al., 2017; Pontiroli et al., 2011). Meanwhile, some 
studies defined LOD as the minimum amount of analyte that can be statistically 
differentiated from a blank. This definition, however is more practical for chemical 
application (Armbruster and Pry, 2008). According to the MIQE, LOD is the lowest 
copy number of a target that can be determined correctly at a certain degree (Bustin 
et al., 2009). Although the guideline does not specify the percentage of probability, 
95% interval is commonly used. To determine LOD, replicates of diluted DNA 
templates were used. The larger number of replicates tested, the higher confidence 
level will be achieved. Some groups used between 6 and 9 replicates to determine 
LOD (Euler et al., 2013; M. D. Moore and Jaykus, 2017; Muhd Radzi et al., 2015). 
In this study 24 replicates were tested. In the subsequent steps, Probit regression 
analysis was used to determine LOD at 95% probability. 
In terms of analytical sensitivity, the developed multiplex qPCR assay was 
able to detect as low as ~5.61 leptospiral DNA copies per reaction at 95% 
probability. The determined LOD is comparable to other probe-based qPCR assays 
that amplified between 1 – 10 Leptospira DNA copies per reaction (Ahmed et al., 
2009; Bourhy et al., 2011; Brenner et al., 1999; Levett et al., 2005; Merien et al., 
2005; A. Slack et al., 2007; Thaipadungpanit et al., 2011). During the acute phase of 
leptospirosis, it is estimated that bacterial load ranges between 10
2
 – 107 leptospires 
per ml of blood (Musso et al., 2013). Taking into account the nucleic acid extraction 
and PCR set-up in this study, the detection of 5.61 DNA copies per reaction equals a 
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concentration of 175.3 leptospires per ml blood. The developed multiplex qPCR 
assay is supposed to be able to detect leptospires of this range. In addition, PCR is 
more useful than EMJH culture for patients who have received prior antibiotic 
treatment (Boonsilp et al., 2011). Following administration of antibiotic, Leptospira 
is inactivated, leading to a negative culture.  
The analytical sensitivity of the multiplex qPCR assay for the detection of B. 
pseudomallei DNA was approximately 8.24 DNA copies per reaction, equivalent to 
257.5 CFU per mL of blood. Other reported hydrolysis probe-based molecular assays 
amplified 5 – 10 DNA copies per reaction (Al-Marzooq and Mustafa, 2011; Kaestli 
et al., 2012; Novak et al., 2006; B. Zhang et al., 2012). During septicemic 
melioidosis, the estimated bacterial load was between 1 and 10
3
 copies per mL of 
blood. This number is highly variable, depending on individuals (Wuthiekanun et al., 
2008). Even though the multiplex assay‘s LOD is within this range, a portion of low-
level bacteremia may remain undetectable. As compared to culture method, PCR is 
more sensitive and less susceptible to pre-administration of antibiotic. Besides, 
culture method is also prone to contamination and requires up to seven days of 
incubation. 
In the Salmonella target, the developed multiplex qPCR assay can detect 
approximately 19.3 DNA copies per reaction, or 603.1 CFU per mL blood. This 
LOD is relatively higher than the estimated number of Salmonella load in blood, 0.3 
– 387 CFU per ml (J Wain et al., 1998; Zhou et al., 2016). Even though the other 
reported studies had analytical sensitivity of 1 – 1000 DNA copies per reaction, most 
of them were designed against limited serovars, required pre-enrichment steps and 
not validated for clinical use (González-escalona et al., 2012; Maurischat et al., 
2015; Reynisson et al., 2006). Differences of amount of clinical specimen used, as 
 219 
well as the variation in commercial extraction kit also affected the sensitivity of 
assay (Tennant et al., 2015).  
In the fourth target, the developed multiplex qPCR assay can amplify 
approximately 18.1 malarial DNA copies per reaction. Since the target gene presents 
in 5 copies per Plasmodium genome, the calculated LOD could be around 3.7 
organisms per reaction or 115.6 organisms per ml blood (Gonçalves et al., 2012; 
Mangold et al., 2005). Other reported studies had LOD is between 5 and 250 copies 
per reaction (Divis et al., 2010; Mangold et al., 2005; Pholwat et al., 2017; 
Rougemont et al., 2004).  
Noticeably, in one sub-category of the MIQE guideline, the Cq variation at 
LOD of this assay was not determined because the LOD was determined statistically 
using Probit regression model. However, partial data of the multiplex qPCR assay 
performance at 20 fg DNA (for Leptospira, B. pseudomallei and Salmonella) and 2 
ag (for Plasmodium synthetic DNA) showed that the CV% values were between 2% 
and 4%. As there is no definite acceptable range of CV% available, a threshold of 
5% is favourable (Giry et al., 2017). In this study, the reported variations at LOD and 
at repeatability and reproducibility testing were relatively small; even though some 
reports anticipated that a very low (and very high) concentration of DNA template 
will result in high CV%. (Srisutham et al., 2017; Tennant et al., 2015). To enhance 
precision of assay that suffers from high CV%, larger volume of each PCR 
component and minimum of 3 – 4 replicates could be considered (Svec et al., 2015). 
Among the most important factor that influence LOD (or sensitivity) is the 
DNA extraction process, a part of the qPCR itself. Usually, DNA recovery from the 
clinical samples is 30% (Augustin et al., 2017). If this low DNA recovery is 
ignored, the initial microbial concentration in the clinical samples will be 
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underestimated. In addition, the DNA recovery efficiency is dependent on the type of 
specimen used. Therefore, using a set of diluted microorganism spiked into different 
matrices, such as blood, serum and plasma may provide useful information on the 
sensitivity of the assay across the potential clinical specimens. In addition, spiking 
experiment in different matrices also gives important information on potential 
presence of inhibitors in the tested samples, such as heparin (L. D. Smythe et al., 
2002). Remarkably, with the availability of many commercially available nucleic 
acid extraction kits that utilise silica column, the inhibitory effects are reduced, as 
compared to conventional methods that rely on organic-phase separation or alcohol 
precipitation (Khot and Fredricks, 2009). In this study, however, different matrices of 
specimen were not evaluated. 
Some studies proposed modifications to enhance nucleic acid extraction and 
PCR performance. The modifications include elution of DNA in reduced volume of 
elution buffer (i.e. 100 l versus 50 l versus 25 l) in order to concentrate the DNA 
(Dauphin et al., 2010; Desneux and Pourcher, 2014; Tennant et al., 2015), pre-
warming of elution buffer (Taskin et al., 2011), using larger amount of initial clinical 
specimens (200 l versus 1000 l) (Psifidi et al., 2015), and implementing pre-
enrichment steps (G. G. Stone et al., 1994; Zhou et al., 2016). Some assays also had 
increased total volume of up to 50 l reaction to maximise the amount of eluted 
DNA used (Meumann et al., 2006). The developed multiplex assay is a 20 l 
reaction, containing 2 – 8 l of DNA sample, previously eluted in pre-warmed 50 l 
TE buffer. 
Type of protease enzymes used in the extraction process also may affect 
DNA extraction. Its presence helps the degradation of cellular proteins and 
nucleases. Among the proteases that are available include papain, bromelain and 
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proteinase K (Mótyán et al., 2013). A study had shown that different proteases were 
optimal for different samples. For an example, proteinase K was capable of yielding 
the highest number of DNA from semen and saliva, as compared to other proteases 
(Eychner et al., 2015). The same protease also was efficient for DNA extraction from 
blood (Merk et al., 2006). In this study, the Proteinase K was readily supplied by the 
manufacturer of the DNA extraction kit. Performances of different types of proteases 
were not evaluated in the current study. Interestingly, one study pointed out that high 
yield of nucleic acid does not always guarantee better chance of detecting microbial 
DNA. It is because the total amount of extracted DNA is significantly represented by 
larger mass of host cells, as compared to the infecting (or spiked) microorganism 
(Podnecky et al., 2013). 
In addition, performance of thermostable polymerase enzyme with 5‘ 
exonuclease activity in TaqMan qPCR platform also affect processivity; the 
capability of a polymerase to continuously replicate DNA without dissociation from 
DNA target (Holland et al., 1991; Ishino and Ishino, 2014). In this study, a 
commercial SsoAdvanced Universal Probes super mix containing Sso7d fusion 
protein was used. The patented 7 kDa fusion protein, originated from Sulfolobus 
solfataricus help to stabilise the Taq polymerase binding to the DNA template and 
subsequently improves PCR efficiency, as compared to unmodified polymerase 
(Geetha Yadav, 2015; Kalichuk et al., 2016; Wang et al., 2004). Apart of the 
modification to the polymerase, the PCR mix manufacturer (Biorad, Germany) does 
not disclose the detail composition of its buffer and associated additives, which could 
also affect the molecular performances (Śpibida et al., 2017). Further study may 
compare performance of the developed multiplex qPCR assay using other brands of 
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PCR mixes containing different types of polymerases, buffers and additives (if any) 
to evaluate the amplification effects (Śpibida et al., 2017).  
Several PCR additives, also known as stabilisers or enhancers can be added to 
improve amplification of difficult sequences. Some additives also can serve as 
lyoprotectants that inhibit potential loss during lyophilisation process. For examples, 
addition of betaine can help to stabilise the polymerase and hinder formation of 
primers secondary structures (Jensen et al., 2010). Similarly, dimethyl sulfoxide 
(DMSO) also reduces intermolecular binding especially in GC-rich sequences 
(Bhagya et al., 2013; Z. Zhang et al., 2010). In this study, trehalose was used as 
additive during lyophilisation. However, there was no significant difference of assay 
performances between oligonucleotides mixture with- and without- additional 
trehalose, stored at different temperatures for 28 days. It is proposed that the effect 
will be more significant if prolong storage time is tested. Another possibility is that 
the amplicons produced in this study are 107 – 215 bp in length, with GC contents of 
between 40.7% and 58.5%, fall within the optimal range of qPCR products. Other 
studies have reported that addition of trehalose facilitated amplification of GC-rich 
DNA templates (as high as 80%) by decreasing the melting temperature and 
stabilising the polymerase (Spiess et al., 2004; Q. Yang et al., 2016; Z. Zhang et al., 
2010).  
 
  
 223 
4.2 Analytical specificity 
Analytical specificity of the developed multiplex qPCR was evaluated on 357 
organisms. Overall, the developed assay was highly specific for the intended targets, 
Leptospira, B. pseudomallei, Salmonella and Plasmodium. Properties of target genes 
are important factor that determine specificity. In this assay, two housekeeping genes 
(Leptospira 16S rRNA gene & Plasmodium 18S rRNA genes) and two species-
specific/genus-specific genes (orf2-TTSS of B. pseudomallei & StyR-3 of 
Salmonella) were used. Major advantage of targeting 16S rRNA and 18S rRNA 
genes is that the gene present in 2 – 5 copies per Leptospira and Plasmodium 
genomes, respectively. However, designing oligonucleotides against housekeeping 
genes that present across many microorganisms is challenging. Therefore, 
polymorphic region of the conserved genes that is unique to the organism of interest 
need to be carefully identified. Sometimes, the regions may contain high CG content 
that disfavour amplification of the target (Bhagya et al., 2013; Kotłowski et al., 
2004). Meanwhile, a novel gene that is distinctive to a particular genus or species 
serves as a good PCR target because theoretically, there is less chance of sequence 
similarity with other organisms.  
Eventually, the assay should be validated empirically using genomic DNA of 
other organisms to confirm the specificity. In an instance, a molecular assay targeting 
clyA gene that is conserved in S. Typhi and S. Paratyphi A showed cross-reaction 
with two diarrheagenic E. coli strains (Tennant et al., 2015). In other circumstances, 
the unique sequence may be short and do not allow many manipulations during 
oligonucleotides designing. TaqMan qPCR usually can amplify 70 – 150 bp, and up 
to 400 bp amplicon efficiently (Rodríguez et al., 2015). 
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In this study, the 16S rRNA gene used in the developed multiplex qPCR 
assay was aimed to include the entire Leptospira genus, comprising the pathogenic, 
intermediate and saprophytic clusters, in contrast to majority of reported assays that 
exclusively targeted the former group. The pathogenic group of Leptospira, such as 
L. interrogans and L. borgpetersenii are commonly isolated from clinical specimens 
(Bourhy et al., 2010; Chiani et al., 2016). However, increasing numbers of studies 
have reported detection of the non-pathogenic leptospiral group from human 
infections, such as L. fainei, L. wolffii and L. broomii (Arzouni et al., 2002; Bourhy 
et al., 2013, 2011; Chiani et al., 2016; Krogfelt et al., 2001). Despite disputation on 
the pathogenicity of some Leptospira serovars (A. T. Slack et al., 2009), detection of 
the bacterial DNA from sterile specimens should be regarded as important. However, 
careful experiment design should be implemented to avoid risk of false positivity due 
to contamination of assay from the laboratory settings (Koizumi et al., 2003). Across 
the whole Leptospira genus, the developed assay was evaluated on 11 leptospiral 
species available in the laboratory. Further study could empirically validate the 
specificity of the developed assays on the non-tested Leptospira spp. 
During the analytical specificity testing of the developed multiplex qPCR 
assay, six B. cepacia and one B. thailandensis strains were used. Limited number of 
B. pseudomallei complex and B. cepacia complex were tested due to unavailability 
of the strains in the laboratories. Even though in silico BLAST analysis showed that 
the absence of orf2 gene from non-B. pseudomallei, further study could further 
validate empirical specificity of the developed assay on B. pseudomallei relatives 
including B. mallei and Ralstonia spp. 
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Similarly, the microbial panel for analytical specificity testing of the 
developed assay also lacks P. malariae and P. ovale strains. Although both species 
are uncommon to Malaysia, empirical specificity of the assay should be validated on 
the strains due to their infectivity to human. Retrospectively, the first imported case 
of P. ovale was reported in Malaysia in 2010 (Y. A. L. Lim et al., 2010). Meanwhile, 
P. malariae might be potentially misidentified as it shares many microscopic features 
with P. knowlesi; an emerging causative agent for malaria in Malaysia, and usually 
confirmed by PCR (William et al., 2014). 
In this study, the multiplex qPCR assay was designed to target both typhoidal 
and non-typhoidal human salmonellosis. Twenty-four Salmonella serovars and 10 
Salmonella spp. clinical isolates were evaluated in the analytical specificity. Those 
serovars represent strains that cause typhoid fever (S. Typhi), enteric fever (+ S. 
Paratyphi A, B and C) and invasive nontyphoidal Salmonella disease (the remaining 
serovars). The developed multiplex qPCR assay exclusively amplified all Salmonella 
strains tested. Presumably, the assay may also amplify other serovars as 
demonstrated by the in vivo BLAST specificity analysis. Further study could validate 
the assay on more Typhi, Weltevreden, Enteritidis, Typhimurium and Corvallis that 
were commonly isolated in Malaysia (Hendriksen et al., 2011). 
 
4.3 Effect of PCR cycles 
Another factor that determines LOD is the PCR cycles. Commonly, a 
hydrolysis probe qPCR contains 35 – 45 cycles of amplification. In this study, the 
assay consisted 50 cycles, in parallel with several studies, to increase the intensity of 
fluorescence signals (Afonina et al., 2007; Tennant et al., 2015; U‘Ren et al., 2005; 
Villumsen et al., 2012). Few assays used up to 60 cycles of amplification (Grúas et 
 226 
al., 2014; Meumann et al., 2006). Those assays that increased PCR cycle beyond 40 
usually considered any Cq above the threshold as a positive result (Adamska M, 
Leonska-Duniec A., Maciejewska A., Sawczuk M. et al., 2010). In this assay, 
positivity cut-off is set at Cq value of 40. Any Cq value arisen after cycle 40 is 
suggesting of inefficient PCR amplification (Millon et al., 2011; Svec et al., 2015).  
 
4.4 Internal amplification control (IAC) 
Internal amplification control (IAC) is an important component of qPCR 
assays. Incorporation of IAC to a molecular assay enable confirmation of true 
negative results and avoid false negative results that are usually caused by the 
presence of inhibitors and unsuccessful/sub-optimal nuclei acid extraction, a part of 
faulty polymerase and defective PCR composition, such as buffers and dNTPs. 
Remarkably, majority of the described molecular assays are lacking IAC (Khot and 
Fredricks, 2009; Price et al., 2012). In practical, IAC target can be an endogenous 
gene that naturally presents in the sample matrix or an exogenous sequence that 
artificially introduced into the specimens (Mackay, 2007). Common endogenous 
gene (also known as housekeeping or reference gene) includes GAPDH, rnaseP, 
actin and several others. Using endogenous gene as IAC target can determine the 
efficiency of DNA extraction and predict presence or absence of PCR inhibitors. 
However, the concentration of extracted DNA is uncontrollable and sample 
dependent. Overwhelming amount of host DNA may have detrimental effects on 
amplification of microbial template that usually presents in low number.  
In contrast, exogenous IAC target is unique sequences from non-target 
organisms (Saunders and Lee, 2013). The exogenous IAC can be added prior to 
DNA extraction, either to the crude sample or preferably to the lysis buffer. The 
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latter step is favourable because it minimises DNA degradation and potential loss. 
However, should the IAC template to be added earlier in the crude samples, a higher 
concentration of template, i.e. 150 fg IAC template per preparation, or utilisation of 
protective coated particles can be considered (Mikel et al., 2016; Wei et al., 2016). 
Advantages of adding IAC template prior to DNA extraction include the ability to 
determine successful nucleic acid recovery, as well as the presence of inhibitors. In 
the developed assay, 2 fg IAC template per reaction was included to the master mix 
to allow homogeneousness and rule-out presence of PCR inhibitors. Using 
exogenous IAC allow more room for optimisation of molecular assays, such as the 
primers-probe and IAC concentrations, that can be manipulated to minimise 
amplification competition with the microbial targets. 
Some study recommended that IAC amplicon of less than 150 bp will not 
affect PCR efficiency and subsequent amplification competition (Hoorfar et al., 
2004). Using longer amplicon may not be optimal for relatively short extension time 
(~ 30 seconds) in qPCR platform (Oikonomou et al., 2008). Moreover, it is also 
recommended that the PCR efficiency between the desired target and IAC target 
should be similar, between 90% – 110%. The developed assay utilised IAC amplicon 
of 107 bp in length. However, its PCR efficiency was 76.9%, due to the lower 
amount of primers used, purposely designed to minimize parallel competition with 
the other microbial target. In the scenario which microbial target is abundant, 
reduced or zero amplification of IAC is anticipated (Oikonomou et al., 2008).  
Alternatively, non-competitive IAC strategy can be implemented, in which 
amplification of microbial target and IAC happen in two different reactions, 
concurrently. While the non-competitive strategy will not affect the sensitivity of the 
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assay, the PCR cost is increased due to higher volume of PCR mix and consumables 
required during the experiments. 
 
4.5 Clinical evaluation 
Clinical performance of the developed multiplex qPCR was evaluated on 
confirmed clinical specimens. The diagnostic sensitivity and specificity were very 
high, with PPV and NPV of around 100%. Upon implementation in clinical settings, 
several factors that affect PCR performance should be taken into considerations. 
Duration of illness or day of onset has been shown to affect the usefulness of 
molecular assays. Generally, the onset of fever within two weeks is indicated for 
molecular testing. For example, the malarial parasitemia is detectable during 5 – 10 
days of infection (Trampuz et al., 2003). Likewise, for leptospirosis, PCR was 
reported to be most sensitive between 5 and 10 days post infection (Musso et al., 
2013). However, some cases reported detection of leptospiral DNA after 15 days of 
stipulated days of onset. In addition, Salmonella also presents in the bloodstream 
during the first one or second week of illness (Crump et al., 2015). However, for 
molecular detection, it is reported that Salmonella DNA is amplifiable within 48 – 72 
hours of infection, in one case; during 6 hours post-infection (Darton et al., 2017). 
Meanwhile, bacteremic melioidosis multiply between day 1 and 21 of infection (B J 
Currie et al., 2000). In another cases, PCR for B. pseudomallei was positive until day 
50 of illness (Kim et al., 2015). Theoretically, PCR is most useful during the acute 
phase of infection. For an example, implementing molecular assay on convalescent / 
chronic leptospirosis sample may be suboptimal and potentially results in false 
negativity. 
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Another important factor is the type of specimens used in the molecular 
assay. To date, there are limited numbers of studies that determine microbial load 
from real clinical samples. Alternatively, artificially spiked specimens were used to 
mimic the infections. In leptospirosis and melioidosis suspected cases, plasma was 
slightly better than serum for molecular testing (Richardson et al., 2012; Robertson 
et al., 2015; Stoddard et al., 2009). Meanwhile, serum was reported to be superior to 
whole blood (S. B. Agampodi et al., 2012). However, another study reported that the 
differences between plasma, serum and whole blood were not significant (Bourhy et 
al., 2011). For Salmonella, whole blood is considered as the optimal specimens for 
PCR, most useful during the first 5 days of infection (Andrews and Ryan, 2015; 
Hatta and Smits, 2007). Alternatively, bone marrow and buffy coats can be used for 
salmonellosis diagnosis (John Wain et al., 2008).  
In the malarial cases, whole blood was 3-fold more sensitive than plasma 
(Lamikanra et al., 2012). Meanwhile, no significant difference was observed 
between plasma and serum, used in a malarial PCR assay (Waggoner et al., 2015). In 
addition, heparin-containing samples should be avoided due to inhibitory reaction 
(Levett et al., 2005). In this study, the developed assay was validated on EDTA 
whole bloods, a single clinical matric that can be used consistently across all of the 
tested infectious diseases. 
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CHAPTER 5 
SUMMARY, LIMITATIONS AND RECOMMENDATIONS FOR FUTURE 
STUDY 
 
The present study successfully developed a multiplex qPCR assays for 
simultaneous detection of Leptospira, B. pseudomallei, Salmonella and Plasmodium 
DNA, with the incorporation of an IAC. The determined analytical sensitivities were 
5.61 copies, 8.24 copies, 19.3 copies and 18.1 copies per reaction, respectively, with 
100% specificity. Similarly, the high clinical sensitivities (100%) and specificities 
(98.8% – 100%) were also observed, upon evaluation on confirmed patient 
specimens. 
Among the limitations of this study is the number of clinical isolates used for 
determination of the analytical specificity. Noticeably, a small number of B. 
pseudomallei genetic relatives, especially B. mallei, B. thailandensis, B. 
oklahomensis and Rastolnia spp. were included in the panel of organisms. Similarly, 
between 2015 and 2018, the Leptospira genus received additional 13 novel 
leptospiral species, in which 10 species are pathogenic or intermediate. Incorporating 
more bacteria and other pathogens in the analytical evaluation will provide more 
information on the assay‘s specificity, eventually expand its feasibility in 
environmental and veterinary research. 
During the prospective clinical evaluation, the developed assay was used to 
screen 155 patient samples with febrile symptom. Due to constraints of time and 
limited availability of resources, the initial qPCR results were not tallied with other 
microbiological tests, such as MAT, blood culture and BFMP, as well as the final 
diagnosis upon patients‘ discharge. By comparing the final diagnosis and other 
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external factors, such as day of illnesses, severity of diseases, it is believed that more 
consequential data can be generated. Subsequently, these data will provide insights 
on factors that contribute positivity (or negativity) of molecular tests for 
leptospirosis, melioidosis, salmonellosis and malaria. In addition, following 
molecular detection, conventional methods such as serological typing, or PCR may 
be required to further speciate Plasmodium and Salmonella. 
Absolute quantification of microorganism in blood is another area to be 
explored. As reported by other studies, level of bacteraemia and parasitaemia may 
influence severity and clinical outcomes of infected patients. Moreover, such data is 
important to be used to monitor treatment effectiveness or failure. Further validation 
of the developed assay for absolute quantification of Leptospira, B. pseudomallei, 
Salmonella and Plasmodium DNA in blood samples is favourably anticipated. 
Moreover, future study may also compare performance of molecular assays on 
different clinical specimens such as plasma, serum, buffy-coat to determine the most 
suitable samples for molecular assays. In other circumstances, presence of 
Leptospira in other specimens such as urine (after initial blood sample is PCR 
positive) can be used to project potential positive growth in artificial culture, which 
is valuable for epidemiological perspective.  
Another limitation lies on the TaqMan hydrolysis probe platform itself. A 
TaqMan hydrolysis probed-based assays validated in Bio-rad machines may not be 
used in Applied Biosystems machines or others‘, and vice versa. To enable 
implementation of the developed assay on other machines, further studies may be 
needed to re-optimise the assay (especially the probes compatibility). In addition, 
ones may also include effects of different PCR master mixes, different types of 
nucleic acid adapters and other PCR parameters on the performances of the assay. 
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Nonetheless, in its current form, this assay is relatively sensitive, able to detect 
between 5 and 20 copies of pathogens per reaction. 
Overall, this study successfully developed a multiplex TaqMan hydrolysis 
probe-based assay for simultaneous detection of Leptospira, B. pseudomallei, 
Salmonella and Plasmodium DNA with high sensitivity and specificity. Moreover, 
subsequent diagnostic evaluation suggested that this assay performed remarkably on 
the clinical specimens. 
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APPENDIX C: SAMPLE SIZE CALCULATIONS 
Retrospective sample size calculations (sensitivity test) 
According to the Buderer (1996); 
              
    
         )
  
     
Where,  
             = sample size for sensitivity test 
Z   = Z statistic corresponding to 95% confidence  = 1.96 
      = Assay sensitivity or specificity   = 0.98 
P  = Prevalence of disease 
Pleptospirosis  = 8.4% (Rafizah et al., 2013) 
Pmelioidosis  = 5% (Berger, 2018) 
Psalmonellosis = 7.4% (Brown et al., 1984)  
Pmalaria  = 6.2% (Berger, 2018) 
d   = precision       = 0.10 
 
For leptospirosis samples, 
   = Prevalence of disease (leptospirosis)  = 0.084 
                      
    
            )
     
           = 89.6 samples 
 
For melioidosis samples, 
   = Prevalence of disease (melioidosis)  = 0.05 
                     
    
            )
     
         = 150.6 samples 
 
For salmonellosis samples, 
   = Prevalence of disease (melioidosis)  = 0.074 
                     
    
            )
     
          = 101.8 samples 
 
For malaria samples, 
   = Prevalence of disease (melioidosis)  = 0.062 
                      
    
            )
     
          = 121.4 samples 
 
 
   
Retrospective sample size calculations (specificity test) 
According to the Buderer (1996); 
              
    
         )
  
      ) 
Where,  
             = sample size for specificity test 
Z   = Z statistic corresponding to 95% confidence  = 1.96 
      = Assay sensitivity or specificity   = 0.98 
   = Prevalence of disease 
 leptospirosis  = 8.4%  (Rafizah et al., 2013) 
 melioidosis  = 5%   (Berger, 2018) 
 salmonellosis = 7.4%  (Brown et al., 1984)  
 malaria  =  6.2%  (Berger, 2018) 
d   = precision       = 0.10 
 
For leptospirosis samples, 
   = Prevalence of disease (leptospirosis)  = 0.084 
                      
    
            )
     
          )   = 8.2 samples 
 
For melioidosis samples, 
   = Prevalence of disease (melioidosis)  = 0.05 
                      
    
            )
     
         )  = 7.9 samples 
 
For salmonellosis samples, 
   = Prevalence of disease (melioidosis)  = 0.074 
                     
    
            )
     
          )  = 8.1 samples 
 
For malaria samples, 
   = Prevalence of disease (melioidosis)  = 0.062 
                     
    
            )
     
          )  = 8.0 samples 
 
 
  
   
For sensitivity and specificity testing using retrospective clinical samples, the 
larger number between              and              was selected. In general, 
            was larger than the             , hence was selected as minimum number 
of samples to be collected. Summary of samples required for retrospective clinical 
samples evaluation was listed in the following table. 
Table ‎A1  Summary of samples required for clinical validation 
Cases nsensitivity nspecificity 
nrequired 
(including drop-out) 
Leptospirosis 90 8 100 
Melioidosis 151 8 168 
Salmonellosis 102 8 114 
Malaria 121 8 136 
  
   
Prospective sample size calculation 
  
       )
  
, where  
n = sample size 
Z = Z statistic corresponding to 95% confidence  = 1.96 
P = expected prevalence     = 0.084 (Rafizah et al., 2013) 
d = precision       = 0.05 
⸫ No. of samples,   
                  )
     
   = 118 samples 
  
   
APPENDIX D: ROLES OF UNIVERSAL ADAPTER AND UNIVERSAL 
PRIMER DURING AMPLIFICATION 
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Detection of B. pseudomallei DNA among febrile patients presenting to 
tertiary hospi tals in north eastern Malaysia 
MRMAii 1,2, NManingl, CYYean1.• 
Introd uction 
Melioidosis, caused by Burkholderiapseudomallei, is an important infection, endemic to many 
tropical regions including South East Asia and northern Australia. In Malaysia, it is estimated 
that 19% of melioidosis patients died within the first 48 hours of admission, due to septic shock. 
Early detection plays an essential role in patients prognosis but clinical diagnosis of melioidosis 
is difficult, as other tropical infections, such as leptospirosis, dengue and scrub typhus also 
portray similar disease manifestations. A better detection method is therefore urgently needed to 
allow timely diagnosis and accurate treatment for melioidosis. Our study aimed to evaluate the 
performance of qPCR for the detection of B. pseudomallei among febrile patients who presented 
to healthcare facilities in north eastern Malaysia. 
Methods 
A total of 108 blood samples from febrile patients were collected between April 2016 and May 
2017 from Hospital Saios Malaysia, Hospital Raja Perempuan Zainab II and Kota Bharn Public 
Health Laboratory, Malaysia. Genomic DNA were extracted and analysed using real time qPCR 
to detect the presence of B. pseudomallei. Subsequent cl inical data, including related 
microbiological investigation results of patients with positive assay were retrieved to confirm the 
molecular findings. 
Results 
Three samples (2.8%, n = 3/1 08) were found to have detectable B. pseudomalleiDNA. Parallel 
laboratory investigations revealed that these 3 patients had positive blood cultures. B. 
pseudomallei were isolated in two samples. Meanwhile, the other patient's blood culture grew 
multiple organisms; Klebsiella ozanae and K. o:rytoca. Upon retrieval of extensive clinical data, 
the qPCR-pos·itive, culture-negative patient was reported to have liver abscesses and underlying 
diabetes mellitus type II. This scenario is possible as conventional culmre methods have limited 
sensitivity (-60%). Therefore, multiple sampling and radiological investigation are 
recommended in patients with suspected melioidosis. We also found that two of the melioidosis 
patients also had simultaneous leptospirosis, based on the concun-ent leptospiral investigations. 
Discussion and Conclusions 
This sntdy provides preliminary data in favour of utilisation of qPCR as a sensitive screening 
tool for melioidosis diagnosis in laboratories of tertiary hospitals in Malaysia, and other endemic 
regions. Moreover, it also highlights the possibilities of misdiagnosis of 
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Introduction 
Melioidosis. caused by Burkholderia pseudomallei, is an important infection, endemic to man~· 
tropical regions including South East Asia and northern Australia. In Malaysia, it is estimated 
that 19% of melioidosis patients died within the first 48 hours of admission, due to septic 
shock. Early detection plays an essential role in patients prognosis but clinical diagnosis ol 
melioidosis is difficult, as other tropical infections, such as leptospirosis, dengue and scrub 
typhus also portray similar disease manifestations. A better detection method is therefor<-
urgently needed to allow timely diagnosis and accurate treatment for melioidosis. Our stud\ 
aimed to evaluate the performance of qPCR for the detection of B. pseudomallei among febril• 
patients who presented to healthcare facilities in north eastern Malaysia. 
Methods 
A tota l of lOB blood samples from febrile patients were collected between April 2016 and May 
2017 from Hospital Sa ins, Malaysia, Hospital Raja Perempuan Zainab II and Kota Bharu Public 
Health Laboratory, Malaysia. Genomic DNA were extracted and analysed using real time qPCR 
to detect the presence of B. pseudomallei. Subsequent clinical data, including related 
microbiological investigation results of patients with positive assay were retrieved to confirm 
the molecular findings. 
Results 
Three samples (2.8%, n = 3/1 08) were found to have detectable B. pseudomallei ONA. Para lie 
laboratory investigations revealed that these 3 patients had positive blood cultures. B 
pseudomallei were isolated in two samples. Meanwhile, the other patient's blood culture grew 
multiple organisms; Klebsiella ozanae and K. oxytoca. Upon retrieval of extensive clin ical data. 
the qPCR-positive, culture-negative patient was reported to have liver abscesses and under-
lying diabetes mellitus type II. This scenar io is possible as conventional culture methods have 
limited sensitivity ( -60%). Therefore, multiple sampling and radiological investigation are 
recommended in patients with suspected melioidosis. We also found that two of the 
melioidosis patients also had simultaneous leptospirosis, based on the concurrent leptospiral 
investigations. 
Discussion and Conclusions 
This study provides preliminary data in favour of utilisation of qPCR as a sensitive screening 
tool for melioidosis diagnosis in laboratories of tertiary hospitals in Malaysia, and other 
endemic regions. Moreover, it also highlights the possibilities of misdiagnosis of melioidosis 
/ leptospirosis, in theeventwhenonlyasingle laboratory test is available or requested. 
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